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Worcester Polytechnic Institute 
Abstract 
THE DESIGN AND DEVELOPMENT OF A 
DIRECT AND CONTINUOUS SENSOR FOR 
THE MEASUREMENT OF INHALED NITRIC 
OXIDE CONCENTRATIONS 
 
by Bhairavi R. Parikh 
Chairperson of the Supervisory Committee:  Professor Robert A. Peura 
Department of Biomedical Engineering 
Gaseous nitric oxide, in concentrations between 0 and 20 ppm, is currently being used to 
treat patients with post-surgical complications and respiratory disorders.  Currently 
available instruments are expensive and have problems that limit their usefulness for this 
application.  This thesis discusses the development of an inexpensive, direct and 
continuous sensor for the measurement of inhaled nitric oxide. 
 
The prototype sensor incorporates a 0.125 cm, gas permeable, flow-thru liquid cell into a 
probe that can be incorporated into a ventilator circuit.  Sensor operation is based on the 
complexation reaction of NO with cytochrome-c (Fe III), a biologically derived heme.  
The complex is monitored spectrophotometrically in the visible region of the spectrum at 
563 nm by an optical spectrograph card.  LabVIEW is used for all hardware control, 
signal acquisition, data processing, display and storage.  The sensor has a sensitivity of 
2x10-4 Abs/ppm, where Abs denotes absorbance units, a minimum detectable limit of 1.5 
ppm, resolution of 0.5 ppm, is stable over the course of 8 hours, has less than 1 ppm error 
and a response time of less than 2 minutes.  All aspects of sensor design and development 
will be discussed.  
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GLOSSARY 
 
absorption spectra  A continuous recording of absorbance vs. wavelength.  Absorbance is defined as the 
negative Log of the transmitance.  Transmitance is the ratio of the transmitted light beam to the incident 
light beam. 
acute pulmonary embolism  Intense and sudden blocking of a pulmonary artery by a clot or foreign 
material which has been brought to its site of lodgment by the blood current. 
adhesion  The stable joining of parts to each other, which may occur abnormally. 
adult respiratory distress syndrome  A clinical syndrome that includes pulmonary insufficiency. ARDS is 
a descriptive term that is applied to a variety of diffuse infiltrative processes in the lung. Manifestations 
include severe shortness of breath, rapid breathing and arterial hypoxaemia (low oxygen). Chest X-ray 
shows bilateral diffuse infiltrates. Treatment most often includes mechanical respiratory support. Causes 
include toxic gas (chlorine, NO2, smoke) exposure, severe metabolic derangement, gastric acid aspiration, 
pancreatitis, sepsis and trauma. 
aggregation  Massing of materials together as in clumping. 
alveoli  Small outpouchings along the walls of the alveolar sacs and ducts through the walls of which gas 
exchange takes place between alveolar gas and pulmonary capillary blood, where alveolar refers to a 
general term used to deignate a small saclike dilitation. 
anionic ligand  A negatively-charged ion that binds to another molecule. 
antibonding p orbital The second to lowest energy level in a given shell.  When molecular orbitals are 
higher in energy state than the original atomic orbitals they are called antibonding molecular orbitals and 
are filled after the bonding molecular orbitals. 
antibonding π orbitals  Localized molecular orbitals that have a nodal plane n the plane of the molecule. 
When molecular orbitals are higher in energy state than the original atomic orbitals they are called 
antibonding molecular orbitals and are filled after the bonding molecular orbitals. 
arterial hypoxemia  Below-normal oxygen content in arterial blood due to deficient oxygenation of the 
blood and resulting in hypoxia, which is defined as the reduction of oxygen in body tissues below 
physiologic levels. 
 
congential diaphragmatic hernia  Condition present at birth where there is abnormal protrusion of 
abdominal contents upward through a defect in the diaphragm. This condition is treated as a surgical 
emergency due to interference with the infant's breathing. Smaller, less serious diaphragmatic hernias 
may also be seen in adults. 
cytochrome-c  A type of cytochrome, a protein which carries electrons, that is central to the process of 
respiration in mitochondria (an organelle found in eukaryotes which produces energy). 
 
diffusion  The process of becoming diffused or widely spread, the spontaneous movement of molecules or 
other particles in solution, owing to their random thermal motion, to reach a uniform concentration 
throughout the solvent, a process requiring no addition of energy to the system. 
dilate  To grow wide; to expand; to swell or extend in all directions. 
d-orbital electron An electron in the third energy level in any given shell.  s denotes the lowest energy 
level, p the next energy level, d is the third and f is the fourth in increasing order. 
 
electrostatic interaction  The interaction between atoms due to the force between them.  The force is 
generated between charged objects and is proportional to the electric charge. 
extrapulmonary right to left shunting    diversion of blood  from the pulmonary to the system circulation 
through an anomalous opening. 
 
hemoglobin  Four subunit globular oxygen carrying protein.  There are two alpha and two beta chains in 
adult humans, the haem moiety (an iron containing substituted porphyrin) is firmly held in a nonpolar 
crevice in each peptide chain.  Hemoglobin is the oxygen carrying protein found in blood.  Since it has a 
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higher affinity for NO than for O2 or for CO (carbon monoxide), hemoglobin will preferentially and 
instantaneously bind NO.  Thus, upon introduction of NO into the blood stream, it is rapidly taken up and 
inactivated by hemoglobin. 
hexa-coordinated  A molecule where the ligand has 6 bonds to a metal atom. 
hypercholesterolemia  Abnormally high concentrations of cholesterol are present in the bloodstream.This 
can lead to heart disease, hardening of the arteries, heart attacks, and strokes. 
hypertension  Persistently high arterial blood pressure 
hypoxemia  Below-normal oxygen content in arterial blood due to deficient oxygenation of the blood and 
resulting in hypoxia. 
 
intravenous  Within a vein or veins. 
iron porphyrin ring  Iron porphyrins are pigments, which are all chelates with iron and are constituents 
of haemoglobins and cytochromes. 
ischemic  Affected by ischemia which is a low oxygen state usually due to obstruction of the arterial blood 
supply or inadequate blood flow leading to hypoxia in the tissue. 
 
ligand  Any molecule that binds to another. 
 
mass spectrometers  Mass spectrometers use the difference in mass-to-charge ratio (m/e) of ionized 
atoms or molecules to separate them from each other. Mass spectrometry is therefore useful for 
quantitation of atoms or molecules and also for determining chemical and structural information about 
molecules. Molecules have distinctive fragmentation patterns that provide structural information to 
identify structural component.  The general operation of a mass spectrometer is to create gas-phase ions, 
then separate the ions in space or time based on their mass-to-charge ratio and finally measure the 
quantity of ions of each mass-to-charge ratio. 
methemoglobin  Hemoglobin in a form incapable of carrying oxygen where the iron is in the 3+ state 
(hemoglobin Fe III). 
myoglobin  Protein found in red skeletal muscle.  It is a single polypeptide chain of 153 amino acids, 
containing a haem group bonded via its ferric iron to two histidine residues. It binds oxygen 
noncooperatively and has a higher affinity for oxygen than haemoglobin at all partial pressures. In 
capillaries oxygen is effectively removed from haemoglobin and diffuses into muscle fibres where it binds 
to myoglobin which acts as an oxygen store. 
 
neuronal network  A network of neurons. 
neurons innervate  The distribution or supply of nerves to a part. 
neurotransmission  Passage of signals from one nerve cell to another via chemical substances or 
electrical signals. 
neurotransmitter  Any of a group of substances that are released on excitation from the axon terminal of 
a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to 
either excite or inhibit the target cell. 
neutral gaseous ligand  Any neutral gaseous molecule that binds to another 
nitrovasodilators  A class of agents are metabolized to nitric oxide (NO) which acts as a potent local 
vasodilator. 
no synthase Nitric oxide synthase (NOS) is an enzyme that produces NO from substrates. 
non-bonding orbitals  A molecular orbital derived only from an atomic orbital of one atom; lends neither 
stability nor instability to a molecule or ion when populated with electrons. 
norepinephrine Norepinephrine, a catecholamine based upon it's chemical structure, 
 is a potent stimulant to constriction of arteries, raising blood pressure, and 
 redistributing blood flow to essential organs, the brain, heart, and the skeletal 
 muscles. It has a smaller effect on blood sugar, and on increasing the heart rate. 
 This set of responses has been called the "fight, or flight" response. 
 
orbital  A function that describes the distribution of an electron in an atom or molecule.  It may be 
considered to be the region of space occupied by a single electron or by two electrons of opposite spin.  
The pauli exclusion principle states that only two electrons can be described by the same orbital and these 
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two electrons must have opposite spin.  thus electrons with the same spin keep apart in space whereas 
electrons of opposite spin may occupy the same region in space. 
ozone  A colorless gaseous substance (O3) as an allotropic form of oxygen, containing three atoms in the 
molecule. It is a strong oxidizer, and probably exists in the air. 
 
peristaltic  Applied to the peculiar worm-like wave motion of the intestines and other similar structures, 
produced by the successive contraction of the muscular fibers of their walls, forcing their contents 
onwards. 
persistent pulmonary hypertension Persistently high pulmonary arterial blood pressure 
PGI2 (Prostaglandin I2)  Synthesized by endothelial cells lining the cardiovascular system; it is the most 
potent known inhibitor of platelet aggregation and a powerful vasodilator and thus a physiologic 
antagonist of thromboxane A2.. 
photomultiplier tube  Photomultiplier Tubes (PMTS) are light detectors that are useful in low intensity 
applications such as fluorescence spectroscopy. Due to high internal gain, PMTs are very sensitive 
detectors.  PMTs are similar to phototubes. They consist of a photocathode and a series of dynodes in an 
evacuated glass enclosure. Photons that strikes the photoemissive cathode emits electrons due to the 
photoelectric effect. Instead of collecting these few electrons (there should not be a lot, since the primary 
use for the PMT is for very low signal) at an anode like in the phototubes, the electrons are accelerated 
towards a series of additional electrodes called dynodes.  These electrodes are each maintained at a more 
positive potential. Additional electrons are generated at each dynode. This cascading effect creates 105 to 
107 electrons for each photon hitting the first cathode depending on the number of dynodes and the 
accelerating voltage. This amplified signal is finally collected at the anode where it can be measured. 
polar  Describes a molecule that has a permanent electric dipole. A dipole is a  molecule that has both 
negative and positive charges. 
prostaglandin E1 (PG E1)  Potent vasodilator and inhibitor of platelet aggregation. 
prostaglandins  Any of a group of components derived from fatty acids.  The abbreviation for 
prostaglandin is PG, specific compounds are designated by adding one of the letters A through I to 
indicate the type of substituents found on the hydrocarbon skeleton and a subscript (1, 2 or 3) to indicate 
the number of double bonds in the hydrocarbon skeleton. All of the prostaglandins act by binding to 
specific cell surface receptors causing an increase in the level of the intracellular second messenger cyclic 
AMP (and in some cases cyclic GMP also). The effect produced by the cyclic AMP increase depends on 
the specific cell type. In some cases there is also a positive feedback effect where increased cyclic AMP 
increases prostaglandin synthesis leading to further increases in cyclic AMP.  
pulmonary circulation  Movement in a regular or circuitous course, as the movement of the blood 
through the pulmonary blood vessels. 
pulmonary shunting  Diversion of blood from injured or unventilated areas of the lung to areas where 
oxygenation is better. 
pulmonary vascular resistance An expression of the resistance offered by the pulmonary arterioles, and 
to a lesser extent by the capillaries, to the flow of blood. 
pulmonary vasculature  Pulmonary blood vessel architecture. 
pyrrole nitrogens  Heme is made up of a protoporphyrin IX and an iron atom which is found at the center 
of the molecule. Protoporphyrin is composed of four 5-membered pyrroles, or heterocyclic rings, which 
are fused together to form a tetrapyrrole. Fe2+ is held at the center of the molecule via the four pyrrole 
nitrogen atoms shown here. 
 
redox state  The oxidation state of the molecule. 
reduce  To bring to the metallic state by separating from impurities; hence, in general, to remove oxygen 
from; to deoxidize; to combine with, or to subject to the action of, hydrogen; as, ferric iron is reduced to 
ferrous iron; or metals are reduced from their ores; opposed to oxidize. 
reperfusion injury  Reperfusion is the delivery of blood flow to areas that previously had either 
compromised or no blood flow.  Reperfusion injury refers to functional, metabolic, or structural changes, 
including necrosis, in ischemic tissues thought to result from reperfusion to ischemic areas of the tissue. 
The most common instance is myocardial reperfusion injury. 
right ventricular dysfunction  Disturbance, impairment or abnormality of the functioning of the right 
ventricle of the heart. 
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right ventricular failure  A weakening of the right ventricle that results in the back up of blood in the 
venous system, liver, gastrointestinal tract and extremities. The causes of this condition include left-sided 
congestive heart failure, emphysema, valvular heart disease, cardiomyopathy, anaemia, hyperthyroidism, 
cor pulmonale and congenital heart disease. Risk factors include diabetes, alcoholism, obesity and 
smoking. 
 
septic shock  Condition of clinical shock caused by endotoxin in the blood.  Shock is a condition of 
profound hemodynamic and metabolic disturbance characterized by failure of the circulatory system to 
maintain adequate perfusion of vital organs, it may result from inadequate vasomotor tone. 
sp hybridization  Combination of 2s and 2p orbitals to produce a new orbital.  The 2 denotes the shell 
number and represents the distance from the nucleus. 
systemic arterial hypoxemia  Below-normal oxygen content in systemic arterial blood due to deficient 
oxygenation of the blood and resulting in hypoxia.  Hypoxia is the reduction of oxygen supply to tissue 
below physiological levels despite adequate perfusion of the tissue by blood. 
systemic hypoxemia  Same as above. 
systemic vascular resistance  An expression of the resistance offered by the systemic arterioles, and to a 
lesser extent by the capillaries, to the flow of blood. 
systemically  Pertaining to or affecting the body as a whole. 
 
transient graft dysfunction  Disturbance, impairment or abnormality of the functioning of a graft. 
 
vascular endothelium  The layer of epithelial cells that lines the cavities the blood vessel, originating 
from the mesoderm. 
vascular resistance  An expression of the resistance offered by the systemic arterioles, and to a lesser 
extent by the capillaries, to the flow of blood. 
vasodilator   Causing dilation or relaxation of the blood vessels. 
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C h a p t e r  1  
1. INTRODUCTION – PROBLEM IDENTIFICATION 
Nitric oxide (NO) is a simple gaseous compound which plays an important role in a 
number of physiological processes including neurotransmission, immune system 
mediation and blood pressure regulation (Feldman, 1993).  Interest in NO mainly stems 
from its role as a potent local vasodilator, prompting its therapeutic use as an inhaled 
agent to selectively dilate the pulmonary vasculature (Pearl, 1993).  It is currently being 
used to treat post surgical patients and patients with respiratory disorders.  Although NO 
has proven to be an extremely useful therapeutic agent, excessive levels of NO can be 
detrimental to the patient.  Thus, to achieve the best therapeutic effects, levels of NO 
must be monitored accurately and continuously over the entire course of treatment.  
Available instruments for the measurement of NO, including chemiluminescence 
analyzers, mass spectrometers and electrochemical sensors, have a number of problems 
that limit their usefulness for this application.  Thus, the development of a direct and 
continuous sensor for the measurement of inhaled nitric oxide to evaluate the safe 
administration of inhaled NO for therapeutic uses would be both clinically and 
scientifically justified, as well as required.  
1.1 Nitric Oxide Physiology 
Nitric oxide plays numerous roles in physiological processes including 
neurotransmission, immune system mediation and vasodilation.  NO’s role as a 
neurotransmitter is best shown by its roles in digestion and penile erection.  In erection, 
electrical stimulation of the neurons that innervate the penis causes NO mediated 
relaxation of the smooth muscle.  This allows increased blood flow and erection.  In 
digestion, NO synthase (NOs) occurs in the neuronal network of the gastrointestinal 
tract.  Here, NO release mediates the relaxation of the gut, which is part of the normal 
peristaltic activity of digestion (Koshland, 1992). 
 
NO, synthesized by the vascular endothelium, mediates blood pressure by diffusing into 
blood vessels and the underlying smooth muscle and decreasing vascular resistance.  
This type of molecule is termed a vasodilator as it opens up the blood vessels.  Because 
NO is a potent local vasodilator in-vivo, there has been marked interest in NO as a 
therapeutic local vasodilatory agent.  If NO is delivered as an inhaled agent, it will 
selectively dilate the vessels in the lungs, but not throughout the rest of the body.   
 
NO plays an important role in a number of physiological conditions because of this role.  
For example, in ischemic diseases such as hypercholesterolemia, hypertension and 
reperfusion injury, NO release is either suppressed or it is immediately inactivated by 
hemoglobin.  This results in reduced vasodilation, inadequate blood supply and ischemia.  
Coronary artery disease is marked by either decreased NO production or increased 
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inactivation of NO by hemoglobin.  Here, nitrovasodilators, ultimately transformed into 
NO, are used as therapy.  
1.2 Nitric Oxide Based Therapies  
Stemming from its role as a local vasodilator, there is profound interest in NO as a 
therapeutic agent.  If given systemically, NO would be rapidly inactivated by circulating 
hemoglobin, thereby rendering it useless and motivating its therapeutic use as an inhaled 
agent.  As an inhaled agent it is delivered directly to the pulmonary vasculature through 
the alveoli, where it causes local pulmonary vasodilation.  Any NO that diffuses into the 
systemic vasculature will be inactivated before it can produce any systemic effect.  In 
addition, because it is inhaled, NO is delivered preferentially to well-ventilated areas of 
the lung.  Vasodilation of the well-ventilated areas results in blood being diverted to these 
areas where oxygenation is better.  Blood flow to injured or unventilated areas of the lung 
is undesirable because it gets compromised oxygenation.  Since blood flow is stolen from 
injured or unventilated regions of the lung, the ventilation-perfusion ratio is increased and 
pulmonary shunting is reduced.  Thus, NO reduces pulmonary hypertension and 
augments arterial oxygenation without reducing systemic blood pressure (Kavanaugh and 
Pearl, 1995). 
 
Because of NO’s role as a potent local pulmonary vasodilator, it is being investigated and 
used as a therapeutic agent for a number of conditions which were previously treated 
using vasodilators which also affected the systemic vasculature.  Following adult cardiac 
surgery, patients can have an elevated pulmonary vascular resistance (PVR) resulting 
in right ventricular dysfunction and right ventricular failure.  Therapy for this 
condition is unsuitable because intravenous vasodilators are not selective for the 
pulmonary circulation, resulting in a decrease in mean arterial pressure (MAP) and 
further exacerbating right ventricular dysfunction.  In the past, intravenous 
prostaglandin E1 was used to dilate the pulmonary vasculature and norepinephrine was 
used to selectively constrict the systemic vasculature.  NO will selectively dilate the 
pulmonary vasculature, alleviating the necessity for counter measures.  Several other 
surgical procedures and physiological conditions are characterized by the same symptoms 
and can be effectively treated with inhaled nitric oxide therapy.  These include orthoptic 
heart transplantation, lung transplantation, acute pulmonary embolism and adult 
respiratory distress syndrome. 
 
Since NO selectively reduces pulmonary blood pressure without affecting systemic 
arterial pressure, it is being delivered to patients as an inhaled agent through a modified 
ventilator circuit.  High concentrations of inhaled NO can be toxic to the patient through 
the production of NO2 (resulting in pulmonary edema) and/or methemoglobin 
(compromising the ability of the blood to carry oxygen).  Thus concentrations must be 
monitored accurately and continuously throughout the course of treatment.  Currently 
available techniques are not suitable for this application due to size, cost, response time 
and accuracy constraints. 
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1.3 NO Toxicity 
Because of NO’s high affinity for hemoglobin, the rate of uptake in the lung for 
concentrations of NO less than 100 ppm is faster than the oxidation rate.  Thus NO can be 
inhaled safely in concentrations less than 100 ppm (Higenbottam, 1993).  However, 
excessive levels of NO can be detrimental to the patient.  NO can combine with oxygen 
(O2) to form nitrogen dioxide (NO2) (Kavanagh and Pearl, 1995), where levels of 5 ppm 
for short term exposure as a time weighted average or 3 ppm as a time-weighted average 
(TWA) over 8 hours are considered toxic (Tibballs et al., 1993).  NO2 exposure results in 
pulmonary edema and damage to the pulmonary epithelium (Tibballs et al., 1993).  To 
put it into perspective, a 20 ppm mixture of NO/N2 with 98-100% O2 for 5-12 minutes 
produces a toxic amount of NO2 (Tibballs et al., 1993).  NO also combines with 
circulating hemoglobin to produce methemoglobin (Tibballs et al., 1993), which in 
excess compromises the ability of blood to carry oxygen.  NO levels greater than 25 ppm 
(TWA over 8 hours) and 100 ppm immediate exposure are considered toxic to the host 
(Tibballs et al., 1993).   
 
Because high levels of NO are detrimental to the patient, to achieve therapeutic effects, 
its concentration must be maintained within a certain window.  To achieve this, it is 
important to measure concentrations of inhaled NO being delivered to the patient through 
a ventilator circuit, accurately and continuously.  Ideally, gaseous NO would be 
quantified just prior to the patient inlet.  There are techniques available for this 
application, but they have problems which limit their usefulness, as explained in the next 
section. 
1.4 Current NO Measurement Techniques 
There are a number of methods currently available for the measurement of gaseous NO.  
Chemiluminescence is the gold standard for the measurement of gaseous NO.  It is 
initiated by the reaction of NO with ozone.  Chemiluminescence analyzers are very 
expensive and have complex maintenance requirements - they are not economically 
feasible. 
 
Mass spectrometers can also be used to measure concentrations of gaseous NO both 
directly and indirectly.  This technique does not have an adequate response time for the 
desired application.  Mass spectrometers are both cumbersome and expensive. 
 
Electrochemical probes are available for the detection of gaseous NO.  The Sensor Stik 
(Model 4586, Exidyne Instrumentation Technologies. Exton, PA) requires 4 – 6 hours 
long stabilization and calibration.  The Drager model (PAC 11, Drager AG. Lubeck, 
Germany) does not require calibration and stabilization.  Both monitors follow positive 
changes in NO concentration efficiently, however, they have long time constants for 
abrupt negative changes in NO concentration.  Neither model is sensitive enough to 
measure low dose NO concentrations (Strauss et al., 1996).  The PrinterNOx is an 
electrochemical sensor available from Micro Medical Devices, Inc.  This provides 
simultaneous measurement of NO and NO2 concentrations.  For NO the response range is 
0 to 100 ppm, with a 0.05 ppm resolution and response time of less than 10 seconds.  The 
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MicroGas, also made by Micro Medical Devices is a small digital meter designed to 
monitor concentrations of one gas.  It can detect up to 100 ppm NO with a sensitivity of 
0.1 ppm and a response time of less than 30 seconds.   
  
Another method  for measuring NO from intact tissues and cells relies on the fact that 
metalloporphyrins catalyze the oxidation of NO, generating electrical current.  This 
technique requires a sample in the liquid phase, demanding conversion of gaseous NO 
into a liquid, which ultimately reduces response time (Malinski, 1992). 
1.5 Summary 
Gaseous nitric oxide, in concentrations between 0 and 20 ppm, is currently being used to 
treat patients with post-surgical complications and respiratory disorders.  High levels of 
NO result in the production of methemoglobin and NO2, both being toxic to the host 
system.  Currently available instruments for the measurement of inhaled NO, at the 
patient inlet of a ventilator circuit, are expensive and/or have problems that limit their 
usefulness in clinical applications.  Thus, the development of an inexpensive, direct and 
continuous sensor for the measurement of inhaled nitric oxide would be beneficial in 
order to enable controlled delivery of optimal NO concentrations and to alleviate 
possibilities of over-administration of NO. 
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C h a p t e r  2  
2. SPECIFIC AIMS 
The long term goal of this project is to design and develop a clinical sensor for the 
measurement of inhaled nitric oxide in concentrations relevant to a clinical setting.   
 
The goal of the present research is to design and develop a prototype sensor for the 
measurement of inhaled nitric oxide in concentrations relevant to a clinical setting.  The 
goal of this project is different from the long term goal in that it is intended to develop a 
bench-top spectrophotometer based instrument to prove feasibility of the proposed 
method.  The development of a smaller, LED-based instrument that meets clinical and 
patient safety requirements, and that is manufacturable and stable through the process is 
left for future work. 
 
This work encompasses the identification of materials with the highest sensitivity to nitric 
oxide and incorporation of the chosen compound into a sensing element.  The integration 
of the sensing element into a sensor that samples gas from a ventilator circuit is the next 
step.  Building of a system to sample the gas, make it react with the sensing element and 
subsequently acquire, process, store and display the processed signal, is the following 
step.  Developing equations to relate sensor design features to sensor performance and 
evaluate the credibility of the sensor follow.  The final step completing the research is 
sensor testing to evaluate sensitivity, selectivity, response time, stability and accuracy and 
precision.  In further detail, the specific aims are listed below. 
 
Aim I:  Selection of Nitric Oxide Sensitive Compounds 
 
•= Identify compounds whose optical properties change as a function of nitric oxide 
concentration.  The chosen compounds have to be evaluated for sensitivity to NO and 
specificity for NO in the presence of oxygen. 
•= Determine the reversibility of the sensing compounds reaction with nitric oxide to 
identify potential sensor configuration. 
 
Aim II:  Design and Develop a Nitric Oxide Sensor 
 
•= Design a physical sensor. 
•= Determine if the sensing compound can be immobilized in a polymer matrix to 
produce a solid phase sensor. 
•= Determine if a flow-through liquid phase system can be developed in the absence 
of an appropriate immobilizing agent. 
•= Design hardware necessary to implement the chosen physical sensor design. 
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•= Design software drivers for all hardware components, ensure timely sensor operation, 
collect and process signals, as well as store, display and process data.   
•= Design – develop the required signal processing routines, including sample averaging 
and integration, to maximize sensitivity without sacrificing response time. 
•= Optimize SNR through signal filtering and time-based averaging methods.   
 
Aim III:  Development of Mathematical Model and Calibration Equations 
 
•= Develop the mathematical/physical/computer models that relate NO sensitivity to 
factors that are controlled by instrument design.   
•= Develop calibration methods to relate the measured optical properties of the sensing 
compound to the acquired signal.  
 
Aim IV:  System Testing 
 
•= Testing the sensor for five parameters:   
sensitivity to nitric oxide; 
specificity for NO in the presence of oxygen; 
response time; 
stability of the sensor over an 8 hour period; and, 
accuracy and precision. 
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C h a p t e r  3  
3. HYPOTHESES AND RESEARCH APPROACH 
The main hypotheses of this research are as follows. 
 
1. A nitric oxide sensitive compound, which for the clinically relevant concentration 
range, provides a spectrophotometrically monitorable reaction in the visible region 
of the spectrum, exists and can be identified. 
 
Compared to the existing technologies, the advantages of using an optical system, 
based on a color change in the visible region of the spectrum, to measure inhaled 
NO concentrations would include low cost, substantially reduced size and a fast 
response time.  Such a sensing mechanism based on the selective complexation of 
a chromophoric compound with NO, would result in a color change in the visible 
region of the spectrum.  Previous research has identified a number of compounds 
which are sensitive to nitric oxide that produce a spectrophotometrically 
observable and reversible reaction in the visible region of the spectrum.  These 
include biologically active hemes, tetraphenyl porphyrin compounds, Fe(II)EDTA 
and Iron(III)Chloride. 
 
The hypothesis will be tested by conducting bench-top experiments with the 
liquid phase sensing compound and nitric oxide using a PC-based 
spectrophotometer system.  All data collection, processing and storage will be 
implemented in LabVIEW.  Compounds will be evaluated for sensitivity to nitric 
oxide and specificity in the presence of oxygen. 
 
2. The chosen compound can be incorporated into a sensing element and still retain its 
reactivity. 
 
The most economical and practical sensor should immobilize the sensing 
compound in a polymer matrix.  To this date, research has not been conducted to 
determine the reactivity of the compounds indicated above to nitric oxide in an 
immobilized state.  The purpose of this research step is to determine the 
immobilizing agent and configuration which will produce a sensor that retains the 
reactivity of the sensing compound in the immobilized state.  Experiments will be 
conducted by flowing gaseous nitric oxide through and across the sensing element 
held within a specially designed chamber.  Configurations will be evaluated solely 
for reactivity. 
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3. The chosen sensing compound can be incorporated into a sensing element in a 
configuration that delivers the clinically required and acceptable sensor 
specifications.   
 
Ideal specifications for the sensor are as follows. 
 
Parameter Specification 
Sensitivity 0.01 Abs/ppm  
(Absorbance units/ppm) 
Minimum detectable limit 0.1 ppm 
Specificity In the presence of oxygen 
levels between 0 and 100% 
Response time <3 seconds 
Stability Within 5% over 8 hours 
Accuracy ±5 % 
Resolution 0.025 ppm 
 
If the sensing compound can be immobilized, it needs to be configured in such a 
manner that the sensor specification requirements are met.  Various modifications 
of the working configurations will be explored to this end. 
 
If the immobilized configuration cannot be used to deliver the necessary sensor 
specifications, a flow-thru liquid system will be explored.  The bench-top 
experiments will be transferred to an alternate configuration which meets the 
goals outlined in the sensor specifications. 
 
4. A unique and constant, sensitive and specific mathematical relationship can be found 
between nitric oxide concentration and the spectrophotometrically measured signal 
of the sensing element. 
 
Based on the nature of the chosen sensing element, a mathematical model will be 
developed to provide guidance in the optimization of sensor performance.  The 
models will be developed for the evaluation of sensitivity, response time and response 
range by variation of system pressure, heme concentration, path length, flow rate and 
flow time.  Data obtained with the completed sensor over a range of NO 
concentrations will be used to determine the relationship between nitric oxide and the 
received optical signal in order to determine calibration techniques and equations. 
 
Figure 3.1 gives a schematic representation of the approach to this research.  The flow 
chart incorporates the four main goals, as outlined in the specific aims:  identification of a 
nitric oxide sensitive compound, design and development of a sensor based on the 
selected sensing compound, development of a mathematical model and sensor calibration 
techniques, and finally, system testing. 
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Figure 3.1  Flow chart depicting the research  
 
Sensor design starts with the identification of compounds whose optical properties 
change as a function of nitric oxide concentration.  Compounds will be chosen on the 
basis of their sensitivity to NO, monitorability of the reaction in the visible region of the 
spectrum and reversibility of their reaction with NO.  All compounds will be evaluated in 
solution by reaction with NO to select the one that is most sensitive to NO and to identify 
relative absorption bands.  Because sensitivity to oxygen is an important parameter, all 
compounds will be evaluated for specificity in the presence of varying oxygen 
concentrations if sensitivity requirements are met. 
Solid Phase Sensor Design-Immobilization Flow-thru Liquid Phase Sensor Design
System Testing
Design of the Calibration Protocol
Mathematical Modeling
Design of the Data Processing Algorithms
Design of Software drivers
Determination of Reversibility of NO Sensitive Compounds
Yes:  Reusable Sensing Element (Photolysis)
No:  Replenishable Sensing Element
Identification of Nitric Oxide Sensitive Compound
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Subsequent to identification of sensor materials, the reversibility of the sensing 
compounds reaction with nitric oxide will be evaluated to determine sensor configuration.  
The most economical sensor will employ a sensing element whose reaction can be 
reversed and the sensor reused.  If the sensing compounds reaction with NO is reversible, 
this greatly reduces the amount of sensing material necessary to run the sensor over a 
long period of time.  In addition, it minimizes the number of electro-mechanical parts 
necessary for sensor operation.  If the reaction is not reversible then a sensing element 
with a long lifetime or a replenishable sensing element will have to be devised.  Thus, 
this phase of the research will focus on the photo-reversibility of the chosen sensing 
compound’s reaction with nitric oxide.  Compounds will be evaluated based on the 
regeneration of the starting compound and the concentration and quality of the 
regenerated compound. 
 
The next set of experiments will be conducted to evaluate the physical sensor design.  
Solid sensor design will be evaluated first since it would produce the most stable system 
and would minimize mechano-electrical system components.  The polymer matrix will be 
chosen based on its transparency in the wavelength region of interest and its permeability 
to nitric oxide.  Subsequent to selecting an appropriate polymer, various configurations 
will be evaluated to maximize sensitivity.  The assembly will be configured into a 
sensing element to maximize sensitivity without overly sacrificing sensor response time. 
 
Flow-thru cell systems will be evaluated as an option to solid phase systems in order to 
maximize sensitivity and reversibility options.  The sensor will be designed to 
incorporate a thin film of the sensing element solution into a chamber that allows gas 
samples to pass through it and react with the heme with subsequent optical measurement.  
Parameters to be tested include the height of the tubing delivering heme to and from the 
sensing element, sampling/delivery system, placement of the solenoid and flowmeter, 
heme injection/ejection methods, the thickness of the sensing element and distance 
between the input and output lenses.  Once the physical design is complete a number of 
sensor parameters will be examined to optimize the system for sensitivity and response 
time including referencing procedures, flow time, flow rate, system pressure and heme 
concentration will be analyzed with respect to optimizing sensitivity without sacrificing 
response time. 
 
The next step is the design of software drivers and of a program that will control the 
operation of the sensor.  This will be done using National Instruments’ LabVIEW virtual 
instrument development platform.  The program will control all hardware components, 
ensure timely sensor operation, collect and process signals, store, display and process 
data.  Signal processing will be implemented to maximize sensitivity without sacrificing 
response time.  Parameters tested include sample averaging and integration time.  
Techniques to be evaluated include signal filtering and time based averaging.   
 
Mathematical modeling equations and calibration methods will be developed after the 
final sensor design is developed and implemented.  Mathematical modeling equations 
will be employed to relate NO sensitivity to factors that are controlled by instrument 
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design.  Equations will be developed by determining the factors that will affect the output 
of the system and physical phenomena that can be used to relate these parameters to the 
system output. Calibration methods will be developed to relate the optical properties of 
the sensing compound to the acquired signal.  Sensitivity, response time and response 
range will be evaluated with the model. This information will be used to indicate the 
ranges of system parameters that provided the best results and also to determine how 
close the practical system is to the theoretical system.  Five parameters will be evaluated 
for their effect on system response including gas pressure, heme concentration, path 
length, flow time and flow rate.  
 
The final phase of this research will involve testing the sensor for five parameters:  a) 
sensitivity to nitric oxide;  b) specificity for NO in the presence of oxygen;  c) response 
time;  d) stability of the sensor over an 8 hour period; and e) accuracy and precision.  
 
In summary, the goal of this project is to design and develop a novel sensor for the 
measurement of inhaled nitric oxide in concentrations relevant to a clinical setting.  
Materials with the highest sensitivity to nitric oxide will be identified and incorporated 
into a sensing element.  Subsequently, the sensing element will be incorporated into a 
sensor that will sample gas from a ventilator circuit.  A system will be built to sample the 
gas, react it with the sensing element and subsequently acquire, process, store and display 
the processed signal.  Equations will be developed to relate sensor design features to 
sensor performance and evaluate the credibility of the sensor.  Sensor testing will be 
performed to evaluate sensitivity, selectivity, response time, stability and accuracy and 
precision, completing the final phase of the research. 
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C h a p t e r  4  
4. BACKGROUND 
This project encompasses the design and development of a new sensor for the 
measurement of inhaled nitric oxide concentrations.  Thus, other techniques suitable for 
this application must be evaluated and discussed.  Subsequently, information pertinent to 
the design and operation of the device will be provided. 
4.1 Current NO Measurement Techniques 
A summary table is provided below for reference on the material presented in this 
section. 
 
Table 4-1:  Summary of NO measurement methods. 
 
Technique Size Cost Response Time Calibration 
Sensitivity 
Chemiluminescence Large Expensive Long Difficult Ideal 
Mass Spectrometry Large Expensive Long Difficult Good 
Electrochemical      
Sensor Stik Adequate Relatively 
inexpensive 
Long in (-) 
direction 
4-6 hours Not 
sufficient 
PAC11 Adequate Relatively 
inexpensive 
Long in (-) 
direction 
Long Not 
sufficient 
Microelectrode  Adequate Relatively 
inexpensive 
Adequate Difficult Not linear 
Metalloporphyrin 
catalyzed  
Adequate Relatively 
inexpensive 
Not 
adequate 
Difficult Adequate 
Sol-gel encapsulated 
hemes 
In research phase 
 
There are a number of methods currently available for the measurement of gaseous NO 
concentration.  Chemiluminescence is the gold standard for the measurement of gaseous 
NO.  It is initiated by the reaction of NO with ozone (O3) (Archer, 1993): 
 
NO+O3 → NO2* + O2 → NO2 + hν (4.1)
 
 
The luminescence is detected by a high sensitivity photomultiplier tube (PMT) and is 
directly proportional to the concentration of NO.  In addition to a PMT, this technique 
requires a sample chamber and an ozone generator making chemiluminescence an 
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expensive measurement technique.  Although chemiluminescence is expensive, it is 
considered the standard for the measurement of gaseous NO due to its high sensitivity 
and accuracy.  The sensitivity threshold is 20-50 pmol and the chemiluminescence/NO 
curve is linear between 300 and 3000 pmol (Archer, 1993).  Chemiluminescence 
analyzers, although extremely sensitive, have complex maintenance requirements and are 
not economically feasible. 
 
Mass spectrometers can also be used to measure concentrations of gaseous NO.  NO is 
trapped as nitrosothioproline by bubbling the gas through a degassed aqueous solution of 
thioproline.  The nitrosothioproline is extracted with ethyl acetate, dried, and derivatized 
by N-methyl-N-(tertbutyldimethylsilyl) trifluroacetamide in acetonitrile.  The samples are 
placed on a CP-Sil-5-CB column interfaced with a mass spectrometer operating in the 
positive chemical ionization mode with isobutane (Archer, 1993).  This technique does 
not have an adequate response time for our application.  Mass spectrometers can also be 
used to measure gaseous NO directly, but they are both cumbersome and expensive. 
 
Electrochemical probes are available for the detection of gaseous NO.  The gas sample is 
passed through a plastic membrane into a liquid acid electrolyte containing the sensing 
electrode (anode), a counter electrode (cathode) and a reference electrode.  The voltage 
between the anode and cathode is kept at a constant level and the current flowing through 
the sensor is proportional to the amount of reacting NO.  The operation of the Sensor Stik 
(Model 4586, Exidyne Instrumentation Technologies. Exton, PA) is based on the 
following reaction: 
 
NO + 2H2O → HNO3 + 3e- + 3H+ (4.2)
 
 
Stabilization and calibration require 4-6 hours prior to use.  The operation of the Drager 
model (PAC 11, Drager AG. Lubeck, Germany) is based on the following reaction: 
 
NO + 2H2O → NO2 + 2e- + 2H  (4.3)
 
 
Calibration and stabilization are not necessary for this model.  Both stik monitors follow 
positive changes in NO concentration efficiently (Sensor Stik 10 seconds, Drager 4 
seconds).  Abrupt negative changes in NO concentration would take 2 hours to record 
with the Sensor Stik and 30 seconds with the Drager model.  Neither model is sensitive 
enough to measure low dose NO concentrations (Strauss, 1996). 
 
Shibuki has reported the measurement of NO release in the cerebellum using a 
microelectrode.  The tip of a miniature oxygen electrode was sealed so that only low 
molecular weight gasses can pass.  A platinum cathode is held at a positive voltage and 
the anode is grounded, then the oxidation of NO at the electrode surface is measured.  
The current generated is linearly proportional to the concentration of NO only between 1 
and 3 µM (Shibuki, 1990).   
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Another method  for measuring NO from intact tissues and cells relies on  the fact that 
metalloporphyrins catalyze the oxidation of NO, generating electrical current.  This 
technique is linear up to 300 µM, has a detection threshold of 10-8 M and a response time 
of 10 ms.  This technique would necessitate a sample in the liquid phase, requiring 
conversion of gaseous NO into a liquid, which ultimately reduces response time 
(Malinski, 1992). 
 
In late 1995, a method for producing thin film sol-gel encapsulated hemes was devised 
(Dave, 1995), but the sensitivity and response time were not adequate for our application.  
In 1997 a spin coating technique for the synthesis of 5 µm thick sol-gel encapsulated 
heme was reported (Aylott, 1999). Gaseous NO was passed for 200 seconds over the film 
prior to optical measurement.  It was found that the concentration of NO could be 
determined with accuracy between 1 and 25 ppm by measuring the absorbance at 414 
nm.  This technique resulted in a sensor with decent sensitivity and a response time of 
approximately 3.5 minutes.  The sensor is not commercially available.  
Commercialization of this product has one major drawback in the selection of 
wavelengths for the measurement.  It is relatively simple to measure 414 nm with a 
UV/VIS spectrophotometer, but miniaturization of this by incorporation of LEDs instead 
of a spectrophotometer would not be possible since LEDs are not available below 
approximately 450 nm, thus driving up the cost of the device. 
 
The current sol-gel configuration involves the encapsulation of the heme into a thin-film 
sensor (Aylott, 1999).  This limits the surface area available for reaction.  There is 
potential for the incorporation of a sol-gel encapsulated heme into a wave-guide 
configuration.  This configuration would dramatically increase the surface area available 
for reaction while increasing the path length for the optical measurement.  If the 
sensitivity is far greater in a wave-guide configuration, it might be possible to choose 
higher wavelengths for the measurement in order to commercialize the instrument.  To-
date, research has not been done to incorporate this configuration into a device.   
4.2 Reaction of NO with Hemes 
The current research will focus on the reaction of NO with a NO sensitive compound to 
produce a spectrophotometrically monitorable reaction in the visible region of the 
spectrum.  This section will evaluate the chemistry behind relevant reactions. 
 
In the blood stream and in the extracellular space, hemoglobin and other heme containing 
enzymes efficiently scavenge NO.  Reaction of NO with heme compounds produces a 
measurable shift in their absorption spectra.  Nitric oxide reacts with hemes in the same 
manner as oxygen and carbon monoxide - it forms a ligand to the iron atom.  Relevant 
reactions are summarized below. 
 
Heme(Fe III) + NO → Heme (Fe III) – NO → Heme (Fe II)  
Heme(Fe II) + NO  → Heme (Fe II) – NO 
Heme(Fe II)O2 + NO  →  Heme (Fe III) + NO3 -          (4.4) 
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These equations hold for hemoglobin and myoglobin.  Cytochrome-c does not have an 
oxygenated form, and its Fe(II) form does not react with nitric oxide to produce an 
observable shift in its absorption spectrum under the given conditions.  Hemes contain 
iron porphyrin rings, which react with NO in a 1:1 ratio.  Thus, hemoglobin, containing 
4 iron molecules will react with four molecules of nitric oxide, while myoglobin and 
cytochrome-c react with only one molecule of NO.  A diagram is given in Figure 4.1 to 
illustrate the general configuration of hemes and how NO binds to them.  The iron atom 
in the heme is hexa-coordinated.  Four of the bonds lie in the same plane as the 
porphyrin ring, the final two bonds are in a direction perpendicular to the plane of the 
ring and are available for bonding.  Common ligands including oxygen, carbon monoxide 
and nitric oxide (Toothill, 1967), bind perpendicular to the plane of the porphyrin ring.  
 
 
Figure 4.1.  Iron-Heme (porphyrin ring) physical structure. 
 
Electronically, NO is an intermediate between oxygen and carbon monoxide, with 11 
electrons in its outer shell (CO has 10 and O2 has 12).  Carbon monoxide is quite reactive 
with hemes.  The CO orbital with sp hybridization has 4 electrons in 2 non-bonding 
orbitals, with one lone pair producing decent reactivity.  Oxygen has 2 additional 
electrons located in two antibonding π orbitals.  These two high energy electrons give 
oxygen its reactive attributes.  Because NO is an intermediate between oxygen and 
carbon monoxide, the last electron must be located in the π* orbital.  The energy 
difference between this antibonding orbital and the σ nonbonding orbital in NO is not as 
well separated as it is in CO, allowing more transitions to occur.  Thus, NO has some 
unique properties in terms of its reactivity as a heme ligand (Tsai, 1994).  Figure 4.2 
summarizes this discussion. 
 
A major factor in heme-ligand coordination is the redox state of the heme iron.  At 
physiological pH, ferric heme (Fe 3+) has a net charge of +1, deriving +3 from the iron 
and -2 from the pyrrole nitrogens. Ferric hemes react more strongly with anionic ligands 
than with neutral gaseous ligands due to electrostatic interaction, but nitric oxide can 
also serve as a decent ligand due to its electronic configuration.  Its odd number of 
electrons makes nitric oxide polar enough to be a reasonably good ligand for ferric 
hemes.  Ferrous hemes (Fe 2+), in contrast have a net neutral charge, obtaining +2 from 
the iron and –2 from the pyrrole nitrogens.  These hemes prefer neutral gaseous ligands 
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due to increased orbital interactions.  Ferrous hemes have one additional d-orbital 
electron (d6) compared to ferric iron (d5).  This additional electron doubles the 
interaction between the iron dxy/dyz orbitals and the antibonding p orbital of the nitrogen 
in NO.  It has been shown, that nitric oxide can serve as a ligand for both ferrous and 
ferric hemes (Tsai, 1994). 
 
NO has proven to be a stronger and faster ligand to hemes than both CO and O2.  The 
association and dissociation constants lend credibility to this statement as shown in the 
following table (Toothill, 1967). 
 
       NO or CO 
                           N or C       O 
                 σ* 
   π 
 
2p               π* 
      σnb     2p 
 
           
           π 
     π           
2s          
 
      σ 
 
 
              2s 
      σnb      
 
Figure 4.2.  Energy diagram of NO and CO.  Note:  The dashed lines indicate electrons that 
are present only in N or in NO;  they are not present in C or CO.  
 
Table 4-2:  Association and Dissociation constants of NO, CO and O2 combining with 
hemoglobin. 
 
Hemoglobin Ligand Association constants (M-1s-1) Dissociation constants (s-1) 
NO 0.330 0.0015 
O2 500 30 
CO 50 0.027 
 
In addition, NO is a stronger ligand than CO because it can be a three electron donor as 
well as a two electron donor, increasing its reactivity.  This third unpaired electron can 
also serve to reduce the iron to the ferrous(2+) state after binding to the ferric(3+) heme 
(Tsai, 1994). 
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A number of other compounds are also reversibly reactive with NO.  Fe(II)EDTA 
(Hishinuma et al., 1979), light yellow in color under oxygen free conditions, changes to 
dark green upon introduction of NO, yielding a Fe(II)EDTA-NO complex which absorbs 
at 434 nm.  Upon evacuation with N2, the original compound is regenerated.  Solutions of 
Iron(III) chloride (Nicholls, 1997) also absorb gaseous NO to yield a reversible complex. 
 
Tetraphenyl porphyn compounds also present the desired qualities.  Exposure of 
Mn(TPP)CN- (Wayland et al., 1976) to 500 torr of NO at 25°C produces a new species 
and subsequent degassing of the resulting solution with nitrogen results in the 
reappearance of the original compound.   
 
FeCl(TPP) reversibly reacts with NO to produce (NO)FeCl(TPP).  Uptake of NO gas by 
crystalline FeCl(TPP)(Vaska and Nakai, 1973) is slow, but when solutions of FeCl(TPP) 
and NO are mixed, the reaction occurs immediately, resulting in the formation of purple 
crystals.  The complex immediately loses NO when dissolved in NO-free organic 
solvents, providing a reversible reaction. 
4.3 Reversibility of heme-NO reactions 
The most economical sensors employ sensing elements whose reactions can be reversed 
and reused.  If the sensing compounds reaction with NO is reversible, this greatly reduces 
the amount of sensing material necessary to run the sensor over a long period of time.  In 
addition, it minimizes the number of electro-mechanical parts necessary for sensor 
operation.  Thus, this section will focus on the reversibility of these reactions in order to 
regenerate the starting compound and prolong sensor lifetime.   
 
Studies have shown that the ferrous heme - NO complex can be flash-photolysed, 
regenerating the starting material completely and rapidly enough to allow for breath to 
breath measurements (Hoffman and Gibson, 1978).  Other studies have shown that 400 µ
s pulse width, high intensity xenon flash lamps can be used to completely dissociate the 
ferric heme-NO complexes, again allowing for breath to breath measurement of inhaled 
nitric oxide (Tamura et al., 1978).  
4.4 Sensing compound immobilization techniques 
There are many different ways to configure a sensor.  Three options exist including: 
immobilization of the sensing material to make a solid phase sensor, thin layer reversible 
liquid sensors, and flow-thru liquid cell systems.  This section will focus on heme 
immobilization techniques that yield a solid phase sensor that is sensitive to gaseous 
nitric oxide.  The requirements of the immobilization system are as follows: 
 
•= The immobilization system should ideally be hydrophilic to ensure compatibility 
with the chosen heme. 
•= If a hydrophilic curing system cannot be found, then it might be possible to create 
an even dispersion of the chosen heme within the immobilization system.  In this 
case, the signal would include scattering produced by the immobilized particles. 
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•= It should cure at less than 45°C to ensure that the protein does not denature during 
the curing process. 
•= It should cure completely clear to achieve maximum signal during absorption 
spectroscopy. 
•= During the curing process it should not give off anything harmful to proteins. 
•= It should be relatively stable when cured, meaning it should not be light or heat 
sensitive.   
•= It should be relatively gas permeable to achieve maximum response time and 
signal level.  It should be a solid at room temperatures.  If the material is not 
highly gas permeable then a thin film should be designed and the surface reaction 
should be examined. 
 
Based on the above requirements, several different materials as well as configurations are 
of interest.  Agar and polyvinyl alcohol (PVA) are of interest because they are readily 
soluble in cold H2O and easy to cure into thin films and gels.  In addition, PVA has been 
used with chemical cross-linking as a support for immobilized enzyme systems with high 
permeability and a high surface area for the formation of thin fibers.  Thin film sensors 
have been used to increase response time as the time course of the diffusion process is 
shortened.  Surface reactions have also been utilized in situations where the reactant does 
not flow freely through the polymer housing.  Finally, methods such as patterning and 
stacking have been used to increase the surface area available for reaction such that there 
is an increase in sensitivity and response time. 
 
Siloxanes are suitable for immobilizing agents because of their high gas permeability 
index (Arkles, 1996), (Arkles, 1995).  Examination of the other properties of siloxanes 
yielded that they generally need to be cured at temperatures in excess or 150°C, they are 
difficult to work with, and normally they are not hydrophilic.  A longer curing period at a 
lower temperature can be used to avoid the excessive temperature.  It was also noted that 
unterminated and unsubstituted siloxanes are impossible to cure into a solid.  
 
Acetoxy type silicone immobilization systems are self-curing.  They are available either 
with or without silica, where silica containing systems cure unclear, or cloudy, but make 
the system more tear resistant, which is of minimal value for this application.  In addition, 
the terminated linear polymers usually form longer and longer chains, thus staying fluid 
and resisting cross-linking, but a trifunctional acetoxy polymer cross-links.  One problem 
might arise in that the acetoxy type curing systems generate acetic acid, which may alter 
the structure and reactivity of the heme. 
 
Other silicone systems also exist, but they are fraught with problems as regarding to this 
application.  Platinum curing systems demonstrate two problems.  It is difficult to achieve 
the silicone to cure into a solid and it uses chloroplutanic acid for the curing procedure, 
which affects the stability of the heme. Alkoxides, curing at less than 45°C are also a 
possibility. Alkoxides generally require a tin catalyst, the amount of which is unknown 
and must be determined based upon the application. They also give off alcohol, which 
affects the reactivity of the heme. Hydrophilic silicone type curing systems contain 
polyethylene oxide. They have good gas permeability, but a low melting point, around 
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0°C, and they generally will not cure into a solid.  Due to these problems, these systems 
are not of interest. 
 
Sol-gel systems are suitable because of their inherent ability to immobilize hemes and 
hemeproteins while retaining their reactivity in a porous glass structure (Dave et al., 
1994), (Dunn et al., 1993), (Chung et al., 1995), (Lan et al., 1994), (Dave et al., 1995), 
(Dave et al., 1996).  Although sol-gels possess many qualities that are desired for optical 
biosensors, there were a few limiting specifications.  Until recently, work with sol-gels 
encapsulated hemes and gas reactions were done with dissolved gasses. With normal slab 
prepared sols, the response time was too long for this application, approximately 20-30 
minutes.  At the time, the gelation process was not amenable to creating thin films with 
hemes, as traditional thin film techniques involved sol-gel deposition from low-viscosity 
sols.  This involves a lower water to TMOS (tetramethyl ortho silicate) ratio, increased 
methanol concentration and lower pH values.  The increased alcohol concentration and 
decreased pH were detrimental to protein stability (Dave et al., 1995).  Thus, sol-gels 
were not further explored.   
 
In late 1995, a method for producing thin film sol-gel encapsulated hemes was devised 
(Dave et al., 1995), but the sensitivity and response time were still not adequate for this 
application.  In 1997, a spin coating technique for the synthesis of 5 µm thick sol-gel 
encapsulated heme was reported (Aylott et al., 1999).  Two hundred seconds of gaseous 
NO was passed over the film prior to optical measurement.  It was found that the 
concentration of NO could be determined between 1 and 25 ppm by measuring the 
absorbance at 414 nm.  This technique resulted in a sensor with a reasonably good 
sensitivity and a response time of approximately 3.5 minutes. A discussion of the 
potentials of sol-gel encapsulated hemes will ensue in Chapter 10. 
4.5 Optical Spectroscopy 
Since the reaction of hemes with nitric oxide can be monitored spectrophotometrically in 
the visible region of the spectrum, a discussion of spectroscopy follows.  Optical 
spectroscopy is a method which requires the use of absorption, emission or scattering of 
electromagnetic radiation (of various wavelengths) by atoms or molecules to qualitatively 
or quantitatively study these atoms or molecules, or to study physical processes.  Light, a 
form of electromagnetic radiation, can be described in terms of both particles and waves.  
Light waves consist of perpendicular, oscillating electric and magnetic fields.  The 
electric and magnetic fields are perpendicular to each other and equal in energy.  The 
wavelength (λ) is the crest-crest distance between waves, measured in meters (m).  The 
frequency, ν, is the number of complete oscillations that the wave makes each second, 
units are seconds-1 (s-1).  The frequency and wavelength are associated by the following 
equation: 
 
ν = c / λ  (4.5) 
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where c is the speed of light (3 x 108 m/s).  When light is considered as particles called 
photons, one can consider its energy.  Each photon carries an energy (E), units of joules 
(J).  The relationship between the frequency and energy is as follows: 
 
E = h ν (4.6) 
 
where h is Planck’s constant (6.63 x 10-34 J⋅s). 
 
The interaction of electromagnetic radiation with matter generally produces three effects:  
scattering, absorption and emission.  The interaction of radiation with matter can cause 
redirection of the radiation and transitions between energy levels of the atom or 
molecules.  Absorption of a photon is a transition from a lower level to a higher level 
with transfer of energy from the radiation field to the atom or molecule.  When irradiated, 
a molecule is said to have been promoted to an excited state.  Emission of a photon is a 
transition from a higher level to a lower level.  When emitting, the molecule transitions 
from an excited level to the ground state.  The redirection of light is called scattering.   
 
Net absorption depends on the difference between the populations of the energy levels.  
When light is absorbed by a sample, the radiant power (P, the energy per second per unit 
area) of the beam of light is decreased. The absorbance is given as follows: 
 
A = log10 (Po / P)   (4.7) 
 
Where Po is the incident power and P is the transmitted power.  Total absorption at a 
wavelength depends on the number of molecules in which transitions are induced, or the 
concentration of the absorbing species.  The equation is given as follows: 
 
Aλ = ελ c l  (4.8)
 
 
where ελ is the extinction coefficient in M-1⋅m-1 at a wavelength λ ,  c is the concentration 
in mol/L and l is the pathlength in m.  This relationship is referred to as Beer’s Law.  Let 
us assume that light is passing through a sample as shown in Figure 4.3.   
 
 
 
 
                    
 Incident        Transmitted 
 Light         Light 
 
   x = 0   dx   x = b 
 
Figure 4.3.  Path of light through an absorbing solution. 
 P       P - dP 
    
Absorbing 
   Solution 
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Light of radiant power P is passing through an infinitesimally thin layer of solution 
whose thickness is dx.  The decrease in power (dP) is proportional to the incident power 
(P), to the concentration of the absorbing species (c), and to the thickness of the section 
(dx): 
 
dP = -β P c dx  (4.9) 
 
where β is a constant of proportionality.  Rearranging the equation gives: 
 
  -dP / P = β c dx (4.10) 
 
where P = Po at x = 0 and P = P at x = l.   
 
Integrating and evaluating the integral gives: 
 
-ln P – (-ln Po) = β c l 
ln (Po / P) = β c l 
                   log (Po / P) = (β / ln10) c l (4.11) 
 
Finally: 
 
 A = log (Po / P) = ε c l (4.12)
 
 
This is Beer’s Law as given above.  The values of A and ε depend on wavelength, thus 
the relationship can be restated as equation (4.8): 
 
Aλ = ελcl 
Under ideal conditions, the absorbance at a specific wavelength is directly proportional to 
the concentration of the absorbing species.  The absorption spectrum is a collection of 
absorbances over a range of wavelengths.  In solution, the UV and visible spectrum 
usually consists of broad bands arising from the superposition of vibrational and 
sometimes rotational energy changes upon the electronic transitions.  Thus, each 
electronic absorption produces a series of lines that are so closely spaced as to appear 
continuous.  Broadening of the lines occurs as a result of the intermolecular forces 
operating between the closely packed molecules or ions in the condensed medium.  
Specificity of electronic spectra, usually measured in the UV and visible region, is 
therefore quite low, however, optical spectroscopy is suited for quantitative 
measurements.  Chemical species can thus be identified by their absorption maxima, 
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forming the basis for a selective sensor if there are not interferences from other absorbing 
species in the system.  For the current application, the absorbance of the complex at a 
peak wavelength will be correlated to the concentration of nitric oxide.  The wavelengths 
of relevant peaks for hemes in the UV/VIS are given in Table 4-3.  
 
Table 4-3:  Peak wavelengths of hemes in the UV/VIS region. 
 
Heme Peaks in nm References 
Hemoglobin   
Fe(2+) (Ferrous) 430, 555 (Giardina and Amiconi, 1981) 
Fe(3+)  
(Ferric or Met) 
406, 499, 575, 
628 
(Bazylinski and Hollocher, 1985), (Soller et 
al., 1996) 
Fe(2+)NO 418, 535, 580, 
610 
(Bazylinski and Hollocher, 1985), (DiFeo et 
al., 1990) 
Fe(3+)NO 419, 530, 565 (Bazylinski and Hollocher, 1985), (DiFeo et 
al., 1990) 
Fe(2+)O2 415, 542, 578 (DiFeo et al., 1990) 
Myoglobin   
Fe(2+) 434, 556 (Rothgeb and Gurd, 1978), (DiFeo et al., 
1990) 
Fe(3+) 409, 505, 582, 
635 
(Bazylinski and Hollocher, 1985), (Rothgeb 
and Gurd, 1978) 
Fe(2+)NO 424, 540, 585 (Bazylinski and Hollocher, 1985), (Das et al., 
1993) 
Fe(3+)NO 530, 560, 575 (Bazylinski and Hollocher, 1985) 
Fe(2+)O2 418, 543, 581 (Rothgeb and Gurd, 1978) 
Cytochrome-c   
Fe(2+) 414, 520, 550 (Kudera, 1990) 
Fe(3+) 409, 530 (Soller et al., 1996) 
Fe(3+)NO 420, 528, 563 (Yoshimura et al., 1987), (Kudera, 1990) 
 
Beer’s Law works very well for dilute solutions, usually less than 0.01 M.  At higher 
concentrations (>0.01M) the average distance between the species responsible for 
absorption is diminished to the point where each affects the charge distribution of its 
neighbors.  This interaction can alter their ability to absorb a given wavelength of 
radiation.  This affects the linearity of the system.  In addition, departures from Beer’s 
Law are observed if there are significant alterations in the refractive index (η) due to the 
concentration changes, changing the measured absorbance. 
 
Thus, Beer’s Law can be used to measure the concentration of an analyte given that the 
absorbance of a solution at a particular wavelength is the sum of the absorbances at that 
wavelength of each species in the solution, if the molar extinction coefficient is known 
for each species at that wavelength.  At a particular wavelength the molar absorptivity 
constant (ε) is constant and the pathlength can be held constant.  Thus, for a given 
species, the concentration can be calculated from the absorbance, ε, and pathlength.   
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4.6 Optical Spectrometers 
An optical  spectrometer is a device used to measure the absorbance and/or the 
transmission of light.  Light from a continuous source is passed through a sample of path 
length l.  The emerging light is then passed through a monochromator, which selects a 
narrow band of wavelengths from the incident beam.  The light source is usually a 
tungsten-halogen lamp for visible applications since it is an excellent source of visible 
and near-infrared (NIR) light.  The monochromator works to disperse light into its 
component wavelengths.  In our application, a diffraction grating is used for this purpose.  
The grating is ruled with a series of closely spaced parallel grooves.  The grating is 
coated with aluminum to make it reflective, and the aluminum is coated with SiO2 to 
prevent the metal from oxidizing.  The diffraction grating periodically modulates the 
phase or the amplitude of the incident wave.  When a wave of wavelength λ, traveling at 
a small angle θi with a respect to the z axis is incident upon a grating with thickness 
varying periodically with period Λ in the z = 0 plane, the incident wave is converted into 
several plane waves at small angles: 
 
 sin(θq) = sin(θi) + q ( λ / Λ) (4.13) 
 
where q (± integer) is the diffraction order.  The diffracted waves are separated by an 
angle: 
 
 θ = λ / Λ  (4.14) 
 
Since the angle θq is dependent on the wavelength λ, an incident polychromatic wave is 
separated by the grating into its spectral components.  The focusing element focuses the 
light on the exit slit.  In any type of monochromator, the width of the exit slit determines 
the range of wavelengths passed on to the sample.  The narrower the slit, the narrower the 
bandwidth emerging from the monochromator.  Narrow slits are useful for resolving 
closely spaced peaks, but the amount of detected light decreases as the slit size decreases.  
Thus, resolution is achieved at the expense of decreased signal to noise ratio.  The 
emerging light is measured by a detector, from which absorbance is calculated at a 
specific wavelength.  The detector used for this application is a CCD (charge-coupled 
device) array detector.  A CCD is an integrated circuit that contains an array of capacitors 
that store charge when light creates electron hole pairs.  The charge accumulates and is 
read in fixed time intervals.  A schematic of a CCD is given in Figure 4.4 (Tissue, 1998). 
 
A CCD array is a metal-oxide-silicon capacitor, as shown above.  This consists of an 
insulating silicon dioxide layer over a p-type silicon substrate, topped by a thin metal 
electrode.  When bias is applied, holes move away from a depletion layer in the silicon 
beneath the gate, creating a potential energy well.  Electrons generated when the device is 
illuminated accumulate in this well, and the charge accumulated is proportional to the 
irradiation.  The bias voltage is varied to shift each collection of charge over by one gate 
each clock cycle in order to read the array.  Thus, each row of the CCD is read as a time-
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varying signal.  These detectors are characterized by high sensitivity and low noise 
(Lerner, 1996). 
 
 
 
 
 
hν 
     metal contacts      metal contacts 
 
SiO2 
 
 
 
p-type   
Silicon 
 
Figure 4.4.  CCD schematic. 
4.7 LabVIEW 
LabVIEW is a program development application that uses a graphical programming 
language, G, to create programs in block diagram form.  It can be effectively used as a 
data acquisition software package, for hardware control and data collection, processing, 
storage and display 
 
LabVIEW has extensive libraries of functions for any programming task.  It includes 
libraries for data acquisition, GPIB and serial instrument control, data analysis, data 
presentation, and data storage.  LabVIEW also includes conventional program 
development tools, so one can set breakpoints, animate the execution to see how data 
passes through the program, and single-step through the program to make debugging and 
program development easier. 
 
LabVIEW programs are called virtual instruments (VIs) because their appearance and 
operation can imitate actual instruments. However, VIs are similar to the functions of 
conventional language programs.  A VI consists of an interactive user interface, a data 
flow diagram that serves as the source code, and icon connections that allow the VI to be 
called from higher level VIs. More specifically, VIs are structured as follows: 
 
•= The interactive user interface of a VI is called the front panel, because it simulates 
the panel of a physical instrument. The front panel can contain knobs, push 
buttons, graphs, and other controls and indicators.  Data can be entered using a 
mouse and keyboard, and then the results viewed on the computer screen. 
•= The VI receives instructions from a block diagram, which is constructed in G. The 
block diagram is a pictorial solution to a programming problem. The block 
diagram is also the source code for the VI. 
Potential Well 
e- e- 
       e- 
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•= The icon and connector of a VI work like a graphical parameter list so that other 
VIs can pass data to a subVI. The icon and connector allow the use of VIs as top-
level programs, or as subprograms (subVIs) within other programs or 
subprograms. 
4.8 CDI Spectrometer Module 
The CDI (Control Development Inc.) spectrometer module consists of a CIN (code 
interface node) linking CDI’s custom software to LabVIEW.  The CDI software allows 
the user to set all parameters pertaining to a spectrophotometric measurement, collect, 
view and store data across a range of wavelengths. 
4.9 Mathematica 
Mathematica (Wolfram Research, Champaigne, IL), a fully integrated environment for 
technical computing, is very suitable to be used to solve systems of differential equations 
like the ones developed as a model for the NO sensor.  
 
The chosen algorithm within Mathematica implements the Runge Kutta (RK) Fehlberg 
formulas as a starting method.  A starting method is used to determine the first few 
approximations of the solution (y).  Subsequently, a continuing method (Adams-
Bashforth-Moulton Method) is used to approximate further values of y in an accurate 
manner.  The Runge-Kutta method will be examined first in this chapter.  Let us take a 
first order system comprising of one ordinary differential equation (ODE): 
 
y’ = f(x,y) 
The solution is determined as follows: 
 
yn+1 = yn + (1/6) (k1 + 2k2 + 2k3 + k4) 
where 
 
k1 = hf(xn,yn) 
k2 = hf(xn + 0.5h, yn + 0.5k1) 
k3 = hf(xn + 0.5h, yn + 0.5k2) 
k4 = hf(xn + h, yn + k3) 
Please note that h is the step size.  After the first few approximations are made, a 
continuing method can be implemented.  The Adams-Bashforth-Moulton Method is 
implemented as a predictor-corrector method where the predictor (pyn+1) is used as the 
 26
first approximation to determine the corrector (yn+1), or the second approximation.  Note 
that this method uses previous values of the solution to determine future values, thus it 
cannot be used as a starting method.  This is why a starting method must be used to 
determine the first few values.  The Adams-Bashforth-Moulton method will be examined 
next.  Let’s take a first order, initial value system comprising of one ODE: 
 
y’ = f(x,y);  y(x0)=y0 
The solution is determined as follows: 
 
Predictor: pyn+1 = yn+1 + (h/24)(55y’n – 59y’n-1 + 37y’n-2 – 9y’n-3) 
Corrector: yn+1 = yn + (h/24)(9py’n+1 + 19y’n – 5y’n-1 + y’n-2) 
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C h a p t e r  5  
5. SENSOR DESIGN 
5.1 Underlying Science of Optical Sensor  
Although several methods are currently available for the detection of NO, none provides 
a direct and continuous measurement in a cost effective and simple manner.  The design 
of such a sensor starts with the identification of substances that are sensitive to, and 
specific for NO in the presence of oxygen and other anesthetic gasses.  The sensor 
designed for this project is based on a mechanism which allows a reaction of NO with a 
nitric oxide sensitive compound.  As the chosen compound reacts with nitric oxide, its 
optical properties are changed.  The quantification of the NO concentration occurs 
through the measurement of changes in the absorption spectra of the NO sensitive 
compound. 
 
Spectrophotometry can be used in conjunction with a sensing element, Beer’s law and a 
calibration equation to create a sensor that clinically measures inhaled NO 
concentrations.  To create a sensor for the measurement of inhaled NO concentrations, 
the sensing compound is incorporated into a sensing element.  The sensing element reacts 
with gaseous nitric oxide to form a spectrophotometrically monitorable product in the 
visible region of the spectrum.  The concentration of NO should be directly proportional 
to the concentration of this product.  In addition, the light absorbance at a specific 
wavelength is directly proportional to the concentration of the absorbing species as 
determined by Beer’s Law.  Thus, the absorbance of the complex at a specific wavelength 
is proportional to the concentration of NO.  The signal level will determine whether this 
measurement can be made with a few light-emitting diodes (LEDs) at specific 
wavelengths or whether an entire spectrometer is necessary.   
 
The most economical measurement solution is to use two LEDs, in conjunction with 
detectors to determine light intensity/absorption at the given wavelengths.  One LED is 
selected at a wavelength where the sample has maximum absorbance.  The other is 
chosen at a reference wavelength, at which the absorbance does not change with NO 
concentrations.  The absorbance at the reference wavelength is then subtracted from the 
sample absorbance to account for any system fluctuations not related to NO 
concentrations such as stray light, detector response and source fluctuations.  If the signal 
level is too low to accurately measure clinically needed NO concentrations, another 
approach may be taken.  A spectrometer can be used to obtain the absorbance over a 
range of wavelengths relative to a broad peak.  Integrating over the peak and relating this 
to NO concentrations might give a better signal to noise ratio.   
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In order to deduce a nitric oxide concentration from the absorption measurement, whether 
at dual wavelengths or over a peak, a calibration curve must be generated.  Known 
concentrations of nitric oxide are delivered to the sensor at set points between the 
expected high and low values.  The absorption is recorded at these points and a 
mathematical relationship is derived to relate nitric oxide concentration to the processed 
signal.  The calibration curve is then used to deduce NO concentrations during system 
use.  
5.2 Methods for Testing the Sensing Compounds 
Sensor design starts with the identification of compounds whose optical properties 
change as a function of nitric oxide concentration.  The chosen compounds must be 
evaluated for sensitivity to NO and specificity for NO in the presence of oxygen.  In the 
blood stream and in the extracellular space, hemoglobin and other heme containing 
enzymes efficiently scavenge NO.  Since the body finds the most efficient methods to 
operate, mimicking its behavior could create an effective sensor.  In addition, reaction of 
NO with heme compounds produces a measurable shift in its absorption spectra.  There 
are also other compounds that react with NO to produce a measurable shift in the 
absorption spectra.  Thus, evaluated compounds include hemoglobin and myoglobin in its 
met, deoxy and oxy forms, cytochrome-c in its met and Fe(II) forms, iron chloride, 
Fe(II)EDTA (iron II EDTA), FeClTPP (iron chloride tetraphenyl porphyrin), and 
MnTPPCN- (manganese tetraphenyl porphyrin cyanide).  All compounds were chosen on 
the basis of their sensitivity to NO, monitorability of the reaction in the visible region of 
the spectrum and reversibility of their reaction with NO.  Their testing methods are 
presented below. 
 
Cytochrome-c, myoglobin, and hemoglobin (all horse heart derived) were obtained from 
Sigma Chemical Co. (St. Louis, MO).  The hemes were dissolved in pH 7.0 monobasic 
potassium phosphate and sodium hydroxide buffer to yield the unreduced Fe III forms of 
each (95% pure):  cytochrome-c (100 µM), myoglobin (100µM) and hemoglobin (25 
µM). The deoxygenated, reduced forms (Fe II) of each heme were prepared by reducing 
the Fe III form with a molar excess of sodium dithionate.  Fe(II)EDTA and Fe(III)Cl 
were obtained from Sigma Chemical Co. (St. Louis, MO).  Fe(II)EDTA was dissolved in 
distilled water to yield a 100 µM solution.  Iron(III) chloride was dissolved in absolute 
ethanol to yield the same concentration.  MnTPPCN- was dissolved in toluene to yield a 
100 µM solution and FeClTPP was dissolved in CHCl3 to yield a 100 µM solution. 
 
Diethylamine NONOate (DEAN) (Cayman Chemical Co., Ann Arbor, MI) was used as 
the NO releasing agent for the heme compounds and Fe(II)EDTA, and was handled in an 
oxygen free environment. It was prepared by dissolution in deaerated pH 8.50 buffer to 
an approximate concentration of 0.450 mg/ml. The final concentration was verified 
spectrophotometrically at 250 nm (extinction coefficient = 6500 (Maragos et al., 1991)). 
The solution was then diluted 1:10 four times to obtain a range of NO concentrations 
between 0.01 µM and 100 µM.  All solutions were again deaerated by flushing with 
nitrogen for 15 minutes. They were kept on ice and free from oxygen at all times.  
Gaseous NO (2500 ppm = 111 µM) was used as the NO source for the TPP compounds 
and iron chloride, and was obtained from NE Air Gas Co.  Diethyl amine NONOate is 
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released by bringing the pH of the solution to under 8.0, by mixing a small amount of 
high pH DEAN into a large amount of lower pH heme solution.  Both DEAN and the 
heme are dissolved in phosphate buffer, making the solutions miscible.  The non-heme 
compounds had to be dissolved in organic solvents, which are not miscible with 
phosphate buffer.  Thus, gaseous nitric oxide was used to initiate the reaction. 
 
The reaction of the hemes and Fe(II)EDTA with NO was monitored by a dual wavelength 
spectrometer system installed on a personal computer.  The system consists of a 
miniature tungsten-halogen light source (Ocean Optics, Inc., Dunedin, FL) connected to a 
bifurcated 600 µm core fiber bundle. The input fiber is connected to the sample to be 
measured.  The collimating lenses are built into the fiber connectors. The output of the 
sample is connected to a 100 µm core multimode fiber, which provides the input for the 
optical spectrograph card (Control Development, Inc., South Bend, IN). The card has a 
micro-optic dual beam spectrograph consisting of the diffraction grating, focusing 
elements, exit slit, detector and analog-to-digital converter. The detector is a 
thermoelectrically cooled charge couple device (CCD). The system provides 0.8 nm 
wavelength resolution.  A 14 bit analog to digital converter is used and for data 
acquisition.  LabVIEW for Windows (National Instruments, Austin, TX) was used for 
hardware control, timing, data acquisition and data processing. 
 
Both the sample and reference cells (1 cm pathlength) contained 3 ml volumes of the 
heme solution injected into polystyrene cuvettes. The cuvettes were fitted with a rubber 
septum and sealed with Parafilm to prevent escape of the generated gas. The sample cell 
was injected with a predetermined volume of DEAN to initiate release of NO. The 
reference cell was injected with an equal volume of deaerated pH 8.50 buffer to maintain 
an equal heme concentration in both cells. Difference absorbance spectra were recorded 
every minute for 10 minutes between 375 nm and 720 nm to identify NO-induced 
changes in the absorption spectrum and the time of complete reaction. Spectra were 
recorded from deaerated solutions and from solutions exposed to room air (21% O2) and 
solutions bubbled with 100% O2 to evaluate specificity of each heme to NO in the 
presence of oxygen.  The reaction of the TPP compounds and iron chloride was also 
monitored by a dual wavelength spectrometer system installed on a personal computer 
operating in a single beam mode.  NO (2500 ppm = 111 µM) was bubbled through a 
sealed quartz cuvette containing 3 ml volumes of the solutions.  The cuvette was fitted 
with a rubber centered screw-top for introduction and venting of the gas.  The gas was 
bubbled for 10 minutes and changes were recorded every minute between 375 nm and 
720 nm.  Spectra were recorded from deaerated solutions and from solutions which were 
exposed to room air (21% O2) to evaluate specificity of each heme to NO in the presence 
of oxygen. 
 
For the heme based compounds, difference absorbance spectra were recorded for NO 
concentrations between 0.01 µM and 100 µM. The absorbance at the time of complete 
reaction was plotted against the concentration of NO to determine the molar extinction 
coefficient (ε) from linear regression. The slope of the line, m, is used as a measure of the 
sensitivity of each heme to NO. The extinction coefficient for cytochrome-c, myoglobin 
and hemoglobin is determined 4 times in separate experiments and the mean and standard 
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deviation are reported.  Fe(II)EDTA’s difference absorbance spectrum was recorded for 
100 µM NO concentration.  The absorbance spectra of iron chloride and the TPP 
compounds reaction with NO was measured with 2500 ppm (111 µM) NO 
concentrations. 
5.3   Methods for Testing the Reversibility of Heme-NO reactions 
Subsequent to identification of sensor materials, the reversibility of the sensing 
compounds reaction with nitric oxide has to be evaluated to determine sensor 
configuration.  The most economical sensor will employ a sensing element whose 
reaction can be reversed on a breath to breath basis, and then reused.  If the sensing 
compounds reaction with NO is reversible, this greatly reduces the amount of sensing 
material necessary to run the sensor over a long period of time.  In addition, it minimizes 
the number of electro-mechanical parts necessary for sensor operation.  If the reaction is 
not reversible, then a sensing element with a long lifetime or a replenishable sensing 
element has to be devised.  Thus, reversing these reactions in order to regenerate the 
starting compound and elongate sensor lifetime is important.   
 
Studies have shown that the ferrous heme - NO complex can be flash-photolysed, 
regenerating the starting material completely and rapidly enough to allow for breath to 
breath measurements (Hoffman and Gibson, 1978).  Other studies have shown that 400 
µs pulse width, high intensity xenon flash lamps can be used to completely dissociate the 
ferric heme-NO complexes, again allowing for breath to breath measurement of inhaled 
nitric oxide (Tamura, 1978).  Methods for testing reversibility are presented as follows. 
 
Cytochrome-c (Cyt-c), myoglobin (Mb) and hemoglobin (Hb), all horse heart derived, 
were obtained from Sigma Chemical Co. (St. Louis, MO).  The hemes were dissolved in 
pH 7.0 monobasic potassium phosphate and sodium hydroxide buffer to yield the 
unreduced Fe III forms of each (95% pure):  cytochrome-c (100 µM), myoglobin (100 
µM) and hemoglobin (25 µM).  The deoxygenated, reduced forms (Fe II) of each heme 
were prepared by reducing the Fe III form with a molar excess of sodium dithionate.  The 
oxygenated forms of myoglobin and hemoglobin were prepared by bubbling 100% 
oxygen through 3 ml aliquots of the respective heme for 5 minutes.  The starting heme’s 
identity was characterized from its known absorption spectrum (Rothgeb and Gurd, 
1978), (DiFeo et al., 1990), (Kucera, 1990), (Waterman, 1978), (Bazylinski and 
Hollocher, 1985).  Nitric oxide (2500 PPM) was purchased from Northeast Air Gas, Co. 
 
The reaction of the hemes with NO was monitored by the spectrometer system described 
in Section 5.2.  The sample cells contained a 3 ml volume of 100 µM heme solution 
injected into polystyrene cuvettes.  Each cuvette was fitted with a rubber septum and 
sealed with Parafilm to prevent escape of the gas.  The rubber septum was outfitted with 
two 22 gauge needles, one for introduction of nitric oxide, the other for pressure release.  
Nitric oxide, diluted to 100 µM with nitrogen, was bubbled through the sample cell until 
no further change in spectrum was observed. 
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Absorption spectra were recorded prior to the introduction of the NO, and after saturation 
of the sample solution with nitric oxide.  Saturation was noted when there was no further 
change in the spectrum upon introduction of additional NO.  The reaction product was 
identified from its known absorption spectrum (Rothgeb and Gurd, 1978) , (DiFeo et al., 
1990), (Kucera, 1990), (Waterman, 1978), (Bazylinski and Hollocher, 1985).  Photolytic 
reversibility of the heme-nitric oxide product was examined by subjecting the reaction 
product to the output of a 500W, Kodachrome ELH bulb similar to that described in 
literature (Sawicki and Morris, 1981) at set intervals for 15 minutes (15 s, 30 s, 45 s, 60 s, 
2 min, 3 min, 4 min, 5 min, 10 min and 15 min).  Spectra were recorded after each 
interval to characterize the kinetics of the photolytic reaction.  Photolysis was 
characterized by a shift of peaks back to that of the starting material.  Complete 
photolysis was determined by no further shift in peak position or intensity.  Nitric oxide 
was reintroduced to the product of the reversed reaction to ensure that the reconstituted 
heme compound had the same properties as the starting material. 
 
All experiments were rerun with a 1:30 dilution to obtain better spectra in the 375-450 
nm region due to limitations with the optical spectrograph card.  All experiments were 
repeated three times.  Experiments were re-run once each with modifications as follows.  
Nitrogen was bubbled through the cuvette during photolysis to displace the lysed nitric 
oxide such that it cannot re-react with the heme.  Nitrogen was bubbled continuously 
through the cuvette, except at the time of spectroscopic measurement for the same reason.   
The polystyrene cuvettes were replaced with quartz cuvettes to ensure that the cuvette 
was not limiting bandwidth or intensity.  The ELH bulb was replaced with a high 
intensity xenon flash lamp apparatus to provide more intensity and a different spectral 
range.  The system was continuously exposed to the ELH bulb to elongate the exposure 
to the light source.  This was repeated with the xenon flash lamp. 
5.4 Heme Immobilization Techniques 
The next set of experiments was conducted to evaluate the physical sensor design.  Two 
configurations were tested including immobilization of the sensing compound to produce 
a solid phase sensor and flow-through liquid phase systems.  Solid sensor design was 
evaluated first since it would produce the most stable system and would minimize 
mechano-electrical system components.  Various procedures were employed to 
immobilize the chosen sensing compound into a polymer matrix and then configure the 
solid sensing element to maximize sensitivity without overly sacrificing sensor response 
time.  The polymer matrix must be transparent in the wavelength region of interest and be 
highly permeable to nitric oxide.  Subsequent to selecting an appropriate polymer, 
various configurations were evaluated to maximize sensitivity.  Films were studied in a 
single layer, stacked and patterned.  Gels, evaluated to increase permeability of NO, were 
evaluated in a single layer and a patterned configuration.  Stacking and patterning 
techniques were employed to increase the surface area available for reaction, assuming 
that it is largely a surface reaction.  The requirements of the system are given as follows: 
 
•= The immobilization system should ideally be hydrophilic to ensure compatibility 
with the chosen heme. 
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•= If a hydrophilic curing system cannot be found, then it might be possible to create 
an even dispersion of the chosen heme within the immobilization system.  In this 
case, the signal would be plagued by scattering produced by the immobilized 
particles. 
•= It should cure at less than 45°C to ensure that the protein does not denature during 
the curing process. 
•= It should cure completely clear to achieve maximum signal during absorption 
spectroscopy. 
•= It should not give off anything harmful to proteins during the curing process. 
•= It should be relatively stable when cured, meaning it should not be light or heat 
sensitive.   
•= It should be relatively gas permeable to achieve maximum response time and 
signal level.  It should be solid at room temperatures.  If the material is not highly 
gas permeable then a thin film should be designed and the surface reaction 
examined. 
 
Based on the above requirements, several different materials as well as configurations 
were examined.  Agar and polyvinyl alcohol (PVA) were examined because they are 
readily soluble in cold H2O and easy to cure into thin films and gels.  In addition, PVA 
had been used with chemical cross-linking as a support for immobilized enzyme systems 
with high permeability and a high surface area for the formation of thin fibers.  The gas 
permeability of these compounds is not ideal for this application, but if the film is thin 
enough, an appropriate response time might be achievable.  In addition, surface reactions 
were examined assuming that the gas does not flow freely through the immobilized heme.  
Gels were also examined under the assumption that increasing the water content would 
increase the flow of NO through the immobilized sensing compound.  Various 
thicknesses of gels and films were evaluated for both compounds.  In addition, stacked 
films and patterned films were examined to increase the surface area for reaction, thus 
increasing the sensitivity. 
 
Siloxanes (Arkles, 1995 and 1996), are contenders for immobilization agents because of 
their high gas permeability index. Examining the other properties of siloxanes, it was 
found that they generally need to be cured at temperatures in excess or 150°C, they are 
difficult to work with and they are not normally hydrophilic. Thus, a longer curing period 
at a lower temperature was implemented to avoid the excessive temperature. It was also 
noted that unterminated and unsubstituted siloxanes are impossible to cure into a solid. 
Thus, some modification was necessary to initiate the curing process. 
 
Acetoxy type silicone curing systems are self-curing. They are available either with or 
without silica, where silica containing systems cure unclear, or cloudy, but make the 
system more tear resistant, which is of minimal value for this application. In addition, the 
terminated linear polymers usually form longer chains, thus staying fluid and resisting 
cross-linking, but a trifunctional acetoxy polymer cross-links. One problem might arise in 
that the acetoxy type curing systems generate acetic acid, possibly altering the structure 
and reactivity of the heme. 
 
 33
Upon examining the properties of various siloxanes, diacetoxy methyl terminated 
polydimethyl siloxane and heptane dis-cyclohexaamino terminated polydimethyl siloxane 
were examined first for their high gas permeability, ease of curing and clear curing 
properties, but they are not hydrophilic.  
 
Three configurations were tested as follows: 
 
•= An even dispersion of the heme through the polymer. 
•= A sandwich of the heme in between two layers of polymer. 
•= A protocol which involves modification of the heme such that it can be dissolved 
in organic solvents or directly in the fluid polymer of choice (Haire, 1984). 
 
Other silicone systems also exist for immobilization, but they are fraught with problems 
that affect this application.  Platinum curing systems have two problems. It is difficult to 
cure them into a solid and chloroplutanic acid is used for the curing procedure, which 
affects the stability of the heme. Alkoxides, curing at less than 45°C are also a possibility. 
Alkoxides generally require a tin catalyst, the amount of which is unknown and must be 
determined based upon the application. They also give off alcohol, which affects the 
reactivity of the heme. Hydrophilic silicone type curing systems contain polyethylene 
oxide. They have good gas permeability, but a low melting point, around 0°C, and they 
generally will not cure into a solid.  Due to the listed problems, these systems were not 
examined. 
 
Sol-gel systems are suitable because of their inherent ability to immobilize hemes and 
hemeproteins while retaining their reactivity in a porous glass structure (Dave, 1994, 
1995, 1996), (Dunn, 1993), (Chung, 1995), (Lan, 1994).  Although sol-gels possess many 
qualities that are desired from optical biosensors, they have a few limiting specifications.  
On the positive side, sol-gel encapsulated hemes are stable and reactive for up to one year 
post manufacturing.  But, until recently, work with sol-gels encapsulated hemes and gas 
reactions were done with dissolved gasses. With normal slab prepared sols, the response 
time is too long for this application, approximately 20-30 minutes.  At the time, the 
gelation process was not amenable to creating thin films with hemes as traditional thin 
film techniques involved sol-gel deposition from low-viscosity sols.   This involves a 
lower water to TMOS (tetramethyl ortho silicate) ratio, increased methanol concentration 
and lower pH values.  The increased alcohol concentration and decreased pH are 
detrimental to protein stability (Dave, 1995).  Thus, sol-gels were not further explored.  
5.5 Methods for Heme Immobilization Testing 
The next set of experiments was conducted to evaluate physical sensor design.  Three 
options were explored to achieve the necessary sensor specifications, including 
immobilization of the sensing material to make a solid phase sensor, thin layer reversible 
liquid sensors and a flow-thru liquid cell system.  This section will focus on heme 
immobilization techniques that yield a solid phase sensor that is sensitive to gaseous 
nitric oxide. 
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Cytochrome-c, horse heart derived, Agar and PVA were obtained from Sigma Chemical 
Co. (St. Louis, MO).  Cytochrome-c and H2O were mixed until the heme was thoroughly 
dissolved.  The immobilizing agent was slowly added while the solution was on a stir 
plate at a low speed.  Stirring was continued until the Agar or PVA was completely 
dissolved.  The solution was cast into its appropriate container and dried as directed in 
Table 5-1.  The film or gel was cut to its appropriate size after drying and inserted into 
the measuring device, as shown in Figure 5.1.  Assuming successful immobilization, 
reactivity was checked by flowing 173 ppm gaseous NO over the sensing element for 10 
minutes or until a reaction was seen after the system had been referenced to the film.  The 
reaction of the hemes with NO was monitored by a dual wavelength spectrometer system 
installed on a personal computer as described in Section 5.2. 
 
A single solid thin film was examined first in a variety of configurations.  In order to 
increase the sensitivity of the sensing element, stacking was implemented. Stacks of thin 
solid films were fitted into a plastic comb holder with 1 mm spacing in between films to 
allow for suitable airflow through the sensing element. The next step was to reduce the 
thickness of the films, in order to increase the proportion of heme that was reacting with 
NO. Glass cover slips were coated with a thin film and dried and stacked, one drop of 
solution on a cover slip.  The next step was to reduce the amount of heme that was not in 
the light path. Optimally, the diameter of the films would be just greater than the 
diameter of the light source to optimize the signal. Thus, stacks of metal spacers with 
holes in the middle were created; generally two to three drops of heme were cast and 
dried in the hole.  Dimple slides and box slides were used to increase the depth of the cast 
heme to try to increase sensitivity. 
 
Single slabs of gels were examined next. A single slab was created by partially drying 
aliquots of solution in metal weigh boats and cutting them to size. The reactivity of the 
heme was examined by immersing the slab in a solution of sodium dithionate in H2O. 
Sodium dithionate is a strong reducing agent.  Thus, if the slab remains reactive, then the 
sodium dithionate should reduce the Fe III heme to the Fe II heme and change color.  If 
the slab changed color, a reaction was assumed.  In order to increase the surface area 
available for reaction with NO, patterns were imprinted on the resulting gel. First, the 
gels were imprinted with fine bubble wrap before they dried. In the second phase, a thin 
comb of needles was repeatedly poked into the finished gel. If the patterning was 
successful, reactivity with gaseous NO was checked. 
 
Two polydimethyl siloxanes (PDMS) were examined for reactivity with nitric oxide in 
three different immobilized states: diacetoxy methyl terminated polydimethyl siloxane 
and heptane dis-cyclohexaamino terminated polydimethyl siloxane both in 
tetrahydrofluoro dioxane.  Simple mixing over a 30-minute period with a low speed 
stirring plate created an even dispersion of the heme through the polymer.  The solution 
was mixed to create a 100 µM solution.  Two ml of the solution was allowed to dry in a 
metal weigh boat and once curing was complete, reactivity was checked as previously 
described.  The procedure was repeated with 1 ml, 5 ml and 10 ml of solution.  The entire 
procedure was repeated with a 25, 50 and 200 µM solutions.  The next configuration 
involved sandwiching the heme in between two slabs of cured siloxane.  One ml of 
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siloxane solution was cured over low heat in metal weigh boats in two segments.  A 0.05” 
Teflon spacer was placed on top of one cured siloxane slab.  The slab was cut to the size 
of the spacer (1” in diameter) and 0.25 ml of a 100 µM heme solution was poured into the 
spacer.  The second slab was cut and placed on top and the edges were sealed with "crazy 
glue".  The procedure was repeated with 0.50 ml solution and 1 ml solution and also with 
25, 50 and 200 µM solutions and reactivity was checked with the configuration, as shown 
in Figure 5.1.  The final configuration test involved heme modification such that it would 
dissolve in the polymer solution without affecting the reactivity by addition of 
polyethylene glycol (PEG) (Haire et al., 1984).  Proportions are given in Table 5-2.  The 
slabs were dried at 27°C for 1 day and reactivity was checked with the optical 
configuration, as shown in Figure 5.1. 
 
All experiments were repeated four times.  If immobilization was successful, one sensing 
element from each experiment was immersed in a sodium dithionite solution to ensure 
reactivity.  A color change would indicate that the heme was still reactive.  The 
remaining three pieces were reacted with nitric oxide. 
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Table 5-1:  Methods for heme immobilization.  The rows indicate the identifying number 
for that experiment.  The first column refers to the polymer used to create the solid phase 
and the end product, variances are in the methods used to polymerize the solution.  Thus, 
PVA film refers to films made from polyvinyl alcohol (PVA) and PVA gels are gels 
produced from PVA. The shaded trials are used to separate different sets of experiments. 
 
PVA 
Film 
Ml 
dried 
Solv. 
(ml) 
Cyt-c 
(mg) 
(g) Temp 
(°C) 
Drying 
dish 
Drying 
time 
Drying method Notes on Drying 
1 10 20 50 2.0 22 glass 4 days Air  
2 10 40 100 4.0 30 glass 21 hours Oven  
3 10       H2O bath  
4 10       Oven 1:1 H2O:EtOH 
solvent 
5 10     foil 21 hours Oven  
6 10       H2O bath  
7 10       Oven 1:1 H2O:EtOH 
solvent 
8 16 20 50 2.0 25 glass 7 days Oven  
9 10 40 100 4.0 27 Glass 3 days Oven Covered, holes 
10 10        Covered 
11 20        Uncovered 
12 10 20 50 2.0 25 glass 5 days Oven Uncovered 
13 10        Covered, holes 
14 10 20 50 4.0 25 glass 5 days Oven Covered, holes 
15 10   1.0     Covered, holes 
16 10 40 100 4.0 27 Glass 36 hours Oven Covered, holes 
17 4 10 25 1.0 25 4.5 ml 
cuvette 
7 days Oven  
18 1         
19 4     1.5 ml 
cuvette 
   
20 1         
21 1 
drop 
8 10 0.8 27 Cover 
slips 
stacked 
1 day Oven  
22 2 ml     Stacked 
films 
   
23 2-3 
drops 
    Metal 
Spacers 
stacked 
   
24 2-3 
drops 
10 25 2.0  Dimple 
slide 
   
25 0.5 
ml 
    Box slide    
 
 
PVA 
Gels 
Ml 
dried 
Solv. 
(ml) 
Cyt-c 
(mg) 
(g) Temp 
(°C) 
Drying dish Drying 
time 
Drying 
method 
Notes on 
Drying 
26 20 60 150 18 27 Plain gel 
metal boats 
1 day oven  
27      Imprinted 
with bubble 
wrap-metal 
weigh boats 
   
28      Poked with 
needles in 
metal weigh 
boats 
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Agar 
Film 
Ml 
dried 
Solv. 
(ml) 
H2O 
Cyt-c 
(mg) 
(g) Temp 
(C) 
Drying dish Drying 
time 
Drying 
method 
Notes on 
Drying 
29 10 50 12.5 0.5 22 Glass 4 days air  
30 10    27 Glass 21 hours oven  
31 10       H2O bath  
32 10     Foil  oven  
33 10       H2O bath  
 
Agar 
Gels 
Ml 
dried 
Solv. 
(ml) 
Cyt-c 
(mg) 
(g) Temp 
(°C) 
Drying dish Drying 
time 
Drying 
method 
Notes on 
Drying 
34 20 50 12.5 2.5 27 Plain gel in 
metal weigh 
boats 
1 day Oven  
35      Imprinted 
with bubble 
wrap in 
metal weigh 
boats 
   
36      Poked with 
needles  in 
metal weigh 
boats 
   
 
Table 5-2:  Polydimethyl siloxane proportions used to produce films.  Again, the rows 
represent the identifying number for the trial. 
 
Sil 
Films 
Cytochrome-c 
(ml) 
PEG PDMS Total Volume 
Dried (ml) 
37 2 1 1 5 
38 2 2 1 5 
39 2 4 1 5 
40 2 8 1 5 
41 2 1 2 5 
42 2 1 4 5 
43 2 1 8 5 
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Figure 5.1.  Experimental setup used for testing solid phase sensing elements.  This setup 
was used to deliver gas to the solid phase sensing element and spectroscopically evaluate 
the subsequent reaction. 
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5.6 Flow-through Sensor Design 
Flow-thru cell systems were designed and evaluated as an option to solid phase systems 
in order to maximize sensitivity and reversibility options.  System design was evaluated 
quantitatively and qualitatively to maximize sensitivity and response time.  Parameters 
that were tested include tubing placement, solonoid and flowmeter placement, heme 
injection and ejection methods, sensing element thickness and the positions of the 
input/output lenses.  Mechanical and electrical components were designed as functional 
pieces to ensure stable sensor operation.  Once the physical system design was 
completed, sensor parameters were evaluated to optimize sensitivity without overly 
sacrificing response time.  Parameters include referencing procedures, flow time and flow 
rate, system pressure, and heme concentration.  System timing was set following 
completion and evaluation of previous experiments.  
 
5.6.1 Methods for Flow-through Sensor Experiment Design 
 
Cytochrome-c, horse heart derived, was obtained from Sigma Chemical Co. (St. Louis, 
MO).  Cytochrome-c was dissolved to a concentration of 5 mg/ml in pH 7.40 monobasic 
potassium phosphate and sodium hydroxide buffer to yield the unreduced Fe III forms 
(99% pure).  The starting heme’s identity was characterized from its known absorption 
spectrum.  173 ppm NO, balance N2, was obtained from NorthEast Air Gas Co. 
 
The reaction of the hemes with NO was monitored by a spectrometer system installed on 
a personal computer as described in Section 5.2.  The basics of the completed 
measurement system are given as an example; a diagram is given in Figure 5.2.  
Cytochrome-c is injected into the sensing element via a motor controlled by the PC 
through a data acquisition card (PC-DIO-24F-5).  Thirty seconds were allowed for the 
system to come to equilibrium and a reference spectrum was taken. Gaseous NO, 173 
ppm in N2 (Northeast Airgas Co., Hudson, MA), was delivered to the sensing element for 
1 minute.  Precise timing was achieved through an in-line solonoid, which was controlled 
by a PC through the PC-DIO-24F-5.  Precise NO concentrations were monitored via an 
in-line flowmeter.  It was assumed that the concentration of NO could be controlled by 
regulating the flow of NO and diluting it to various concentrations with a precise flow of 
N2 as described in literature (Tibballs et al., 1993), (Aylott et al., 1999).  The reaction 
between cytochrome-c and NO, resulting in the formation of a cytochrome-c-NO 
complex, was allowed to come to equilibrium for 1 minute.  Testing of this parameter is 
described in Section 5.6.4.  A spectral measurement was recorded by the spectrometer 
system as Absorbance vs. Wavelength (nm) at the end of this period.  The absorbance 
was recorded at 563 nm, corresponding to the peak wavelength of the cytochrome-c-NO 
complex.  Prior to all sets of experiments, a baseline background and reference spectra 
with buffer in the path were taken and stored to ensure that the system had stabilized.  All 
experiments were run with a 0.05 second integration time, averaging of 5 times per cycle, 
cytochrome-c concentration of 5 mg/ml, 1 minute flow time of NO, 68.95 kPa (10 psi) 
and 200 cc/min total flow rate, unless otherwise noted.  Specifics are given for each set of 
experiments in the following paragraphs. 
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5.6.2 Configuration of the Flow-Through Sensor 
 
The sensor incorporates a 1.27 mm (0.05”) thick, gas permeable, flow-thru liquid cell 
into a probe, which can be incorporated into a ventilator circuit.  As discussed earlier, 
cytochrome-c(Fe III) was the best choice for use as a sensing element because it is 
insensitive to oxygen, it has a linear response to NO in the range of interest and it 
provides good sensitivity.  Thus, sensor operation is based on the complexation reaction 
of NO with cytochrome-c (Fe III).  The complex is monitored spectrophotometrically in 
the visible region of the spectrum at 563 nm (Yoshimura et al., 1987), (Kudera, 1990), 
resulting in a sensor specific to NO in the presence of oxygen.  The goal is to develop a 
sensor that is sensitive to concentrations of NO as low as 1ppm and linear in the range of 
1-100 ppm. 
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Figure 5.2.  System diagram for the flow-through sensor.  System used to deliver heme and 
gas to sensing element and subsequently acquire a spectroscopic measurement of the 
resultant reaction. 
 
• Base 
• Collector 
• Emitter 
Transistor 
+12 
 Ground 
Power 
Supply 
  Motor 
Motor
Control 
Chip 
DAQ
± 5V Digital Control
Lines 
1 cc syringe
Roller 
Head 
PC:
Running
LabVIEWTM
Optical
Spectrograph
Card
Waste
     Solenoid
Closed
1
3
2
Lens
Membrane
Lens
Mixed Gas
Heme Solution 
 
One-Way
Valves
Flowmeter
Gas Vent 
 
 42
5.6.3 Physical Design of the Flow-through Sensor  
 
There are a number of questions that need to be addressed before a suitable physical 
design is implemented to ensure stable operation of the system.  The sensor incorporates 
a thin film of heme solution into a chamber that allows gas samples to pass through it and 
react with the heme.  The NO complexes with the heme and produces a 
spectrophotometrically monitorable product in the visible region of the spectrum.  Post 
reaction, an optical measurement is taken perpendicular to the plane of the sensing 
element to relate NO concentration to the absorbance of the complex at a specific 
wavelength.  A diagram is provided in Figure 5.2 outlining major system components.  A 
discussion of necessary system components follows. 
 
The height of the tubing for delivery of heme to and from the sensing element is a critical 
parameter because it affects fluid dynamics.  It is important that the system delivers heme 
to and from the system in a consistent manner and that the fluid stabilizes post injection 
to allow for reaction.  Major components of the gas delivery system which affect its 
operation include the digital flowmeter, used to determine exact gas flow, and the 
solenoid, used to control gas flow.  Placement of these devices affects the pressure within 
the system and the precision of the measurement.  The heme injection/ejection system 
must deliver fluid to and from the system in an exact manner, meaning the volume of 
heme coming in must equal the volume of heme leaving the system.  In addition, there 
should be no mixing of incoming and outgoing fluids.  The thickness of the sensing 
element will affect not only the fluid dynamics of the heme coming and going from the 
sensing element, but will also affect the measurement level.  Finally, the distance 
between the input and output lenses should be optimized for the system to provide the 
maximum light throughput. 
 
Once the physical design is complete, a number of sensor parameters need to be 
examined to optimize the system for sensitivity and response time.  Referencing 
procedures need to be evaluated to ensure that the system is noise-free and the baseline is 
stable during each cycle, whether the reference is taken at the onset of a shift or at the 
beginning of each cycle and whether buffer or heme is used as the reference.  The next 
three parameters are solely timing issues:  how long does it take the system to equilibrate 
after heme injection, how long does the sample gas need to flow and how long will it take 
for the reaction to equilibrate after gas flow is off.  The system must come to equilibrium 
after heme injection and prior to onset of reaction so that the only changing parameter is 
the reaction.   The total time of NO flow has paramount effects on the signal level.  It is 
necessary to set this parameter such that a maximum signal is achieved at the highest 
expected NO concentration without saturating the heme and overly sacrificing response 
time.  Finally, the reaction should be allowed to come to an equilibrium so that the 
measured signal is at its highest point.   
 
The flow rate also affects the sensitivity of the system.  Higher flow rates will deliver 
more NO molecules to the system in a shorter period of time and will increase the 
pressure within the sensing element.  The increase in pressure will push on the 
membrane, subsequently reducing pathlength, but it will also drive more NO molecules 
through that membrane causing an increase in the number of reactions occurring in a 
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specified period of time.  Thus, the flow rate needs to be optimized to give the highest 
signal level.  Pressure that the gas sample is delivered with needs to be evaluated to 
determine the level at which a maximum signal is achieved.  The cytochrome-c 
concentration should be set such that at a maximum NO concentration, the reaction will 
not saturate given the flow rate, pressure, sensing element thickness and total time of NO 
flow.  Finally, a representative calibration curve has to be provided utilizing the chosen 
physical configuration and sensor parameters. 
 
Thus, this section deals with physical design aspects of a flow-thru liquid sensor.  In 
addition, sensor parameters based on this design, including referencing procedures, flow 
time, flow rate, system pressure and heme concentration are analyzed with respect to 
optimizing sensitivity without sacrificing response time. 
 
Tubing height was examined as follows.  Buffer was injected into the system and 30 
seconds were allowed for the system to come to equilibrium prior to referencing.  Heme 
was injected into the system and fluid dynamics were observed over the course of 10 
minutes.  Four configurations were tested: placing the input tubing at a level higher than 
the output tubing, placing the output tubing higher than the input tubing, and placing both 
the input and output tubing higher and lower than the sensing element.  Fluid dynamics 
were observed.  The configuration that resulted in a system in which injected fluid 
remained motionless and stable until ejection was noted. 
 
Flowmeter and solenoid placement was examined by positioning the flowmeter before 
and after the sensing element and placing the solenoid before and after the sensing 
element.  Buffer was injected into the system and 30 seconds were allowed for the system 
to come to equilibrium prior to referencing.  Cytochrome-c was injected into the system 
and 30 seconds were allowed for the system to come to equilibrium.  N2 was delivered to 
the system for one minute and spectral measurements were taken every 15 seconds for 10 
minutes.  The entire procedure was repeated 5 times.  Pressure changes within the system 
were qualitatively evaluated.  The system that produced no changes in the spectrum due 
to pressure changes before and after nitrogen flow was noted.  
 
Three injection/ejection methods were examined.  Injection of heme followed by 
displacement with air (2 pump system), injection of heme followed by displacement with 
buffer (2 pump system) and injection of heme followed by withdrawal of heme with a 
one pump system.  Buffer was injected into the system and 30 seconds were allowed for 
the system to come to equilibrium prior to referencing.  Cytochrome-c was injected into 
the system and 30 seconds were allowed for the system to come to equilibrium.  The 
heme was then displaced and the sensing element was observed through the lens (with the 
output fiber disconnected).  The cycle was repeated 10 times for each of the three 
methods.  The system that yielded equal exchange of fluids and no mixing of incoming 
and outgoing heme was noted. 
 
Thickness of sensing element was examined by varying the combination of spacers and 
input needles.  Spacers ranging from 0.254 mm (0.01”) to 2.54 mm (0.1”) were examined 
with input needles ranging from 14 gauge to 22.5 gauge.  Cytochrome-c was injected into 
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the system and flow of fluids through the system was observed for each feasible 
combination.  30 seconds were allowed for the system to equilibrate prior to referencing.  
Gaseous NO (173 ppm) was delivered to the system for one minute and spectral 
measurements were taken every 15 seconds for 10 minutes.  The thickness was evaluated 
by noting the time it took to fill and empty the chamber and the time it took the reaction 
to equilibrate.  Input needle size was examined by noting the force with which and the 
time it took to push the heme into the chamber through the needle.  The combination that 
gave the smallest response time and required the smallest amount of force was noted. 
 
Distance between input and output lenses was determined by the physical constraints of 
the system and by optimal distance specifications. 
 
5.6.4 Sensor Parameters 
 
Referencing procedures were examined with the following set of experiments.  Buffer 
was injected into the sensing element and 30 seconds were allowed for the system to 
come to equilibrium.  Then, a reference spectrum was taken.  Heme was then injected 
into the system and 30 seconds were again allowed for the system to come to equilibrium. 
Gaseous NO at 173 ppm, was delivered to the sensing element for 1 minute.  The reaction 
was allowed to come to equilibrium for 1 minute and a spectral measurement was 
recorded.  The cycle was repeated from the point of heme injection and data was recorded 
every half-hour for 8 hours.  The experiments were repeated with the system being 
referenced to cytochrome-c instead of buffer.  The final set of experiments involved 
referencing to cytochrome-c once at the beginning of every cycle, after injection of the 
heme and system stabilization.  The referencing procedure that reduced drift and noise to 
a minimum level measured at wavelengths between 500 nm and 600 nm was noted. 
 
The time it takes for the system to come to equilibrium post heme injection was 
examined by injecting heme into the system and recording the spectra at set intervals for 
2 minutes.  The absorbance at 530 nm was plotted against time and the point at which the 
signal reached a plateau was noted.  Measurements were taken at 5, 10, 15, 20, 25, 40, 
65, 90, 115 and 120 seconds. 
 
The effects of total time of NO flow was examined by injecting heme into the system and 
allowing 30 seconds for the system to come to equilibrium prior to referencing.  After 
establishing 200 cc/min (173 ppm) NO flow, spectral measurements were recorded at 0, 
6, 12, 18, 30, 45, 60, 75, 90, 105, 120, 150, 180 and 240 seconds.  Absorbance at 563 nm 
vs. flow time was plotted and analyzed to determine how long it would take the reaction 
to saturate. 
 
The time it takes the reaction to equilibrate after the flow of sample gas is turned off was 
examined by injecting heme into the system and allowing 30 seconds for the system to 
come to equilibrium prior to referencing.  200 cc/min (173 ppm) NO was delivered to the 
system for 1 minute.  Spectral measurements were taken every 30 seconds for 5 minutes.  
The absorbance at 563 nm was plotted against time and the point at which the reaction 
reached equilibrium was noted. 
 45
 
The effects of flow rate were examined as follows.  Cytochrome-c was injected into the 
system and 30 seconds were allowed for the system to come to equilibrium prior to 
referencing.  173 ppm NO at 400 cc/min was delivered to the system for one minute.  The 
reaction was allowed to equilibrate for 1 minute and a spectral measurement was taken.  
The procedure was repeated for flow rates of 200, 100, 50, and 25 cc/min.  Absorbance at 
563 nm vs. flow rate was plotted and analyzed to determine the flow rate of nitric oxide 
that gives the highest absorbance for a NO concentration of 173 ppm. 
 
System pressure was the next parameter to be evaluated.  Cytochrome-c was injected into 
the system and 30 seconds were allowed for the system to come to equilibrium prior to 
referencing.  173 ppm NO at 200 cc/min and 34.5 kPa (5 psi) was delivered to the system 
for one minute.  The reaction was allowed to equilibrate for 1 minute and a spectral 
measurement taken.  The procedure was repeated for pressures of 6.9 kPa (10 psi), 13.8 
kPa (20 psi) and 27.6 kPa (40 psi).  Absorbance at 563 nm vs. pressure was plotted and 
analyzed to determine the pressure that produces the highest absorbance at 173 ppm NO. 
  
The concentration of cytochrome-c was tested for its effect on sensor sensitivity.  The 
cytochrome-c (10 mg/ml) was injected into the system and 30 seconds were allowed for 
the system to come to equilibrium prior to referencing.  173 ppm NO at 200 cc/min and 
34.5 kPa (5 psi) was delivered to the system for one minute.  The reaction was allowed to 
equilibrate for 1 minute and a spectral measurement was taken.  The procedure was 
repeated at NO concentrations between 173 ppm and 0 ppm (173, 86.5, 43.25, 21.63, 
8.65, 4.33, 1.73 and 0 ppm).  The entire procedure was again repeated for cytochrome-c 
concentrations of 5 mg/ml and 2.5 mg/ml.  Calibration curves at different concentrations 
were plotted and analyzed to determine the effect of concentration on sensitivity. 
 
A representative calibration curve was generated and used to examine the minimum 
detectable limit and linearity.  Cytochrome-c (5 mg/ml) was injected into the system and 
30 seconds was allowed for the system to come to equilibrium prior to referencing.  173 
ppm NO at 200 cc/min and 68.9 kPa (10 psi) was delivered to the system for one minute.  
The reaction was allowed to equilibrate for 1 minute and a spectral measurement was 
taken.  The procedure was repeated at NO concentrations between 173 ppm and 0 ppm 
(173, 86.5, 43.25, 21.63, 8.65, 4.33, 1.73 and 0 ppm).  Five-point spectral averaging was 
employed to reduce the noise level.  The minimum detection limit was determined by 
calculating the nitric oxide concentration from the absorbance at 5 times the noise level 
(S/N=5). Linearity was examined by looking at the r2 value over the entire range of 
concentrations studied.  A value > 0.8 implied a linear trend. 
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C h a p t e r  6  
6. HARDWARE AND SOFTWARE DESIGN 
6.1 Introduction 
The transformation of a sensing compound into a physical sensor is a major process.  It 
incorporates the sensing element into a configuration which allows the sensing reaction to 
occur.  Subsequently the sensor collects, processes, stores and displays data.  For this 
project, a system was needed to deliver the heme and the gas sample to the sensing 
element in order to allow for reaction and measurement. 
 
This chapter describes the system depicted in Figure 5.2.  This system of hardware and 
software was the instrument which was used to test various data acquisition and 
processing algorithms and calibration techniques.  A final instrument will incorporate a 
more manufacturable hardware design based on the current configuration and a more 
rigid software package.  The software will integrate data acquisition and processing 
routines such that an estimate of the NO concentration will be generated and output and 
the graphical user interface (GUI) will be redesigned to provide a user-friendly interface 
which automates all functions. 
 
The design process of the sensor encompassed three segments including design of the 
sensing element, heme injection/ejection system design, and gas flow regulation.  
Software was subsequently used to integrate and drive the resulting hardware 
components, run the measurement system and perform data manipulation, including data 
acquisition, processing, storage and display of data and results.  This chapter deals with 
the description of the sensing element integration into a physical sensor, addressing both 
hardware and software issues.  The design requirements of each subsystem will be 
outlined in its appropriate section. 
6.2 Software Overview 
The system, as depicted in Figure 5.2 operates in conjunction with an IBM compatible 
personal computer (PC).  This highly intelligent controller approach allows the designer 
to develop custom algorithms for specific instrument applications.  For the purpose of 
this project, system software was developed to support the measurement of absorbance, 
which will subsequently be used to estimate the NO concentration.  The software 
operates under the Windows OS (operating system) and interacts with the user through a 
graphical user interface (GUI).  Its basic functions are to allow for a simple operating 
procedure while performing complex functions in the background. 
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The entire operation of the sensor is software controlled by LabVIEW (National 
Instruments, Inc., Austin, TX) running on a PC integrated with selected software and 
hardware components. LabVIEW is a data acquisition and control software package and 
is used for hardware control and data collection, processing, storage and display.   For 
more details on LabVIEW, please refer to Section 4.7.  A basic sequence of events 
describing hardware operation is given in Table 6-1, along with a physical sensor 
diagram in Figure 5.2, and an instrument front panel in Figure 6.2.  The complete source 
code for the custom software is given in Appendix A.   
 
Software was subsequently used to integrate and drive the resulting hardware 
components, run the measurement system and perform data manipulation, including 
acquisition, processing, storage and display.  A simplified block diagram of the system 
software is presented in Figure 6.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.  Simplified block diagram of the system software 
 
The software interacts with the user in the Windows environment through a GUI.  The 
user can select the options on the screen and the GUI will subsequently activate the 
corresponding sensor functions.  The general functions that a user can perform through 
the GUI are to: 
 
•= turn the system on/off; 
•= obtain and view a reference and background spectra; 
•= acquire spectral information between 375 nm and 725 nm; 
•= obtain and monitor spectral information at 6 individual wavelengths vs. time; 
•= save both Absorbance vs. time and Absorbance vs. wavelength data; 
•= select filenames for both data files;  and, 
•= set the number of samples to average and the integration time. 
 
In order to perform these functions, the system may operate in two modes:  continuous 
and non-continuous modes.  In the continuous mode, the system operates the sensor and 
acquires absorbance measurements continuously.  There is no delay between each set of 
measurements as hardware operation provides sufficient time lapse and is the limiting 
factor.  In the non-continuous mode, the system performs only maintenance functions 
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such as updating the clock.  When the user initiates an event in this mode, the GUI 
responds, performs the required function and then returns to the previous idle state. 
 
6.2.1 Software Operation 
 
In summary of the measurement process, the first step is to obtain a background spectrum 
to compensate for any existing background fluctuations and/or noise.  Then the system 
injects heme and allows a specified period of time for the system to stabilize before 
acquiring a reference spectrum to zero the system.  The next step involves the flow of gas 
and the subsequent reaction between the gas and the heme.  Post reaction and equilibrium 
a spectrum is acquired, processed, stored and displayed.  Each spectrum is measured from 
375 nm to 720 nm, with a step of 1 nm (for a total of 345 data points per spectrum), with 
a user selectable integration time.  Several spectra can be averaged (user selectable 
number).  The cycle begins again with the injection of the heme.  Specifics are given in 
the following paragraph.  Please refer to Table 6-1 for a basic sequence of events and 
Figure 6.2 for the depiction of the GUI. 
 
Table 6-1:  Sequence of events in sensor operation 
 
 
•= Block light source physically 
•= Initiate background spectrum acquisition manually, and store it 
•= Press start 
 
a) Motor injects 0.25 cc heme. 
b) Wait for 30 seconds. 
c) Reference spectrum taken and stored internally. 
d) Solenoid turns on. 
e) Gas flows for 1 minute, reacts with heme. 
f) Solenoid turns off. 
g) Wait for equilibrium for 1 minute. 
h) Spectrum acquired, data processed, stored and displayed. 
i) Repeat from (a). 
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Figure 6.2.  Sensor GUI front panel 
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The first step in sensor operation is to turn the system on by using the System on/off  
virtual toggle switch on the front panel of the instrument, refer to Figure 6.2.  The user 
inputs two file names, one for saving the absorbance measurements across the entire 
range of wavelengths, the other for saving information for selected wavelengths and their 
variation in time.  The user must also input the desired wavelengths pertinent to 
spectroscopic measurement.  Integration time (seconds) and averaging (number of 
samples to average) are also user specified, as described in the next chapter.  The next 
step is to acquire a background spectrum.  The user physically blocks the light source 
with a black panel and toggles the Store Background switch on the front panel of the 
instrument.  The instrument then acquires a background spectrum, stores the data 
internally and displays the results on the front panel of the system.  All spectroscopic 
measurements are acquired by controlling the spectrograph card (Control Development, 
Inc., Southbend, IN) through software provided by Control Development Inc. (CDI).  The 
user then toggles the Save Data switch to on, thus telling the system to save data to be 
acquired to the specified file names in ASCII format.  The file can be opened in any 
spreadsheet specified by the user.  In order to begin collection of data, the user must then 
toggle on the Acquire Data button on the front panel.  This begins the collection cycle.  
LabVIEW sends a signal to the PC-DIO-24 (see Section 6.3.2), giving high/low signals to 
the appropriate digital control lines.  The PC-DIO-24 sends a signal to the motor through 
the motor control integrated circuit (Hurst, model 220001) to first purge the system of 
heme and then inject a fresh sample.  Another signal is sent to turn the motor off after one 
complete rotation.  The system is then allowed to settle for 30 seconds.  Through 
LabVIEW, the operation of the system is timed by an internal clock.  Subsequent to 
equilibration, a reference spectrum is acquired to zero the system.  The Store Reference 
switch is set as a default to “on” state.  This allows the system to automatically take a 
reference at this point.  The data is stored internally and displayed on the screen for the 
user. Gas flow is then started.  A low signal is sent to the base of the solenoid control 
transistor, resulting in a +12 volt transistor output.  This high voltage turns the gas to the 
on state.  Gas is allowed to flow for 60 seconds and then a high signal is sent to the base, 
resulting in a low transistor output, turning the solenoid to the off state of no gas flow.  
Again 60 seconds are given to allow the system to equilibrate.  The final step involves 
acquiring a spectrum, processing, storing and displaying the measured data.  Data 
processing techniques are discussed in Chapter 7.  Measurements are obtained in an 
absorbance mode.  The data is stored into two files.  One holds the spectral data across 
the wavelength range of 375 nm to 720 nm, with a step of 1 nm.  The other holds the 
absorbance measurements at a few user selected wavelengths.  The data is displayed in 
real time as absorbance vs. wavelength and as absorbance at a specific wavelength vs. 
time.  The cycle begins again following the completion of the previous measurement 
cycle.  Data processing is conducted manually at a later time. 
 
6.2.2 Graphical User Interface (GUI) 
 
The graphical user interface (GUI) was developed to ensure a user-friendly interface of 
the NO sensor.  This version of the software was intended to allow the user to collect all 
data pertinent to subsequent data processing.  Thus, the GUI does not calculate the final 
NO concentration, it solely enables easy collection of the information necessary to 
calculate this parameter.  Its primary function is to support the operation of the NO 
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sensor.  The spectrometer functions, including background and reference spectra 
acquisition and presentation are made easily removable and are intended for use only 
during development.  They will become automated functions in the final instrument. 
 
Interaction with the GUI is solely through window controls.  The controls, each having its 
own function, are all elements in the window.  The functions of the controls encompass 
user input, output and activation of subroutines.  The GUI remains in the idle mode until 
the user activates the instrument by clicking on a control or by keyboard input.  The GUI 
consists of one window for hardware control and data acquisition, processing, display and 
storage. The main window is shown in Figure 6.2.  The title of the window is “NO Sensor 
Development Software”.  It has 16 controls and 11 indicators, labeled in Figure 6.2: 
 
Spectrum (Absorbance vs. wavelength (nm)) Indicator - Presents spectral information between 375 
nm and 725 nm, step 1 nm as an Absorbance of heme 
exposed to NO. 
Background Spectrum (Counts vs. wavelength (nm)) Indicator - Presents the background spectrum in the 
same wavelength region in A/D counts, with no light 
applied. 
Absorbance at λ (nm) vs. time (min) Indicator - Presents the absorbance at up to 6 selected 
wavelengths vs. time. 
Reference Spectrum (Counts vs. wavelength (nm)) Indicator - Presents the reference spectrum for the 
same wavelength region in A/D counts (spectrum of 
heme not exposed to NO). 
System On/Off Control - Toggle switch for turning the system on or 
off. 
Integration Time (sec) Control - Allows the user to set the integration time 
for the spectrometer in seconds. 
Samples to average Control - Allows the user to set the integer number of 
samples to average. 
Store background Control - Allows the user to store the background 
information at any point during the cycle. 
Store reference Control - Allows the user to store the reference 
spectrum at any point during the cycle. 
Acquire Data Control - Must be on to start a cycle.  Instrument 
cycles continuously until the system is turned off.  
Generally the user will acquire a background and a 
reference and then toggle this switch on. 
Save Data Control - Allows the user to specify if data is being 
saved to disk in ASCII format, readable by any 
spreadsheet program. 
Wavelengths Six controls - Allows the user to set the wavelengths 
at which data will be individually collected. 
Absorbance Six indicators - Display the Absorbance at the user 
selected wavelengths. 
File name for Absorbance vs. Wavelength Control - Allows the user to input a name for the 
specified file. 
File name for Absorbance vs. Time Control - Allows the user to input a name for the 
specified file. 
Time of day Indicator - Displays the system time. 
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Load setup Control - Allows the user to load a previously stored 
setup file with background and reference spectral 
information. 
 
6.2.3 Input/Output Data Files Format 
 
The Absorbance vs. Wavelength file has the headers “Wavelength (nm)” and 
“Absorbance” in columns 1 and 2, respectively.  The Absorbance vs. Time file has the 
headers “Time (min)” and “Absorbance at λ1” in columns 1 and 2, respectively.  
Subsequent columns contain the same header as in column 2, but with the appropriate 
user input wavelength shown.  Both the Absorbance vs. Wavelength file and the 
Absorbance vs. Time file are in ASCII data format, tab delimited.  The file extensions are 
as entered by the user, depending on the software that will be used to access the 
information. 
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6.2.4 Block diagram of system software 
 
Figure 6.3 contains a block diagram of the software at the level of sub-virtual 
instruments, from the software organizational point of view. 
 
 
 
 
 
 
 
 
 
 
 
    
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.  Block diagram of the organization of the sub-virtual instruments (subVI) 
within the main virtual instrument module.  Each box is a subVI. 
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The following is a general description of the function of each VI (Virtual Instrument).  
 
NO Sensor 
 
This is the main VI and it is used to create and control a sequence of events, and tie all 
the other VIs together into a timed operation of the hardware, data collection, processing, 
storage and display.  For reference, a basic sequence of events describing hardware 
operation is given in Table 6-1 along with a physical sensor diagram in Figure 5.2. and an 
instrument front panel in Figure 6.2.  
 
Motor 
 
This subVI sends signals to a PC-DIO-24 card, which generates the signals required to + 
drive a motor control integrated circuit, controlling the direction, state and timing of the 
motor. 
 
Spectrometer 
 
This subVI is used to control and acquire spectral information from the CDI spectrograph 
through a CIN (code interface node) provided by Control Development Inc. (Southbend, 
IN).  The CIN links the VI to the spectrograph allowing the user to input information 
necessary for control and function of the spectrograph. 
 
Write to Digital Line  
 
This subVI sets the output logic states of digital lines to high or low on specified digital 
ports. 
 
Write To Spreadsheet File 
 
This subVI converts a 2D or 1D array of single-precision (SGL) numbers to a text string 
and writes the string to a new byte stream file, or appends the string to an existing file.  
The data can be optionally transposed.  This subVI opens or creates a file before writing 
to it and closes it afterwards.  This subVI can be used to create a text file readable by 
most spreadsheet applications.  It calls the Array to Spreadsheet String function to 
convert the data. 
 
Read From Spreadsheet File 
 
This subVI reads a specified number of lines or rows from a numeric text file beginning 
at a specified character offset and converts the data to a 2D, single-precision array of 
numbers.  The array can be optionally transposed.  The subVI opens the file before 
reading from it and closes it afterwards.  This subVI can be used to read a spreadsheet file 
saved in text format.  This subVI calls the Spreadsheet String to Array function to convert 
the data. 
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Read Lines From File 
 
This subVI reads a specified number of lines from a byte stream file beginning at a 
specified character offset.  The subVI opens the file before reading from it and closes it 
afterwards.  
 
DIO Port Config 
 
This subVI establishes a port configuration.  The taskID that this subVI returns can be 
used only in digital port VIs. 
 
DIO Port Write 
 
This subVI writes the value to the port identified by taskID.   
 
Replace file no error 
 
This subVI opens an existing file, creates a new file, or replaces an existing file, 
programmatically or interactively using a file dialog box.  A dialog prompt, default file 
name, start path, or filter pattern can be optionally specified.  This subVI should be used 
with the intermediate Write File or Read File functions. 
 
Write File+ (string) 
 
This subVI writes data to the file specified by refnum.  Writing begins at a location 
specified by pos mode and pos offset for byte stream file, and at the end of file for 
datalog files.  Data, header, and the format of the specified file determine the amount of 
data written.  
 
Close File+ 
 
This subVI writes all buffers of the file identified by parameter refnum to disk, updates 
the directory entry of the file, closes the file, and voids refnum for subsequent file 
operations. 
 
General Error Handler 
 
This subVI determines whether an error has occurred.  If an error occurred, this subVI 
creates a description of the error and optionally displays a dialog box. 
 
Read File+ (string) 
 
This subVI reads data from the file specified by parameter refnum and returns it in data 
string.  Reading begins at a location specified by parameters pos mode and pos offset and 
depends on the format of the specified file. 
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Open File 
 
This subVI opens the file specified by file path for reading and/or writing. 
 
Find First Error 
 
This subVI tests the error status of one or more low-level functions or subVIs that output 
a numeric error code.  
6.3 Hardware Overview 
The first step in sensor operation, as described above, is to manually block the light 
source such that a background spectra can be acquired.  LabVIEW is used to send a 
signal to the optical spectrograph card to obtain this measurement and store the data.  The 
next step is to use the heme delivery system to inject the sensing compound into the 
sensing element.  The heme is injected into the sensing element by a syringe pump 
attached to a rotary motor.  The motor receives its signals through a PC-DIO-24, 
controlled by LabVIEW.  LabVIEW provides the information necessary to turn the motor 
on and off and to specify the time that it is in the “on” state.  After the period of time 
allowed for equilibration, LabVIEW sends a signal to the optical spectrograph card to 
obtain and store a reference measurement - spectrum of the sensor with heme only.  Then 
the gas delivery system is used to inject the gas sample into the sensing element to allow 
for the reaction to occur.  A 3-way solenoid is used to control the on/off state of the gas.  
LabVIEW is used to send signals to a transistor acting as a driver for the solenoid.  It is 
also used to specify the period of time the solenoid is in the “on” and “off” state.  From 
here, a specified period of time is allowed for the reaction to occur and equilibrate.  
Finally, LabVIEW again sends a signal to the spectrometer system to obtain the 
absorbance measurement of the sensor with heme that reacted with NO, that is processed, 
stored and displayed.  Each section is described in more detail in the following 
paragraphs. 
 
6.3.1 Hardware:  Sensing Element 
 
The purpose of the sensing element is to house the sensing compound, allow for a 
reaction to occur between the sensing compound and the gas sample, and allow for 
measurement of the subsequent reaction.  Specifications of the sensing element are given 
in Table 6-2 and its diagrams are given in Figures 6.4.a to 6.4.c.  The sensing element is a 
vertical structure.  Heme injection into and ejection from the sensing element are allowed 
through ports on either side of the sensing element, via 22.5 gauge needles inserted into 
the ports.  The heme is injected into a chamber that is created by a spacer.  The spacer is 
covered on top by a 0.0125 cm (0.005”) thick gas-permeable silicone sheet (Specialty 
Manufacturing Inc., Saginaw, MI) and on bottom by a lens which is clear in the visible 
region of the spectrum.  The thickness of the sensing element, set at 0.125 cm (0.05”), 
was determined by needle size, spacer size and reaction time, as discussed in Chapter 5.  
The gas permeable membrane is designed to allow passive diffusion of gaseous NO 
across the membrane and be optically clear in the visible region of the spectrum to allow 
for spectroscopic measurements.  Gas samples are introduced and purged above the heme 
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layer through ports on either side of the sensing element, fitted with Teflon tubing 
connectors.  Optical information is transmitted through an input fiber (600 µm core fiber 
bundle) connected to the light source on one end, and the top of the sensing element on 
the other end.  The output fiber (100 µm core mutlimode fiber) is connected to the bottom 
of the sensing element and to the optical spectrograph card.  Glass lenses are fitted into 
either end of the sensing element to allow for light transmission through the sensing 
element while keeping the system closed to air and stray light.  As explained in Chapter 
5, the optimal distance between the lenses is 4.45 cm (1.75”).  Due to physical constraints 
of the system, the sensing element was designed with a 5.08 cm (2.00”) distance between 
the lenses.  With this configuration, the gas is allowed to passively diffuse through the 
gas-permeable membrane into the heme solution.  Once the reaction is complete, a 
spectroscopic measurement is taken and the system is purged of both gas and heme. 
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Table 6-2  Specifications of the sensing element 
 
Specifications Parameter 
Dimension Material 
Body 6.0 cm high x 4.0 cm diameter Stainless Steel 
Glass 2.25 cm diameter x 0.2 cm 
thickness 
Glass 
Membrane 2.5 cm diameter x 0.0125 cm 
thickness 
Medical Grade Silicone Sheeting 
Fiber 
input/output 
SMA connector  
Gas 
input/output 
1.1 cm diameter Teflon connectors 
Heme 
input/output 
22.5 gauge needle stainless steel needles inserted 
into sensing element through 
rubber stopper 
O rings 3.125 cm diameter and 2.35 cm 
diameter 
Rubber 
Spacer  2.5 cm diameter x 0.1 cm 
thickness 
Teflon 
 
 
 
 
Figure 6.4.a  Diagram of the sensing element 
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Figure 6.4.b  Bottom up view of the sensing element 
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Figure 6.4.c  Top down view of the sensing element 
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6.3.2 Hardware:  Heme Delivery System 
 
The heme delivery system must work to inject and eject heme in a complete and efficient 
manner.  The heme is delivered to the sensing element through Teflon tubing which is 
kept level with the sensing element, as discussed in Chapter 5.  The tubing is inserted into 
an airtight, cold, black container containing the heme, to avoid degradation of the heme 
solution.  Flow of the heme through the tubing is accomplished by a motor used in 
conjunction with a syringe apparatus.  They produce a pump injection/ejection system, 
please refer to Figure 5.2.  As the motor depresses the syringe, residual heme in the 
system is pushed into a reservoir.  As the syringe head is released, the apparatus pulls the 
used heme from the sensing element and automatically draws new heme into the sensing 
element, thus amount of heme going out exactly equals the volume of heme coming in.  
The motor is software controlled via a motor control integrated circuit.  The PC sends out 
signals to the motor control integrated circuit through a data acquisition card (PC-DIO-
24, National Instruments, Austin, TX), which relays the information to the motor.   
 
The data acquisition card is an ISA plug and play board.  It uses a 24-bit programmable 
peripheral interface (PPI) to achieve 24 channels of digital I/O.  The PPI (82C55 PPI) 
controls 24 bits of digital I/O and has three 8-bit ports (A,B, and C), which can be 
functionally programmed as either inputs or outputs.  Ports A and B are always used for 
digital I/O, while port C can be configured for digital I/O, control, status, or handshake.  
It can be programmed for unidirectional or bi-directional bus I/O and also for interrupt 
generation.  The digital I/O lines can be set in a user defined state.  Each line is connected 
to a 100 kΩ pull-up resistor and can be pulled high or low.  It has an on-board 50-pin 
ribbon cable connector.  The 8 bits in Port A are PA7 through PA0 on the connector.  
Ports B and C are PB7 through PB0 and PC7 through PC0, respectively.  Each port is 
assigned as either an input or output by the PPI user.  Power from the ISA is also 
available on pin 49 of the connector. 
 
The motor control integrated circuit is a general purpose controller and driver for 4 phase 
stepping motors rated up to 500 mA/phase.  The required supply voltage ranges between 
6 and 24 VDC (+12 volts used), and the unit contains a regulator which provides the 
internal 5V logic supply.  All signals necessary for operation of the motor through the 
motor control integrated circuit are provided by the PC through the PC-DIO-24 card.  
Two modes of operation are possible through the use of multivibrator circuit:  Run 
(continuous operation) and JOG (single steps).  The frequency for continuous operation is 
user defined via a resistor and capacitor.  Direction of rotation is user controlled.  In 
addition, the unit contains a disable switch to de-energize all four phases of the motor 
without interrupting the supply voltage.  The integrated circuit is used in the run mode, 
where the pulse period is approximately 4.4⋅R⋅C, where R and C are externally provided 
resistor and capacitor.  When terminal 4 is pulled low, the multivibrator acts as an 
oscillator, and the motor is in the RUN mode.  When terminal 4 is unconnected, the phase 
drivers will remain in a holding mode with 2 phases on.  The integrated circuit is 
connected as shown in Figure 6.5.  Terminal 6 is left unconnected (pulled up) to achieve 
only a clockwise run.  Terminal 5 is held high so that the JOG switch has no effect on the 
operation of the motor.  Terminal 14 is held high at all times to enable the motor 
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operation.  Refer to Table 6-3 for a summary of connections.  The motor runs for one 
complete rotation during each cycle.   
 
 
 
Figure 6.5.  Connection diagram for the motor controller integrated circuit and the stepper 
motor for the heme delivery system. 
 
Table 6-3:  Signals for motor control integrated circuit via PC-DIO-24 
 
Parameter Run Cycle Off Cycle 
RUN Low High 
JOG High High 
CCW Unconnected Unconnected 
DISABLE High High 
 
18             9            10                                        7            8             2
                                                                                                        1
17                 4         5         6       14                    9      16                3
+Vin
-Vin
Black/White Blue/White
Motor
RedBlueWhite Black
Stepper
Motor
Controller
CCWRUN JOG DISABLE
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6.3.3 Hardware:  Gas Delivery System 
 
The gas delivery system must deliver the gas sample to the sensing element accurately 
and be free from leaks.  The gas is transferred from the source to the sensing element 
through Teflon tubing, connected to the sensing element by Teflon connectors.  A 
connection diagram is given in Figure 5.2.  Teflon and stainless steel are the materials of 
choice, used to avoid degradation of the sensor.  Both Teflon and stainless steel are not 
subject to corrosion when in prolonged contact with nitric oxide.  Gas flow is regulated 
by a solenoid, which is used to toggle the gas flow between the on and off states.  A 
digital flow meter is used to accurately measure the flow of gas.  Accurate concentrations 
of nitric oxide are achieved by adjusting the flow of nitric oxide relative to nitrogen.  For 
example, let us assume that the NO tank concentration is at 200 ppm and a 50 ppm 
delivery concentration is desired with a total gas flow of 100 cc/min.  The flow of nitric 
oxide is set at 25 cc/min and the nitrogen flow is fixed at 75 cc/min.  This produces a 
total flow of 100 cc/min, with a nitric oxide concentration of 50 ppm. 
 
The solenoid (ASCO, Series 8325) used to control gas flow is connected to a 3 way 
subminiature valve made of stainless steel.  The solenoid is controlled by an NPN 
transistor used as a switch.  The base voltage signal for the transistor is supplied by the 
PC through the same PC-DIO-24 used to send signals to the motor control integrated 
circuit.  A low signal sent to the base, results in a +12 volt transistor output.  This high 
voltage turns the gas flow on.  After a specified period of time required for the reaction to 
occur, a high signal is sent to the base.  This results in a low transistor output which turns 
the solenoid to the off state of no gas flow.  A diagram is given in Figure 6.6.  The 
flowmeter (Digital Flow Check, Alltech Associates inc., Deerfield, IL) was used to 
determine exact gas flow.  Solenoid and flowmeter placement issues were discussed in 
Chapter 5.  
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Figure 6.6.  Solenoid connections 
 
6.3.4 Hardware:  CDI Optical Spectrograph Card 
 
The optical spectrograph card (Control Development Inc., South Bend, IN), used to make 
spectroscopic measurements, is a high performance IBM compatible computer module.  
The spectrograph is permanently calibrated for wavelength and the thermo-electrically 
cooled CCD array system is highly stable.  The solid core glass fiber-optic input has low 
loss at the connectors and allows long connections with low loss.  It provides 14 bit high 
speed A/D conversion with 16 bit DAC analog offset, which maximizes the A/D dynamic 
range and the low noise circuitry provides high signal to noise ratio.  The spectrometer 
system is software driven by a custom package linked to LabVIEW.   
 
 
Subsequent to the completion of hardware and software design and implementation, data 
processing issues were examined.   The next chapter deals with using the test system to 
set parameters including integration time and signal averaging, and to discover how to 
perform data processing in order to maximize sensitivity without sacrificing response 
time or increasing system cost. 
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C h a p t e r  7  
7. METHODS 
7.1 Data Processing  
Upon completion of system hardware and software elements, the next step in sensor 
design is to maximize the sensitivity without sacrificing response time by optimizing data 
collection and signal processing techniques.  Techniques to be explored include 
integration time optimization, averaging, comparing acquisition of single spectra to 
filling a buffer and averaging the results, point to point averaging over a wavelength 
region, comparing absolute absorbance measurements to difference spectra, and 
comparing integration over a peak to single wavelength measurements. 
 
Setting data collection parameters starts with the integration time selection.  Spectrometer 
integration time determines how many counts reach the detector for any given sample.  
As the integration time increases, the number of counts reaching the detector increases 
and the response time of the sensor increases.  At a certain level the detector will saturate 
with any increase in integration time while the response time will continue to increase.  
Thus, the integration time should be set to maximize the number of counts reaching the 
detector without saturating it with just the sensing element in the path.  Averaging is used 
to minimize noise without overly sacrificing response time.  As the number of spectra 
that are averaged increases, the noise decreases (with a square root of the number of 
averages) and the response time increases linearly.  At a certain number, the decrease in 
noise will become negligible while the response time will continue to increase.  Thus, the 
averaging number should be set to minimize noise without overly sacrificing response 
time.  Finally, two methods of spectral collection were analyzed including single spectral 
acquisition or by filling a buffer with 17 spectra and averaging the results.  These 
methods are integrated into the software package used to run the spectrometer system.  
This option allows the user to either collect one spectrum at a time, or to hold 17 spectra 
and average them automatically.  When the system holds 17 spectra in a buffer, the 
spectra are collected at a maximum collection rate and then averaged.  When a single 
spectrum is collected at a time, the system is constrained by having to store the data and 
then average it after the specified number of spectra are collected, thus the time course 
for measurement is much longer.  The method that minimizes noise without overly 
increasing response time will be selected. 
 
Point to point averaging over the spectral region of interest will be evaluated to minimize 
noise and increase S/N without losing spectral information.  Point to point averaging is 
done by averaging a certain number of points about the point of interest.  For example, at 
550 nm and 3 point averaging, values at 549 nm, 550 nm and 551 nm are averaged.  
Absolute absorbance measurements will be compared to difference spectra to determine 
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which method yields the highest sensitivity and still provides a linear relationship 
between nitric oxide concentration and the measurement.  In addition, the data will be 
evaluated by single wavelength measurements and integration over a peak to determine 
which will again yield the highest sensitivity while maintaining a linear relationship.  
Methods are presented in this Chapter. 
 
7.1.1 Description of the testing system 
 
Cytochrome-c, horse heart derived, was obtained from Sigma Chemical Co. (St. Louis, 
MO).  Cytochrome-c was dissolved to a concentration of 5 mg/ml in pH 7.40 monobasic 
potassium phosphate and sodium hydroxide buffer to yield the unreduced Fe III forms 
(99% pure).  The starting heme’s identity was characterized from its known absorption 
spectrum.  173 ppm NO, balance N2, was obtained from NorthEast Air Gas Co. 
 
The reaction of the hemes with NO was monitored by a spectrometer system installed on 
a personal computer as described in Chapter 5, section 2.  The measurement system is 
that as described in Chapter 6.  Cytochrome-c is injected into the sensing element via a 
motor controlled by the PC through a data acquisition card (PC-DIO-24F-5).  30 seconds 
were allowed for the system to come to equilibrium and a reference spectrum was taken. 
Gaseous NO, 173 ppm in N2 (Northeast Airgas Co., Hudson, MA), was delivered to the 
sensing element for 1 minute.  Precise timing of flow control was achieved through an in-
line solonoid, which was controlled by a PC through the PC-DIO-24F-5.  Precise NO 
concentrations were monitored via an in-line flowmeter.  It was assumed that the 
concentration of NO could be controlled by regulating the flow of NO and diluting it to 
various concentrations with a precise flow of N2.  The reaction between cytochrome-c 
and NO, resulting in the formation of a cytochrome-c-NO complex, was allowed to come 
to equilibrium for 1 minute.  Prior to all sets of experiments, a baseline background and 
reference spectra were taken and stored to ensure that the system had stabilized.  A 
spectrum was acquired as absorbance vs. wavelength (nm) at the end of this period by the 
spectrometer system. All spectra cover the range from 375 nm to 720 nm, in 1 nm steps, 
yielding 345 spectral components per spectrum.  The absorbance was also recorded at 
563 nm, corresponding to the peak wavelength of the cytochrome-c-NO complex.  All 
experiments were run with a 0.05 second integration time, averaging of 5 times per cycle, 
fill buffer off, cytochrome-c concentration of 5 mg/ml, 1 minute flow time of NO, 10 psi 
(68.95 kPa)  and 200 cc/min total flow rate, unless otherwise noted.  Specifics are given 
for each set of experiments as follows. 
 
7.1.2 Integration time 
 
Prior to system operation the integration time was set to 0.03 seconds.  The measurement 
was prepared as described in Section 7.1.1 and the entire spectrum between 375 nm and 
720 nm was acquired as A/D counts vs. wavelength (nm).  The procedure was repeated 
for integration times of 0.05 and 0.07 seconds.  A graph of A/D counts vs. wavelength 
was plotted and analyzed to determine the integration time that maximizes the number of 
counts reaching the detector without saturating it. 
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7.1.3 Optimization of averaging  
 
Averaging was examined to determine which method would yield the lowest noise 
without sacrificing sensitivity or response time.  Three methods were examined 
including: 
 
1. Rote averaging of spectra where singly acquired spectra are averaged 2, 3, 4, 5, 7, 
10, 15 and 20 times.  Response time was also noted for each averaging value. 
2. Averaging after employing an internal averaging method provided by CDI.  This 
method internally stores 17 spectra.  The 17 spectra are first averaged and then 
displayed as a single averaged spectrum.  This single averaged spectrum is treated 
as a single acquired spectrum (data is not available for the 17 individually 
acquired spectra).  These spectra are then averaged 2, 3, 4, 5, 7, 10, 15 and 20 
times.  Response time was also noted for each averaging value. 
3. Point to point averaging where points are processed as a moving average over the 
wavelength region to effectively smooth the spectrum.  Take 550 nm and three 
point averaging as an example.  Here 549 nm, 550 nm and 551 nm are averaged 
and used as the 550 nm value.  In addition to reading the entire spectrum and 
point to point averaging the results, the signal level at 563 nm (after point to point 
averaging) was also noted to determine the effects of this averaging method on 
the sensitivity. 
 
For all three methods, noise was determined by calculating the standard deviation from 
the mean at each wavelength and then averaging over the wavelength region of interest, 
in this case, 500 nm to 600 nm.  The first two methods were compared to determine 
which method reduces noise without overly sacrificing response time.  The third method 
was also used to reduce noise, but effects on sensitivity were noted.  
 
The measurement was prepared as described in Section 7.1.1. and the entire spectrum 
between 375 nm and 720 nm was acquired.  The procedure was repeated with 2, 3, 4, 5, 
7, 10, 15 and 20 averages.  The absorbance vs. wavelength was plotted and the average 
noise level was calculated to determine how many spectra need to be averaged to yield 
the lowest noise level without overly sacrificing response time or sensitivity depending 
on the method in question. 
 
7.1.4 Absolute vs. Differential absorbance 
 
Absolute absorbance values were compared to difference spectra by determining the 
sensitivity provided by each method and comparing the results.  For difference spectra 
measurements, the measurement was prepared as described in Section 7.1.1. and the 
entire spectrum between 375 nm and 720 nm was acquired. The difference spectra were 
generated by subtracting the reference spectra from the absorbance spectra.    The 
procedure was repeated at NO concentrations between 173 ppm and 0 ppm (173, 86.5, 
43.25, 21.63, 8.65, 4.33, 1.73 and 0 ppm). 
 
For absolute absorbance measurements, the measurement was prepared as described in 
Section 7.1.1. with one exception.  Buffer was injected into the system instead of heme 
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prior to referencing and then cytochrome-c was injected into the system with an 
additional 30 seconds allowed for equilibration.  The entire spectrum between 375 nm 
and 720 nm was acquired.  The procedure was repeated at NO concentrations between 
173 ppm and 0 ppm (173, 86.5, 43.25, 21.63, 8.65, 4.33, 1.73 and 0 ppm).  The minimum 
detection limit was determined by calculating the nitric oxide concentration from the 
absorbance at 5 times the noise level (S/N=5). Linearity was examined by looking at the 
r2 value over the entire range of concentrations studied.  A value > 0.8 implied a linear 
trend.  The method that gave the highest sensitivity and a linear relationship between NO 
concentration and absorbance was noted. 
 
Calibration curves made with single wavelength measurements were compared to 
calibration curves built on peak integration values to determine which method yields the 
best sensitivity.  The calibration curve made with single wavelength measurements are 
plots of the absorbance at a single wavelength vs. NO concentration.  The calibration 
curve made with integration over a peak values are plots of the area under the peak at 563 
nm vs. the NO concentration.  The calibration curves generated for the above 
experiments were used to calculate sensitivity for both methods, where sensitivity is 
defined as the slope of the calibration curve (line).  The sensitivity for single wavelength 
measurements was determined by calculating the slope of the calibration curve.  For the 
integration method, the area inside the 563 nm peak was determined for each NO 
concentration.  A line was drawn connecting the low points on each side of the peak.  
Absorbances were then added for each wavelength inside the peak and the absorbance 
value below the line was subtracted at each wavelength.  This was then plotted against 
the concentration of NO and a line was fitted to this data.  The sensitivity was again 
calculated as the slope of this line, if the relationship was determined to be linear. 
7.2 System Testing 
System testing is the culmination of the design process, which serves to ensure that the 
system meets the required specifications.  The ideal specifications for this project are 
presented in Table 7-1. 
 
Table 7-1:  Specifications for the sensor 
 
Parameter Ideal Specifications Sufficient 
Specifications 
Sensitivity 0.01 Absorbance 
units/ppm 
0.10 Absorbance 
units/ppm 
Minimum detectable 
limit 
0.1 ppm 1 ppm 
Specificity Oxygen Oxygen 
Response time <3 seconds <6 seconds 
Stability Over 8 hours Over 8 hours 
Accuracy ±5 % 5% 
Resolution 0.025 ppm 0.5 ppm 
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For clinical applications, NO is currently being delivered in concentrations between 5 and 
20 ppm, while in the research environment, concentrations as high as 80 ppm are being 
studied.  Sensitivity is a measure of how much the absorbance changes as a function of 
the nitric oxide concentration.  The sensitivity is instrumental in determining the 
minimum detectable limit and the resolution of the system.  The minimum detectable 
limit is defined as the smallest concentration of nitric oxide that it is possible to measure 
accurately.  The resolution is the smallest incremental unit of NO that can be monitored.  
Considering that NO concentrations are being calculated to the nearest ppm, a 0.5 ppm 
resolution with a 1 ppm minimum detectable limit and a ±5% accuracy are adequate (see 
Table 7-1).  In terms of specificity and response time, NO is delivered breath to breath 
through an adapted ventilator circuit along with oxygen and other anesthetic gasses, thus 
the sensor should be specific to NO in the presence of oxygen and have a response time 
less than 3 seconds to ensure measurement for every respiratory cycle.  Two 
complications can arise due to the presence of oxygen.  Oxygen can react with nitric 
oxide to form nitrogen dioxide before NO reacts with the heme and oxygen can react 
with the heme in conjunction with NO.  Either scenario decreases the absorbance level at 
any given concentration of NO because either NO or the heme is being scavenged by 
oxygen.  Stability over 8 hours is imperative to ensure operation over an entire surgery or 
during one shift.  In addition, frequent re-calibrations cause unnecessary down time.  In 
the rest of this Chapter, outcomes of system testing to determine the specifications of the 
system will be discussed.   
 
Sensor specifications were determined with two system configurations.  The first, dubbed 
“normal”, was used to perform extensive testing.  The “optimized” system incorporated a 
higher heme concentration, higher pressure and a lower post-gas flow equilibration 
period to optimize the system for sensitivity and response time under the constraints of 
the physical design.  This system was not used for all experiments due to the increased 
cost and the possible danger of using a higher pressure with the current physical design.  
A discussion will ensue to determine how current specifications can be improved based 
on the current configuration and how the system testing led to the development of 
appropriate calibration techniques. 
 
Calibration techniques were used to determine the relationship between nitric oxide 
concentration and the measured absorbance for the particular day or time period that the 
system was being operated.  Calibration techniques were designed to provide the best 
correlation between NO concentration and the absorbance at a specific wavelength.  
These were evaluated for deviation of known NO concentrations from those derived from 
the calibration equation at fixed points between the expected high and low values.  
Methods are presented as follows. 
 
The measurement was prepared as described in Section 7.1.1.  
 
The absorbance was also specially recorded at 563 nm, corresponding to the peak 
wavelength of the cytochrome-c-NO complex.  All experiments were rerun with a 
cytochrome-c concentration of 10 mg/ml, 20 psi (137.9 kPa) and a post gas flow 
equilibration time of 15 seconds to maximize sensitivity and reduce the response time 
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with the current configuration.  This is termed the “optimized system” for the remainder 
of the chapter.  Specifics are given for each set of experiments as follows. 
 
7.2.1 Sensitivity testing 
 
Cytochrome-c was injected into the system and 30 seconds was allowed for the system to 
come to equilibrium prior to referencing.  One hundred seventy three ppm NO was 
delivered to the system for one minute.  The reaction was allowed to equilibrate for 1 
minute and a spectral measurement was taken.  The procedure was repeated at NO 
concentrations between 173 ppm and 0 ppm (173, 86.5, 43.25, 21.63, 12.98, 8.65, 4.33, 
1.73 and 0 ppm).  Five-point spectral averaging was employed to reduce the noise level.  
The minimum detection limit was determined by calculating the nitric oxide 
concentration from the absorbance at 5 times the noise level (S/N=5).  If the intercept 
produces a negative minimum detectable limit, the minimum detectable limit is 
calculated by assuming a zero intercept (theoretically it should be).  An error is then 
calculated from the intercept and reported with the minimum detectable limit.  The r2 
value is reported to determine linearity.  Slope and intercept are calculated to determine 
sensitivity and offset.  Calculations are also provided for data under 25 ppm NO 
concentrations.  All experiments were run two times per day for four days.  Experiments 
were rerun twice in two days with a cytochrome-c concentration of 10 mg/ml, 20 psi 
(137.9 kPa) and a post gas flow equilibration time of 15 seconds to optimize sensitivity 
and reduce the response time with the given configuration. 
 
7.2.2 Specificity testing 
 
Cytochrome-c was injected into the system and 30 seconds was allowed for the system to 
come to equilibrium prior to referencing.  173 ppm NO was delivered to the system for 
one minute.  The reaction was allowed to equilibrate for 1 minute and a full spectrum was 
acquired.  The procedure was repeated at NO concentrations between 173 ppm and 0 
ppm (173, 86.5, 43.25, 21.63, 12.98, 8.65, 4.33, 1.73 and 0 ppm).  Experiments were 
rerun with 5, 25, 50, 70 and 90% oxygen.   
 
NO flow rate is determined as follows: 
 
source
desired
totalNO
NO
NOFlowFlow ⋅=         (7.1) 
 
Total flow of oxygen and nitrogen combined is equal to the total flow minus the NO flow 
rate.  Oxygen flow is determined as follows: 
 
desiredtotaloxygen OxygenFlowFlow %⋅=        (7.2) 
Nitrogen flow is the total flow minus the NO flow minus the oxygen flow rate.  The r2 
value is reported to determine linearity.  Slope and intercept are calculated to determine 
sensitivity and offset with points below 21.625 ppm in order to keep a similar basis for 
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comparison.  Due to the chosen system parameters, it was not possible to set high 
concentrations of NO with high oxygen concentrations.  Changes in slope and offset with 
varying oxygen concentrations were noted.  All experiments were run two times per day 
for four days.  Experiments were rerun twice in two days with a cytochrome-c 
concentration of 10 mg/ml, 20 psi (137.9 kPa) and a post gas flow equilibration time of 
15 seconds to optimize sensitivity and reduce response time with the given configuration. 
 
7.2.3 Response time testing 
 
Response time was determined by using a stopwatch to determine the total time for each 
cycle and the timing of the sub-steps including heme injection/ejection, system 
stabilization, referencing, sample delivery, reaction equilibration and measurement, 
processing and display.  Data was also determined for the system with a 10 mg/ml 
cytochrome-c concentration, a pressure of 20 psi (137.9 kPa) and an equilibration time of 
15 seconds. 
 
7.2.4 Stability testing 
 
The measurement was prepared as described in Section 7.1.1 and a full spectrum was 
acquired.  A calibration equation was determined by acquiring absorbance measurements 
at 173, 86.5, 43.25, 21.63, 8.65, 4.33 and 0 ppm at the beginning of experimentation.  
These points were used to generate a calibration equation by plotting Absorbance vs. 
[NO].  The slope and offset were noted.  The experimental procedure was repeated at NO 
concentrations between 173 ppm and 0 ppm (173, 86.5, 43.25, 21.63, 12.98, 8.65, 4.33, 
1.73 and 0 ppm).  Experiments were rerun with randomly chosen concentrations of 162, 
143, 113, 107, 82, 57, 24, 23, 17, 11, 8, 3 and 1 ppm.  All 20 concentrations were 
randomly run once per hour for eight hours.  Each single concentration was measured 
eight times and this data was used to assess stability of the concentration measurement.  
The average absorbance and standard deviation of the absorbance for each NO 
concentration are reported to determine the stability of each concentration value over 
time.  In addition, the error is calculated in ppm and as a percentage from actual NO 
concentration by applying the measured absorbance to the calibration equation to 
determine a calculated concentration.  In addition, stability of the calibration equation 
constants (slope and intercept) was also determined by determining a calibration equation 
for each of the eight trials using concentrations of 173, 86.5, 43.25, 21.63, 8.65, 4.33 and 
0 ppm in the calculation of slope and intercept.  The average and standard deviation of 
the slope and intercept are reported to determine stability of the calibration equation.  
 
7.2.5 Accuracy testing 
 
The measurement was prepared as described in Section 7.1.1 and a full spectrum was 
acquired.  The procedure was repeated at NO concentrations between 173 ppm and 0 
ppm (173, 86.5, 43.25, 21.63, 12.98, 8.65, 4.33, 1.73 and 0 ppm).  The r2 value is 
reported to determine linearity.  Slope and intercept are calculated to determine 
sensitivity and offset.  All experiments were run two times per day for four days. 
Experiments were re-run with NO concentrations of 162, 143, 113, 107, 82, 57, 24 and 3 
ppm.  They were also rerun with concentrations of 23, 17, 11, 8 and 1 ppm, this data was 
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used with the calibration curve generated with values less than 25 ppm.  For all sets of 
data, the order of the delivered NO concentrations was randomized.  For all data, the 
concentration of NO was calculated using calibration curves generated each day with a 
high and low nitric oxide concentration and the measured absorbance.  For the full NO 
range, the high NO value used to generate a calibration curve was 200 ppm.  For the NO 
range of less than 25 ppm, the high NO value used to generate the calibration curve was 
25 ppm.  The error was calculated as a percent of the delivered NO concentration .  The 
average error and standard deviation was calculated over the 8 sets of experiments.  
Experiments were repeated two times for the optimized system. 
 
7.2.6 Resolution testing 
 
The resolution was determined by calculating the change in concentration due to the 
minimum detectable change in absorbance.  It was also calculated for data less than 25 
ppm and data from the optimized system. 
7.3 Mathematical Modeling 
Mathematical modeling was used to develop equations that describe system trends with 
respect to sensitivity, response time and response range.  This information was used to 
indicate the ranges of system parameters that provided the best results to optimize system 
performance.  Five parameters were evaluated for their effect on system response 
including gas pressure, heme concentration, path length, flow time and flow rate.  Each 
parameter and its effects on sensitivity, response time and response range will be 
discussed separately.  Thus, this section will focus on mathematical modeling of system 
parameters to determine and optimize sensor response.  A diagram, refer to Figure 7.1, is 
given as a reference. 
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Figure 7.1.  Schematic representation of components essential to mathematical model 
 
The first step is to determine the amount of NO passing through the gas permeable 
membrane.  Let us assume the following: 
 
nnoo(t) = Amount of free NO in the entry chamber at time t in moles 
nnom(t) = Amount of free NO in the membrane at time t in moles 
nnof(t) = Amount of free NO in the heme reservoir at time t in moles 
ncno(t) = Amount of cytochrome-c-NO at time t in moles 
nc(t) = Amount of cytochrome-c in the reservoir at time t in moles 
nco = Initial amount of cytochrome-c in the reservoir at time t=0 in moles 
A(t) = Absorbance at 563 nm at time t 
 
Let us assume that the amount of NO in the chamber at any given instant is the amount of 
NO delivered to the chamber at that instant minus the amount of NO that has passed 
through the membrane at that instant minus the amount of NO that has exited the sensor 
at that instant since the chamber is open on both sides during flow.  Thus, the rate of 
change of NO in the chamber is equal to the rate of entry of NO into the chamber minus 
the rate of exit of NO from the chamber to the reservoir across the membrane minus the 
Heme 
reservoir
Entry 
Chamber
Light Source
Spectrophotometer
Gas 
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rate of exit of NO from the chamber to the outside.  The amount of NO that crosses the 
membrane is determined by the permeability of the membrane to NO. 
 
The permeability coefficient (Cp) is defined as the rate of permeation (Rp in cm3/s) 
multiplied by the thickness (lmem in cm) and divided by the product of its area (Area in 
cm2) and the difference in concentration (∆conc in M) (or pressure (P in cmHg)) between 
the two environments separated by the membrane.  (Note:  all information regarding the 
permeability of gasses through polymers is from Lebovits (1966) and modeling equations 
were derived in conjunction with Dr. Gary Knott, Civilized Software Inc.) 
 
Cp = (Rp · l) / (Area · ∆conc)        (7.3) 
Note that the permeability coefficient for nitric oxide for the membrane of interest was 
estimated from the permeability coefficients given for nitrogen and oxygen as provided 
by Specialty Manufacturing Inc. 
 
The amount of NO that has crossed the membrane (vno in cm3) is calculated by 
multiplying the permeability coefficient (Cp) by the area (Area in cm2), time (t in sec), 
and difference in concentration (∆conc in M) (or pressure (P in cmHg)) and then dividing 
by the thickness of the barrier (lmem).  Please note that the permeability constant can be 
given either as a function of concentration difference or pressure difference between the 
two compartments separated by the membrane (Lebovits, 1966).  This analysis uses the 
permeability coefficient as a function of concentration to simplify calculations. 
 
vno = Cp · Area · ∆conc · t / lmem        (7.4) 
And the rate (Rp in cm3/s) is found as follows: 
 
Rp = Cp · Area · ∆conc / lmem         (7.5) 
The rate can be converted from cm3/s to moles/s (Rpm) by multiplying the quantity in 
cm3/s  by the density  (ρ in g/ml) and dividing by the molecular weight (MW in g/mol).  
Since the density is given at STP, a correction for the system pressure is included. 
 
Rpm = [(Cp · Area · ∆conc · ρ) / (lmem · MW)] ·(Psys/Patm)     (7.6) 
The last term in the equation is a pressure conversion.  The density in the above equation 
is given based on standard temperature and pressure.  Since the system is operating at a 
different pressure, a conversion is necessary.  First, given the volume of the chamber and 
the initial number of moles, the system pressure can be calculated.  Assuming a constant 
volume and temperature, the number of moles at a different pressure can be calculated 
using the following relationship. 
 
P1/n1 = P2/n2           (7.7) 
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Where we can take that:  P1 is atmospheric pressure (Patm), n1 is the number of moles at 
Patm, P2 is the system pressure (Psys), and n2 is the number of moles at Psys.  Thus, the 
equation can be rewritten as follows. 
 
n2 = P2n1/P1          (7.8) 
n2 = Psysn1/Patm         (7.9) 
Now, the concentration difference is in moles/l.  This is the moles of NO in the chamber 
(nnoo in moles) divided by the volume of the chamber (Vc in ml) minus the moles of NO 
in the reservoir (nnof in moles) divided by the volume of the reservoir (Vr in ml). 
 
Rpm = [Cp · Area · ρ/(lmem ·MW)] ·[(nnoo/Vc) - (nnof/Vr)] ·(Psys/Patm)   (7.10) 
 This is the rate of permeation and this is the quantity that is needed to complete the 
model as described above. 
 
As stated above, the rate of change of NO in the chamber (nnoo’(t) in moles/s) is equal to 
the rate of entry of NO (r in moles/s) into the chamber minus the rate of exit of NO from 
the chamber into the reservoir across the membrane (Rpm in moles/s).  
 
nnoo’(t) = r - Rpm         (7.11) 
where the rate of entry into the chamber is calculated as follows: 
 
r = fr · (ρ /MW ) · (partsno/partsgas) · (Vc/Vt) · (Psys/Patm) · (1 min/60 sec)  (7.12) 
Where fr is the flow rate (cc/min), ρ is the density of NO (g/ml), MW is the molecular 
weight (g/mol).  This equation accounts for the amount of nitric oxide as a percentage of 
the total gas.  For example, if there is 173 ppm NO (ppmno), then there are 173 parts of 
NO (partsno) in 1x106 parts of gas (partsgas) .  It also accounts for the volume in the 
chamber (Vc) with respect to the total volume of the system (Vt), where the number of 
moles of gas is multiplied by the ratio of Vc to Vt to obtain the number of moles in the 
chamber and not in the total system. The Psys/Patm term is a pressure conversion for the 
density and the last term simply changes the units of the equation.   
 
The rate of exit of NO into the atmosphere is calculated as follows: 
 
rexit= fr · (ρ /MW ) · (partsno/partsgas) · (Vc/Vt) · (Psys/Patm) · (1 min/60 sec)/NOsurface  
           (7.13) 
 
where NOsurface is the amount of NO that is on the surface of the membrane at any given 
instant, assuming that only the NO molecules that are in contact with the membrane will 
diffuse through the membrane. 
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Thus, 
 
nnoo’(t) = [fr · (ρ/MW ) · (partsno/partsgas) · (Vc/Vt) · (Psys/Patm) · (1 min/60 sec)]  - [Cp · Area 
·[ ρ /(lmem · MW )] · [(nnoo/Vc) - (nnof/Vr)] · (Psys/Patm)] - [fr · (ρ/MW ) · (partsno/partsgas) · 
(Vc/Vt) · (Psys/Patm) · (1 min/60 sec)/NOsurface]       (7.14) 
 
Now, let us calculate the rate of change of the number of moles of NO in the membrane 
with respect to time (nnom’(t)).  This is done by subtracting the rate of change of the 
number of moles of NO diffusing into the heme solution (Rpmheme) from the rate of 
change of the number of moles of NO passing into the membrane (Rpm).  First, the rate of 
change of the number of moles of NO diffusing into the heme solution must be 
determined. 
 
The diffusion coefficient (dheme) given in cm2/s, is known for NO into myoglobin 
solutions (Vanderkooi, 1994).  The rate of diffusion is equal to the rate of permeation if 
the solubility is determined to be 1, which is the assumption in this case since the 
solubility coefficient has not been reported.  Thus, diffusion coefficient is taken to be 
equal to the permeability coefficient for this case (Cpheme).   
 
From above it is known that the rate of permeation (Rpheme) is equal to the permeability 
coefficient multiplied by the product of its area (hemearea) and the difference in 
concentration between the two environments and divided by the thickness of the heme 
solution (l). 
  
The rate can be converted from cm3/s to moles/s (Rpmheme) by multiplying the quantity in 
cm3/s  by the density  (ρ in g/ml) and dividing by the molecular weight (MW in g/mol).  
Since the density is given at STP, a correction for the system pressure is included. 
 
Rpmheme = [(Cpheme · hemearea · ∆conc · ρ) / (l · MW)] ·(Psys/Patm)   (7.15) 
The concentration difference is the difference between the concentration of NO in the 
membrane and the concentration of NO on the other side of the heme solution.  Here the 
assumption is made that there is a concentration gradient and that the concentration of 
heme at the lower boundary will be zero.  Thus, the concentration difference will be 
nnom/vmem, and the rate of permeation is as follows: 
 
Rpmheme = [Cpheme · hemearea · ρ /(l ·MW)] ·(nnom/Vmem) ·(Psys/Patm)   (7.16) 
 This is the rate of permeation of NO through the heme and this is the quantity that is 
needed to complete the model as described above. 
 
nnom’(t) = [Cp · Area ·[ ρ /(lmem · MW )] · [(nnoo/Vc) - (nnof/Vr)] · (Psys/Patm)] – [Cpheme · 
hemearea ·[ ρ /(l · MW )] · (nnom/vmem) · (Psys/Patm)]  (7.17) 
 
Now, let us calculate the rate of change of the number of moles of NO in the reservoir 
with respect to time.  This is done by subtracting the rate of change of the number of 
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moles of NO reacting with cytochrome-c with respect to time from the rate of change of 
the number of moles of NO diffusing into the heme solution with respect to time. 
 
nnof’(t) =[Cpheme · hemearea ·[ ρ /(l · MW )] · (nnom/vmem) · (Psys/Patm)] - ncno’(t) (7.18) 
 
Next, let us calculate the rate of change of the number of moles of complex being formed 
with respect to time.  This is done by subtracting the dissociation rate from the rate of 
association. 
 
ncno’(t) = ka ·  (nnof(t)/Vr) · (nco/Vr - ncno(t)/Vr) · Vr - kd · ncno(t)    (7.19) 
ka is the association constant in M-1s-1 and kd is the dissociation constant (s-1).  The above 
equation is the ordinary differential equation for the chemical kinetics curve describing 
the amount of cytochrome-c-NO at time t due to the reaction of cytochrome-c combining 
with NO to form cytochrome-c-NO.  nnof is the instantaneous free NO at time t, ncno is the 
instantaneous free cytochrome-c-NO at time t and nco - ncno(t) is the instantaneous free 
cytochrome-c at time t.  Thus, 
 
nc(t) = nco - ncno(t)         (7.20) 
This gives us a set of equations that can be solved to yield time-based information on the 
amount of cytochrome-c, NO and cytochrome-c-NO complex. Now, all the information 
necessary to calculate the amount of cytochrome-c-NO is present.  The next step is to 
relate these values to an absorbance, which is the system output.   
 
The operation of the system is based on obtaining a reference signal prior to each 
measurement to “zero” the system.  This provides a value to clear the system from any 
minor changes in light intensity, heme concentrations or physical parameters.  The 
sample signal (Ss) is ratioed to the reference signal (Sr) to provide a value for the sensor 
output (S).  This is equivalent to subtracting the logarithm of the reference signal (Ar) 
from the logarithm of the sample signal (As), where A is termed the absorbance (A is the 
logarithm of S).  Io is the intensity of the incident light, Ir is the intensity of the 
transmitted light from the reference and Is is the intensity of the transmitted light from the 
sample. 
 
S = Ss/Sr          (7.21) 
Ss = Io/Is          (7.22) 
As = log Ss = log Io/Is          (7.23)  
and  
 
Sr = Io/Ir           (7.24) 
Ar = log Sr = log Io/Ir         (7.25) 
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Subtracting the reference from the sensor signal 
 
A = As - Ar          (7.26) 
A = log Io/Is – log Io/Ir         (7.27) 
A = log[(Io/Is)/(Io/Ir)]         (7.28) 
A = log(Ir/Is)          (7.29) 
According to Beer’s Law, A = εcl, where the absorbance (A) and the extinction 
coefficient (ε) are dependent on wavelength. 
 
Thus, 
 
As = εscsl          (7.30) 
Ar = εrcrl          (7.31) 
A = As - Ar          (7.32)  
A = εscsl - εrcrl = (εscs - εrcr) · l       (7.33) 
Now, the sample contains three species:  cytochrome-c-NO (cno), cytochrome-c (c) and 
buffer.  The buffer will not absorb in the region of interest (563 nm).  Thus, the sample 
signal is made up of two components.  This can be modeled as follows: 
 
As = Acno + Ac          (7.34) 
And 
 
εscsl = εcnoccnol + εcccl         (7.35) 
Thus, 
 
A = εcnoccnol + εcccl - εrcrl        (7.36) 
Now, the concentration of cytochrome-c (c) is equal to the initial concentration of 
cytochrome-c (cco) minus the concentration of cytochrome-c-NO (ccno).  In addition, the 
reference is the initial concentration of cytochrome-c (cco). 
 
cc = cco - ccno          (7.37) 
cr = cco           (7.38) 
εr = εc           (7.39) 
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Thus, 
 
A = εcnoccnol + εc(cco - ccno)l - εcccol       (7.40) 
A = ccno(εcno -εc)l         (7.41)  
Now, ccno  is the concentration of the complex, which is the number of moles divided by 
the volume of the reservoir (Vr): 
 
ccno = ncno/Vr          (7.42) 
Thus, 
 
A = ncno(εcno -εc)l/Vr         (7.43) 
From this, various sensor parameters can be estimated including sensitivity, response 
range, and response time. 
 
Sensitivity is defined as the change in absorbance divided by the change in NO 
concentration (ppm): 
 
S = ∆A/∆cno          (7.44) 
Sensitivity was determined theoretically for all parameters and experimentally for various 
heme concentrations.  Other parameters were evaluated at one NO concentration and 
information was derived from this.  Response range was evaluated based on changes in 
the minimum detectable limit.  This is defined as the concentration of NO at which the 
absorbance is five times the noise level which was determined to be 0.0001 absorbance 
units.  This is obtained from the curve of absorbance at 563 nm vs. concentration of NO 
in ppm.  Effects of pressure, heme concentration, path length, flow time and flow rate on 
sensor response time were evaluated by determining the time it took the system to reach 
equilibrium post gas flow. 
 
7.3.1 Limitations/Assumptions 
 
In order to apply the above equations, there are a number of assumption which need to be 
outlined.  The following list encompasses the use of the permeability coefficient in the 
above calculations: 
 
•= The permeability coefficient is an estimate and was not determined 
experimentally. The permeability coefficient is determined by measuring the rate 
of transmission of the penetrant through a polymer membrane forming a partition 
between two chambers, one of which is initially free of the penetrant.  The rate of 
transmission is determined by following the increase in pressure in a constant 
volume receiving chamber.  The permeability of silicone sheeting to nitrogen was 
provided in Lebovits (1966).  The G values of nitrogen and oxygen were also 
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provided in the same reference.  The F value for the polymer multiplied by a G 
value for the gas gives the permeation of the gas through the polymer, thus the G 
value is a scaling factor for the gas of interest.  An intermediate value between 
nitrogen and oxygen for G was used as a multiplying factor for the nitrogen 
permeability constant to obtain a value for nitric oxide.  Thus, the nitrogen 
permeability to silicone sheeting is given as 250x10-10 cm3/cm-s/cm2/cm Hg.  The 
G value for nitrogen is 1.0 and for oxygen it is 3.8.  The intermediate value of 2.4 
was used as the scaling factor for nitric oxide to estimate the permeability 
coefficient. 
•= The permeability constant for the temperature of application is known and has 
been determined by a reliable method. The permeability coefficient was 
determined as described just under equation 7.3 at STP (standard temperature and 
pressure).  The temperature of the experimental setup was kept constant by 
regulating the room temperature of 24°C to within ±2°C.  The constants are 
generally valid from 20 to 30°C. 
•= We assumed that the permeant does not swell or attack the barrier material (gas 
permeable membrane). In general, swelling of the barrier material by a permeant 
affects the temperature dependence of the system.  This assumption is valid 
because the permeant is a gas and not a liquid.  For a gas or vapor kept at constant 
pressure, the rate of permeation is temperature dependent only because of the 
temperature dependence of the permeability constant and not because of barrier 
swelling. 
•= The rate of permeation is proportional to the concentration or pressure 
differential. 
•= The time of exposure is considerably longer than the time needed to reach 
equilibrium. The rate of permeation is proportional to the area of the membrane 
and inversely proportional to the thickness if equilibrium has been met.  If it has 
not been reached, the time needed to reach equilibrium is approximately 
proportional to the square of the thickness.  Thus, the rate of permeation is much 
slower until equilibrium conditions are met.  A thin membrane such as the 
silicone sheeting used in this device (0.0125 cm thick) provides for rapid 
equilibration, on the order of a few seconds.  The time of exposure was set at 1 
minute to ensure that there was sufficient time for an equilibrium condition to be 
reached. 
•= The barrier is free of cracks and pinholes, and permeation occurs only by a 
process of diffusion. 
 
Other assumptions required for the governing equation are as follows. 
 
•= Since the number of moles of heme is much greater than the number of moles of 
NO delivered to the system and the binding constant is high, it was assumed that 
all of the nitric oxide that dissolves in solution reacts with cytochrome-c. 
•= Conversion of the complex to cyt-c(Fe II) does not begin to occur before the time 
of measurement.  This is a valid assumption because no change in the absorbance 
at 550 nm, corresponding to cytochrome-c(Fe II) was evident during the time of 
flow or during the equilibration period. 
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•= Oxidation of NO to NO2 does not occur before NO reacts with the sensor, given 
that the diffusion of NO into the heme solution through the membrane is not a 
limiting factor.  This assumption was held for the purpose of simplifying the 
model.  Previous experiments on specificity, outlined in chapter 5, have shown 
that the presence of high oxygen concentrations decreases the signal level.  Since 
NO reacts with hemes 106 times faster than O2, the decrease was attributed to the 
oxidation of NO to NO2.  The decrease in signal due to high oxygen 
concentrations was insignificant in the optimized system testing, suggesting that 
with an appropriate reconfiguration of the system to minimize response time 
and/or equilibration time, specificity in the presence of oxygen will not be a 
concern.  The model was used to determine trends and not actual values since the 
system was too complex to be accurately modeled. 
•= It was assumed that NO reacts with the heme sensing element before O2 reacts 
with the heme because the NO-heme rate constant is 106 times faster than the O2-
heme rate constant.  
•= The diffusion coefficient of the heme for NO is equal to the permeability 
coeffient, thus assuming that the solubility is equal to 1. 
•= The diffusion coefficient cytochrome-c is equal to the diffusion coefficient of 
myoglobin into the heme.  The values of the diffusion coefficients should be 
similar since both cytochrome-c and myoglobin are hemes with a single iron 
subunit. 
 
Table 7-2:  Mathematical modeling abbreviations, units and values. 
 
Parameter Abbr. Units 
Sample signal Ss  
Reference signal Sr  
Sensor output S  
Incident intensity Io  
Sample signal transmitted intensity Is  
Reference signal transmitted intensity Ir  
Absorbance due to sample signal As  
Absorbance due to reference signal Ar  
Absorbance A  
Extinction Coefficient ε L/(mole
-1cm-1) 
Extinction Coefficient of sample εs L/(mole
-1cm-1) 
Extinction Coefficient of reference εr L/(mole
-1cm-1) 
Extinction Coefficient of  
cyt-c-NO complex 
εcno L/(mole
-1cm-1) 
Extinction Coefficient of cyt-c εc L/(mole
-1cm-1) 
Concentration c mole/L (M) 
Concentration of sample cs M 
Concentration of reference cr M 
Concentration of cyt-c-NO complex ccno mole/L (M) 
Concentration of cyt-c cc M 
Initial concentration of cyt-c cco M 
Initial concentration of NO prior to diffusion 
across the membrane 
cnoo M 
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Concentration of NO that has passed through the 
membrane 
cnof M 
Path Length l cm 
Association constant Ka 1.3x103 mol-1sec-1 
(Sharpe, 1998) 
Dissociation constant kd 0.087 sec-1  
(Sharpe, 1998) 
Initial moles of NO prior to diffusion across the 
membrane 
no moles 
moles of cyt-c-NO complex ncno mole 
moles of cyt-c nc mole 
Initial moles of cyt-c nco mole 
Initial moles of NO prior to diffusion across the 
membrane 
nnoo mole 
Moles of NO in the membrane nnom mole 
Moles of NO that have passed through the 
membrane 
nnof mole 
Reservoir volume Vr ml 
Flow rate fr ml/min 
Flow time ft min 
Density of nitric oxide ρ 1.3402*10-3 g/ml  
(CRC, 1993) 
Molecular weight MW 30.01 g/mol 
(CRC, 1993) 
System pressure Ps, P2 atm 
Atmospheric pressure Patm, P1 1 atm 
Parts NO (x ppm NO) partsno x partsno 
Parts gas (x ppm NO) partsgas 1x106 partsgas 
Chamber volume Vc 0.005 L 
Total system volume Vt 0.075 L 
Time t sec 
Membrane thickness lmem cm 
Heme layer thickness l cm 
Membrane volume = surface area*membrane 
thickness 
Vmem cm3 
Permeability constant for permeability of the 
membrane to NO 
Cp 1.12*10-4 
[(cm3/sec)(cm)]/ 
[(cm2)(M)] 
(Spec. Manuf. Inc.) 
Permeability constant for permeability of the heme 
to NO 
Cpheme 9.5*10-8 
[(cm3/sec)(cm)]/ 
[(cm2)(M)] 
Diffusion coefficient dheme 9.5*10-8 cm2/sec 
(Vanderkooi, 1994) 
Time for NO to traverse the membrane T1 sec 
Membrane surface area Area cm2 
Heme surface area hemearea cm2 
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C h a p t e r  8  
8. RESULTS 
8.1 Sensing Compounds 
The Fe II and Fe III forms of hemoglobin, myoglobin and cytochrome-c were evaluated 
for reactivity with NO which produced observable changes in the measured absorption 
spectra of the starting material.  The reactions of the hemes with NO are given in Table 8-
1.  Nitric oxide induced changes in the spectra of cytochrome-c (Fe III), myoglobin (Fe 
II) and hemoglobin (Fe II) are illustrated in Figure 8.1.   In each of the spectra the solid 
line represents the absorbance spectrum of the unreacted heme and the dotted line is the 
difference spectrum between the reacted heme (sample) and unreacted heme (reference). 
In all cases the reacted heme is a complex of NO with the iron being the center of the 
heme (Ehrenbert and Szczepkowski, 1960), (Di Iorio, 1981), (Bazylinski and Hollocher, 
1985).   
 
Methemoglobin and metmyoglobin both react with NO to form unstable complexes, 
which immediately start converting to hemoglobin (Fe II) and myoglobin (Fe II), 
respectively.  In addition, the relationship between the absorbance at λmax and the 
concentration of nitric oxide is not linear, when measured at time interval between 0 and 
8 minutes.  Cytochrome-c (Fe II) did not react with NO to form a spectrophotometrically 
observable reaction in the region of interest. 
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Table 8-1:  Reactions of hemes with NO:  Absorption maxima of relevant species (nm) 
 
Cytochrome-c 
Cyt-c (Fe III) + NO → Cyt-c (Fe III)-NO → Cyt-c (Fe II) 
Cyt-c (Fe II) + NO → No observable reaction 
Cyt-c (Fe III)  409, 530 
Cyt-c(Fe III)-NO 420, 528, 563 
Cyt-c(Fe II)  414, 520, 550  
 
Myoglobin 
Mb (Fe III) + NO → Mb (Fe III)-NO → Mb(Fe II) 
Mb (Fe II) + NO → Mb (Fe II)-NO 
Mb (Fe II)O2 + NO → Mb (Fe III) + NO3- 
Mb (Fe III)  409, 505, 582, 635 
Mb (Fe III)-NO 530, 560, 575 
Mb (Fe II)  434, 556 
Mb (Fe II)-NO 424, 540, 585 
Mb (Fe II) O2  418, 543, 581 
 
Hemoglobin 
Hb (Fe III) + NO → Hb (Fe III)-NO → Hb(Fe II) 
Hb (Fe II) + NO → Hb (Fe II)-NO 
Hb (Fe II)O2 + NO → Hb (Fe III) + NO3- 
Hb (Fe III)  406, 499, 575, 628 
Hb (Fe III)-NO 530, 565 
Hb (Fe II)  430, 555 
Hb (Fe II)-NO  418, 535, 580, 610 
Hb (Fe II) O2  415, 542, 578 
 
*References for peaks: Provided in Table 4-3 
*References for reactions: (Yoshimura et al, 1987), (Bazylinski and Hollocher, 1985), 
(Doyle and Hoekstra, 1981) 
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Figure 8.1.a  See below 
Figure 8.1.b  See below 
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Figure 8.1.c  See below 
 
Figure 8.1.  Absorption spectra of unreacted hemes (solid line, absorbance) and heme-NO 
complex (dashed line, differential absorbance of reacted heme and the starting compound) 
for a)  cytochrome-c(Fe III) – top graph, b)  myoglobin(Fe II) – middle graph, and c)  
hemoglobin(Fe II) – bottom graph. 
 
In general, heme spectra are characterized by an intense absorption band in the blue 
region (approximately 400 nm to 475 nm) usually referred to as the Soret band, and two 
bands in the green region (approximately 475 nm to 525 nm) of the spectrum, the α and β 
bands, which are not always resolved. The reaction of NO with the heme compounds 
studied produced bands in the green region of the spectrum which were resolved and 
shifted from the absorption bands of the unreacted compound. In cytochrome-c (Fe III)-
NO there was no resolvable band shift in the blue, while for hemoglobin (Fe II)-NO and 
myoglobin (Fe II)-NO the blue band appears to be shifted to 470 nm. The peak position 
of this band is an artifact resulting from the optical properties of the spectrometer.  
Experiments using a blue filter to remove stray light allowed resolution of the Soret band, 
which is significantly more intense than the bands in the green region of the spectrum. 
 
 The hemes’ specificity to oxygen was also determined.  Hemoglobin, myoglobin and 
cytochrome-c were examined in three states:  deoxygenated by bubbling with N2, 
exposed to room air (21% O2) and exposed to 100% O2.  There was no visible difference 
in the spectra of the starting compound between the deaerated and room air samples for 
any of the hemes. Exposure of the starting material to 100% O2 converted the 
hemoglobin and myoglobin to oxyhemoglobin and oxymyoglobin which have different 
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spectra from the deoxygenated forms. Oxyhemoglobin and oxymyoglobin are unstable 
and convert to their respective met forms (Fe III) within 15 minutes. The reaction of the 
oxygenated hemes with NO rapidly produces the Fe III form of hemoglobin and 
myoglobin seen at 630 nm and 500 nm (Figure 8.2). A new band also appears near 560 
nm, but its absorption decreases with increasing NO concentration.  Cytochrome-c (Fe 
III) is stable when exposed to 100% O2. 
 
The sensitivity of each heme to NO in the presence and absence of oxygen was 
determined from the measurement of the molar extinction coefficient (ε), which is the 
change in absorbance per change in NO concentration (mole/liter NO). The values of ε 
for each of the monitored wavelengths in all three hemes is shown in Table 8-2.  
Hemoglobin forms a complex with NO, but is quite sensitive to oxygen.  There is a three-
fold increase in ε on exposure to 21% oxygen, and the starting material is unstable in the 
presence of 100% oxygen. Myoglobin also forms a complex with NO that is stable in the 
presence of 21% oxygen, but the starting material is unstable in 100% oxygen.  
Cytochrome-c (Fe III) is sensitive to NO and stable in the presence of high concentrations 
of oxygen.  All results are summarized in Table 8-3.  
 
Table 8-2:  Comparison of Heme Sensitivity to NO in the Presence and Absence of Oxygen 
 
0% O2 21% O2 100% O2  
Heme λmax (nm) ε (M-1 cm-1) λmax (nm) ε (M-1 cm-1) λmax (nm) ε (M-1 cm-1) 
 
Hb(FeII)-NO 
415 
467 
535 
580 
10570 ± 1986 
  2070 ± 260 
   930 ± 240 
   510 ± 280 
415 
467 
535 
580 
20033 ± 9835 
   780 ± 480 
 3280 ± 260 
 2550 ± 360 
503 
560 
634 
 2190 ± 490 
-3110 ± 350 
 2010 ± 400 
Hb(FeIII)-NO 530 
565 
Not linear 530 
565 
Not linear No oxy form 
 
Mb(Fe II)-NO 
470 
540 
587 
3390 ± 220 
1620 ± 140 
2400 ± 180 
470 
540 
587 
3500 ± 100 
1360 ± 180 
2160 ± 320 
505 
563 
632 
 1530 ± 350 
-1970 ± 320 
 1320 ± 240 
 
Mb(Fe III)-NO 
530 
560 
575 
Not Linear 530 
560 
575 
Not Linear No oxy form 
Cyt-c(Fe II)-NO No reaction No reaction No oxy form 
 
Cyt-c(Fe III)-
NO 
420 
528 
563 
3580 ± 337 
  600 ± 160 
1570 ± 410 
420 
528 
563 
 
 540 ± 100 
1360 ± 350 
420 
528 
563 
 
 550 ± 100 
1500 ± 130 
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Table 8-3:  Summary of hemes reacting with NO 
 
Heme Summary 
Cyt-c(Fe III) Sensitive to NO, specific in the presence of oxygen, linear relationship 
Cyt-c(Fe II) No spectrophotometrically observable reaction in the region of interest 
Mb(Fe III) Low sensitivity, nonlinear relationship 
Mb(Fe II) Sensitive to NO, also sensitive to high oxygen concentrations 
MbO2 Oxymyoglobin is unstable 
Hb(Fe III) Low sensitivity, nonlinear relationship 
Hb(Fe II) Sensitive to NO, also sensitive to high oxygen concentrations 
HbO2 Oxyhemoglobin is unstable 
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Figure 8.2.  Absorption spectra of unreacted oxyhemes (solid line, absorbance) and 
oxyheme-NO complex (dashed line, differential absorbance of oxyheme-NO complex and 
starting material) including oxymyoglobin – upper graph, and oxyhemoglobin – lower 
graph. 
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Fe(II)EDTA was extremely sensitive to oxygen and irreversibly oxidized immediately as 
evidenced by its instantaneous color change.  Iron chloride, Mn(TPP)CN- and 
FeCl(TPP)’s reaction with NO could not be monitored spectrophotometrically in the 
visible region of the spectrum under the conditions studied. 
8.2 Heme-NO Reversibility 
The Fe III  form of cytochrome-c and the Fe III, Fe II and oxy forms of myoglobin and 
hemoglobin were evaluated for reversibility in their reaction with NO gas by changes in 
their absorption spectra.  The results have been summarized in Table 8-4.  Cytochrome-c 
(Fe III), metmyoglobin and methemoglobin react with nitric oxide to produce a 
photoreversible complex with the iron center of the heme.  Myoglobin(Fe II) and 
hemoglobin(Fe II) immediately react with NO to produce an unstable complex.  The iron 
center of the heme oxidizes to the Fe III state within 15 minutes and before complete 
photolysis is possible under our experimental conditions.  Oxymyoglobin and 
oxyhemoglobin react with NO to form their respective met-forms and NO3-, which are 
not lysable products.  Since only the ferric hemes reacted with NO to form products that 
are lysable with the given optical configuration, photodissociation of ferric heme-NO 
complexes was studied.  The lysed products of the Fe III - NO complex can be re-
exposed to NO to again form the complex.  These results have been summarized in Table 
8-5 and representative spectra are given in Figure 8.3.  The wavelengths of the relevant 
peaks are given along with the absorbance ± standard deviation at λmax.  The percent 
recovery of the peak absorbance of the lysed product to that of the starting material and 
of the re-reacted heme to that of the original complex is also given. 
 
Table 8-4:  Summary of results on heme – NO reversibility 
 
Reactant Form Reaction product Photoreversible 
Fe III Cyt-c(Fe III)-NO yes Cytochrome-c 
Fe II No reaction no 
Met Mb(Fe III)-NO yes 
Fe II Mb(Fe II)-NO→Mb(Fe III) no 
 
Myoglobin 
Oxy Mb(Fe III) no 
Met Hb(Fe III)-NO yes 
Fe II Hb(Fe II)-NO→Hb(Fe III) no 
 
Hemoglobin 
Oxy Hb(Fe III) no 
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Table 8-5:  Specific results for photoreversible reactions 
 
Hem Description Compound λmax 
(nm) 
Peak Absorbance 
(±std. dev.) 
Abs units 
% 
Rec 
Reactant Cyt-c(Fe III) 530 1.189 ± 0.017  
Complex Cyt-c(Fe III)-NO 563 0.873 ± 0.019  
Photolysis product Cyt-c(Fe III) 530 1.144 ± 0.013 96 
 
 
Cyt-c 
re-reacted product Cyt-c(Fe III)-NO 563 0.869 ± 0.014 100 
Reactant Mb(Fe III) 582 0.424 ± 0.040  
Complex Mb(Fe III)-NO 575 0.438 ± 0.022  
Photolysis product Mb(Fe III) 582 0.402 ± 0.020 95 
 
 
Mb 
re-reacted product Mb(Fe III)-NO 575 0.449 ± 0.037 103 
Reactant Hb(Fe III) 499 0.944 ± 0.035  
530 0.845 ± 0.038  Complex Hb(Fe III)-NO 
565 0.720 ± 0.011  
Photolysis product Hb(Fe III) 499 0.992 ± 0.012 105 
530 0.893 ± 0.017 106 
 
 
 
Hb 
re-reacted product Hb(Fe III)-NO 
565 0.765 ± 0.018 106 
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Figure 8.3.  Spectra of relevant reactions 
________ Fe III form of heme 
________ Fe III-NO complex 
------------- Fe III-NO complex lysed to yield Fe III form of heme again 
------------ Lysed product re-reacted with NO to form Fe III-NO complex again 
 
Heme spectra are characterized by an intense absorption band in the blue region, usually 
referred to as the Soret band, and two bands in the green region of the spectrum, the α 
and β bands, which are not always resolved.  The reaction of NO with the ferric and 
ferrous heme compounds studied produced bands in the green region of the spectrum 
which were resolved and shifted from the absorption bands of the unreacted species.  
Photolysis of the Fe III - NO complexes produced a noticeable shift in peak position and 
intensity back to that of the original starting material.  Cytochrome-c (Fe III) - NO 
complex has noticeable peaks at 528 nm and 563 nm. Photolysis gave way to a single 
peak at 530 nm and the disappearance of those at 528 nm and 563 nm.  Reintroduction of 
NO again produced the desirable shift in peak position and intensity to that of the 
complexed hemes.  Since the starting material was not 100% pure, there is a small peak at 
550 nm corresponding to the Fe II state.  Myoglobin (Fe III) has peaks at 503 nm, 582 nm 
and 632 nm.  Addition of NO produced a complex with a noticeable peak at 575 nm.  
Photolysis yielded the original compound as evidenced by the shift in peak intensity and 
position.  Reintroduction of NO again produced the complex.  Hemoglobin reacted 
similarly with the ferric peaks at 499 nm, 575 nm and 628 nm.  The complex yielded 
separate peaks at 530 nm and 565 nm.  For each trial the absorbance of the lysed products 
at λmax was measured to be within ±6% of the starting material. Also for each trial, the 
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absorbance of the re-reacted products at λmax was measured to be within ±6% of the 
original complex.  Examination of the Soret band provided no pertinent information.  The 
peak position and intensity of the complexes were near those of the original hemes, 
making differentiation of the products from the reactant difficult.  Thus, this region of the 
spectrum was not studied further. 
 
The reaction of all hemes with gaseous nitric oxide occurs immediately and completely 
upon introduction of NO.  The time course of the lysis reaction was examined by 
recording spectra over a 15 minute time period.  Lysis of cytochrome-c (Fe III), 
metmyoglobin and methemoglobin was 100% complete within 5 minutes.  Cytochrome-c 
(Fe III) reached 95% of the 5 minute value within 2 minutes, metmyoglobin within 2 
minutes and methemoglobin within 3 minutes.  Results are summarized in Figure 8.4. 
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Figure 8.4.  Time course of photodissociation reaction for ferric-heme-NO complexes 
including cytochrome-c(Fe III), myoglobin(Fe III) and hemoglobin(Fe III). 
 
Bubbling of nitrogen during photolysis, either intermittently or continuously, produced 
no decrease in the time it took to lyse the reaction product.  The use of quartz cuvettes did 
not produce any observable deviation from the original results.  Xenon flash lamp 
produced no observable photolysis under the given conditions.  Continuous exposure of 
the reacted product to the ELH bulb or the xenon flash lamp resulted in the heating of the 
heme solution within one minute and subsequent protein denaturation.  The heme could 
not be subsequently reduced or re-reacted with NO. 
8.3  Heme Immobilization Techniques 
Both PVA and Agar could be easily cast into films and gels by simple mixing of the 
heme solution with the immobilizing agent until it was completely dissolved.  The 
mixture was then dried and cut to shape before reactivity was examined.  All methods are 
presented in Table 5-1, and the results are summarized in Table 8-6.  All films and gels 
retained their reactivity as evidenced by the color change when immersed in a sodium 
dithionite solution.  It was found that pipetting of the solution into the drying container 
played a vital role in the quality of the film.  If pipetting was not done carefully, slowly 
and down the side of the container, unwanted bubbles would form.  The first step in 
development of films and gels was air-drying.  This process took an extremely long 
period of time and did not dry evenly or flat.  Experiments #2 through 7, see Table 8-6, 
were designed to determine whether to solution should be dried in an oven or water bath, 
Hemoglobin(Fe III) Lysing Kinetic Experiment
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Time (min)
Ab
so
rb
an
ce
499 nm-700 nm
530 nm-700 nm
565 nm-700 nm
 97
whether a glass or foil drying dish was appropriate, and if the solvent composition 
affected the system.  It was found that solution dried in a glass container in an oven with 
a H20 solvent produced the best results.    Experiment #2 produced a film with good 
texture and was fairly evenly dried.  The reaction between this film and gaseous NO 
produced favorable results as evidenced by a small peak at 563 nm and a slightly larger 
peak at 528 nm.  The reaction took 5 minutes to reach a plateau.  Experiment #8 was 
aimed at examining the drying of a larger volume of heme at a lower temperature to 
increase the path length and therefore the heme available for reaction and to increase the 
uniformity.  It was found that the drying time was too long and the film was still not 
uniform.  Experiments # 9 through 11, designed to produce a more uniformly dried film, 
explored covering options during drying.  It was determined that the best method was to 
dry the film with a cover over it.  In addition, the cover should have a few small holes for 
venting.  The final sets of experiments in this set (#12 through 15) were aimed at 
determining the effects of changing the amount of PVA and slightly lowering the drying 
temperature.  It was found that lower weights of PVA produced better films and that 
lowering the drying temperature did not change the quality of the film, it just increased 
the drying time.  More PVA produced films which were “bubbly”, or not flat.  Too little 
PVA produced films without enough support.  At this point, it was determined that for a 
configuration which involved a single film reacting with gaseous NO, an optimized film 
was created as follows: 
 
•= Pipette carefully. 
•= Use oven, not water bath for drying. 
•= Glass dish for drying container, not foil. 
•= Water for solvent instead of water/ethanol mix. 
•= 27°C drying temperature for 36 hours. 
•= Cover solution while drying. 
•= Poke holes in cover to vent. 
•= Too much PVA causes uneven drying. 
•= Too little PVA creates a film without support. 
 
Film#16 was created with these parameters and results of its testing are shown in Figure 
8.5.  The reaction, evidenced by the 528 nm and 563 nm peaks, took 5 minutes to reach a 
plateau.  The peak amplitude at 563 nm varied by ±19.2% over the three trials.  There is 
an unusually large negative peak at 550 nm.  It is possible that the cytochrome-c (Fe III) 
sample was contaminated by an unusually large amount of the Fe(II) form, which absorbs 
at 550 nm.  After the reference spectrum was taken, there was a conversion of the Fe(II) 
form to the preferred Fe(III) state. 
 
Experiments # 17-25 were aimed at increasing sensitivity by varying the configuration of 
the sensor.  Experiments # 17-20 utilized a cuvette.  Heme was immobilized onto a 
cuvette to maximize the surface area available for reaction.  It was not possible to dry the 
heme uniformly over the cuvette surface.  Experiments # 21 through 23 were aimed at 
increasing sensitivity by increasing the surface area available for reaction through 
stacking.  Stacking glass cover slips coated with heme solution was not feasible due to 
the reflection caused by the cover slips.  Stacking the films was also not possible because 
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it was difficult to stack the films in a parallel fashion.  If the films were dried hard, then 
they were not flat.  If they were dried soft, then they were flat, but could not be stacked.  
The metal spacers with the hole in the center yielded a parallel, stacked configuration.  
There was no visible reaction with 10 slides and with 50 slides there was no light 
throughput.  A good median could not be found.  Experiments# 24 and 25 were designed 
to increase the path length of the sensing element, assuming that there was diffusion of 
the gas through the sensing element.  This did increase the path length, but then there was 
reflection from the container it was dried in and that the film did not dry uniformly.  
When larger volumes were dried and then extracted from the container as in experiment 
#8, it was also found that the film did not dry uniformly. 
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Table 8-6:  Results for PVA films heme immobilization testing.  The details of the methods 
for each experiment set are given in Table 5-1.  The # in the table indicates the experiment 
series number. 
 
# Quality Conclusions Reactivity 
with NO 
1
  
·Bubbles 
·Unevenly dried 
·Not flat 
·Pipette more carefully 
·Try increasing temperature  
·Try different drying method 
·Not checked 
2
  
·Dry 
·More uniform 
·Use oven, not water bath due to 
condensation problems 
·Use glass, not foil to increase 
uniformity 
·Use H2O for solvent instead of 1:1 
H2O:EtOH mixture.  It dries in a 
more uniform fashion. 
·Try lower temperature to increase 
uniformity 
·Reactive 
3
  
·Too much condensation 
·Does not dry completely 
·More uniform 
 ·Not checked 
4
  
·Dry 
·Not uniform 
  
5
  
·Less uniform   
6
  
·Too much condensation 
·Does not dry completely 
·Less uniform 
  
7
  
·Dry 
·Least uniform 
  
8
  
·Over-dried and not uniform ·Temperature too low 
·Dried it for too long 
·Try higher temperature and lower 
drying time 
·Not checked 
9
  
·Uniform 
·Over-dried 
·Good Temperature (27°C) 
·Cover while drying 
·Poke holes in cover 
·Keep lesser volume 
·Not checked 
10
  
·Not uniform 
·Did not dry due to 
condensation 
  
11
  
·Horribly not uniform 
·Over-dried 
  
12
  
·Less uniform ·Cover while drying and poke holes 
in cover 
·Use less PVA, it dries better 
·Too little PVA produces films 
without enough support 
·Higher temperature better 
·Not checked 
13
  
·Uniform   
14
  
·Horribly not uniform 
·Not flat 
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15
  
·Did not hold its shape when 
dry 
  
16
  
·Dry 
·Uniform 
·Good combination of parameters ·Figure 8.5 
17
  
·Would dry one side and 
then the other, which did not 
work because the first side 
would become over-dried 
·Could not dry it uniformly 
over entire surface of 
cuvette at one time 
·Do not use cuvettes ·Not checked 
18
  
   
19
  
   
20
  
   
21
  
·Too much reflection from 
cover slips 
·Stacking not a good idea because of 
reflection from films 
·Trying to increase path length with 
alternative containers not a good 
idea.  Assuming it is largely a surface 
reaction and the containers provide 
an unwanted reflection 
·No visible 
reaction 
22
  
·Hard to stack flimsy films, 
they don’t stay parallel 
  
23
  
·Too much reflection from 
stacked films, no light 
getting through with 50 
films 
·No visible reaction with 10 
films, but minimum light 
gets through 
  
24
  
·Reflection from container 
·Not uniform 
·Path length should be kept small ·No visible 
reaction 
25
  
·Reflection from container 
·Not uniform 
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Figure 8.5.  Absorbance spectrum of a representative reaction between Nitric Oxide and 
Film #16 (cytochrome-c(Fe III) immobilized in a PVA film) 
 
The next step in experimentation focused on increasing reactivity by increasing the water 
content of the sensing element.  Results are presented in Table 8-7.  It was found that 
creating uniform gels and increasing the surface area by either imprinting or needling was 
easy, but there was no visible reaction when it was reacted with gaseous nitric oxide. 
 
Table 8-7:  Results for PVA gels immobilization testing.  The details of the methods for 
each experiment set are given in Table 5-1.  The # in the table indicates the experiment 
series number. 
 
# Quality Conclusions Reactivity 
with NO 
26
  
Dried uniformly Increasing water content did not 
increase reactivity 
No reaction 
visible 
27
  
Imprinting successful   
28
  
Needling successful   
 
In addition to PVA, agar was also examined as an immobilizing agent in both the film 
and gel form.  In general, it was found that PVA immobilized supports had a better 
consistency, better reactivity and they were more uniform when dried.  Specific results 
are provided in Tables 8-8 and 8-9. 
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Table 8-8:  Results for Agar films immobilization testing.  The details of the methods for 
each experiment set are given in Table 5-1.  The # in the table indicates the experiment 
series number. 
 
# Quality Conclusions Reactivity with NO 
29
  
Not uniform 
Took too long to dry 
Not flat 
Try other drying methods and 
temperatures 
Not checked 
30
  
Not uniform Use glass, not foil 
Use oven, not water bath 
PVA better material 
No reaction 
visible 
31
  
Not uniform 
Did not dry completely 
 Not checked 
32
  
Even less uniform   
33
  
Even less uniform 
Did not dry completely 
  
 
Table 8-9:  Results for Agar gels immobilization testing.  The details of the methods for 
each experiment set are given in Table 5-1.  The # in the table indicates the experiment 
series number. 
 
# Quality Conclusions Reactivity with NO 
34
  
Not uniform Increasing water content did not 
increase reactivity  
PVA better material 
No visible 
reaction 
35
  
Imprinting successful 
Not uniform 
  
36
  
Needling successful 
Not uniform 
  
 
Siloxanes were examined in a variety of configurations including an even dispersion of 
the heme through the siloxane, a “heme sandwich” and modification of the heme to 
facilitate dissolution of the heme into the siloxane.    There was no reaction visible for the 
even dispersion or the sandwich.  Various thickness and concentrations for the dispersion 
and the sandwich were tried to increase sensitivity, assuming that sensitivity was the 
problem.  All trials failed.  Attempts to dissolve the heme into the siloxane also failed.  
8.4 Flow-thru Sensor  
8.4.1 Configuration 
 
Tubing delivering heme to and from the sensor was kept at a height level with the sensing 
element.  If the input tubing is kept higher than the output tubing, there is a constant flow 
of heme through the system.  If the output tubing is kept higher than the input tubing, 
heme does not flow through the system.  If both the input and output tubing are higher 
than the sensing element, then the heme is not fully replaced during each cycle, some 
mixing is evident.  Finally, if the tubing is kept lower than the sensing element, then fluid 
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has difficulty travelling through the system. Generally, heme is pushed into the system 
and self-drains, leaving no sensing compound in the sensor. 
 
Placement of the flowmeter and solenoid also affected the sensitivity of the system.  
Placement of the gas flowmeter after the sensing element produced a pressure in the 
system that pushed down on the membrane and reduced the pathlength of the system by 
pushing heme out of the sensing element.  Solenoid placement also affected system 
dynamics.  Placement after the sensing element resulted in pressure build up within the 
sensing element when the solenoid was off and a constant flow when the solenoid was 
on.  The pressure again resulted in depression of the membrane and subsequent reduction 
of pathlength.  Solenoid placement before the sensing element resulted in constant flow 
when the solenoid was on and slow, but constant drainage through the system of any 
residual gasses when the solenoid was off and vented to air.  Placing the vent tubing in 
water resulted in a small amount of drainage in a short period of time until inside and 
outside pressures were equalized. 
 
Fluid injection and ejection methods were also compared.  When a motor is used to push 
heme in with one syringe on the upstroke and the same motor is used to push air through 
on the downstroke, a variety of complications arise.  Primarily, fluid replacement is not 
exact.  If too little air is used, then the heme is not completely ejected and there is a 
mixing of fluids.  If too much air is used then it creates an unwanted pressure in the 
system, drawing new heme directly through the sensing element.  Using air also causes 
air bubbles in the system that are hard to displace with fluid injection.  The same system 
was tested with buffer instead of air.  If too small a volume of buffer is used then there is 
not complete replacement of the injected heme and mixing will occur.  Regardless of 
buffer volume, some mixing was evident because the buffer is used to push out the heme 
and heme is used to replace the buffer.  In addition, inexact volumes result in unwanted 
bubbles in the system.  The final configuration that was tested involved using a single 
syringe to inject and withdraw the fluid.  On the downstroke of the syringe, fluid was 
pulled out of the sensing element and on the upstroke of the syringe, fluid was injected 
into the system.  In this system, there was an exact exchange of fluids and no problems 
with bubble interference. 
 
The thickness of the sensing element was determined by needle size, spacer size and 
reaction time.  The optimal spacer size was 0.127 mm (0.05”) with a 22.5 gauge needle.  
Smaller spacers could not accommodate the needle and larger spacers resulted in too 
large a space to fill with heme solution.  The larger the space, the longer it took to fill and 
purge the space and the longer the reaction took to equilibrate. 
 
According to CDI, the distance between input and output lens should be less than 254 
mm (10”), with optimal spacing at 43.75 mm.  The physical configuration of the sensor 
dictated that the lenses be 50 mm apart. 
 
At this point, the physical design of the sensor was implemented for the remainder of the 
experiments.  Tubing height was kept at a height level with the sensing element to ensure 
that fluid movement remained stagnant during the reaction and measurement phase of 
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sensor operation.  Both the solenoid and flowmeter were placed before the sensing 
element to ensure that there were no unwanted pressures in the system and that 
measurement of gas going into the sensor was accurate.  A one pump system for fluid 
injection/ejection was implemented in order to ensure exact exchange of fluids and 
eliminate air bubbles inherent to the other systems.  The optimal thickness of the sensing 
element was determined to be 12.5 mm with a 22.5 gauge needle for heme input and 
output.  The distance between the input and output lenses was set 50 mm.  Sensor 
parameters were then evaluated with the physical configuration outlined above and 
depicted in Figure 5.1. 
 
8.4.2 Sensor Parameters 
 
Three different referencing procedures were assessed for effects on sensitivity by 
evaluating drift of the system from an average over the course of eight hours.  This was 
done by calculating the standard deviation of multiple absorption measurements (made 
during an 8 hour period) for each wavelength between 500 nm and 600 nm and then 
averaging them.  The results are presented in Table 8-10.  When the system is referenced 
once to buffer at the beginning of the eight hours, the average standard deviation is 
0.0009 absorbance units.  When referenced to cytochrome-c once at the beginning of a 
set, the average standard deviation is 0.0022 absorbance units, and when referenced to 
cytochrome-c prior to each measurement, the calculation yields 0.0007.  This indicates 
that referencing with heme prior to each measurement yields the smallest amount of drift 
and the least error over the course of eight hours. 
 
Table 8-10:  Effect of referencing procedure on sensitivity of sensor 
 
Method Reference Sample Average Std. Dev. 
Once at beginning Buffer Cytochrome-c 0.0009 
Once at beginning Cytochrome-c Cytochrome-c 0.0022 
Each time Cytochrome-c Cytochrome-c 0.0007 
 
 105
The time it takes the system to equilibrate after heme injection was evaluated by injecting 
heme into the sensor and performing continuous measurements until there was no change 
in signal level over the course of two minutes.  It was found that the absorbance reaches 
an equilibrium state at approximately 25 seconds and reaches 90% of this value at 3 
seconds.  Results are provided in Figure 8.6. 
 
Figure 8.6  System equilibration time post heme injection, reaches 90% of SS at 3 seconds 
and equilibrium at 25 seconds 
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The effect of flow time on the sensitivity of the sensor was evaluated to determine how 
long NO can be delivered without saturating the sensor in order to maximize sensitivity 
without sacrificing response time.  The flow time parameter needs to be set at a point just 
below the time at which the signal reaches 90% of its full-scale value in order to 
maximize sensitivity without worrying about saturation.  If this value is too high, the 
sensitivity can be sacrificed in order to maintain an appropriate response time.  The effect 
of flow time on the sensitivity of the sensor was evaluated by measuring the absorbance 
at the wavelength of interest over the course of 5 minutes at a set flow rate, concentration 
and pressure.  It was found that the absorbance reaches an equilibrium state at 
approximately 4 minutes and reaches 90% of this value at 2.9 minutes under the 
conditions studied.  Results are presented in Figure 8.7. 
 
 
 
 
Figure 8.7.  Effect of flow time on measurement level (173 ppm NO at 68.95 kPa (10 psi) 
with 5 mg/ml cytochrome-c sensor and 200 cc/min.) 
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The time it takes for the reaction to come to equilibrium after the gas flow has been 
stopped was evaluated by flowing NO for 1 minute and then observing the reaction every 
30 seconds for 5 minutes.  It was found that the reaction reached a full scale value at 1 
minute and reached 90% of this at 45 seconds.  Results are provided in Figure 8.8. 
 
 
 
 
 
 
Figure 8.8.  Equilibration time post gas flow 
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The effect of flow rate on the operation of the sensor was evaluated by examining the 
absorbance level at a constant concentration and pressure over a range of flow rates from 
25 to 400 cc/min.  It was found that the reaction saturates under the given conditions at 
250 cc/min, reaching 90% of full-scale at 200 cc/min. under the conditions studied.  
Results are presented in Figure 8.9.  Saturation of the reaction implies that if the flow rate 
is increased beyond the given value then the measured absorbance will not change with 
respect to the concentration of nitric oxide because all of the cytochrome-c has reacted 
with nitric oxide.  
 
 
 
 
 
Figure 8.9.  Effect of flow rate on measurement level (173 ppm NO at 68.95 kPa (10 psi)  
with  5 mg/ml cytochrome-c sensor) 
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The effect of pressure on the sensitivity of the sensor was evaluated by examining the 
absorbance level at a constant concentration and flow rate over a range of pressures from 
34.48 to 137.9 kPa (5 to 20 psi).  It was found that the absorbance level, under the given 
conditions, increases linearly with pressure.  Higher pressures were not tested due to 
constraints in the physical design of the system.  Results are presented in Figure 8.10. 
 
 
 
 
 
 
Figure 8.10.  Effect of pressure on measurement level (173 ppm NO at  200 cc/min. with 5 
mg/ml cytochrome-c sensor) 
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The effect of cytochrome-c concentration on the sensitivity of the sensor was evaluated 
by examining the absorbance level at a constant flow rate and pressure at 10.0 mg/ ml, 
5.0 mg/ml and 2.5 mg/ml.  It was found that an increase in concentration produces 
increased sensitivity in the range and under the conditions studied.  There is saturation of 
the cytochrome-c evident at 2.5 mg/ml at approximately 85 ppm.  No saturation point 
was reached for the other concentrations studied.  Although there is an increase in 
sensitivity as the heme concentration is increased, the line fit to the entire concentration 
range does not describe the trend at low concentrations of NO.  Results are presented in 
Figure 8.11.  
 
 
Figure 8.11.  Effect of Cytochrome-c concentration on measurement level (173 ppm NO at 
200 cc/min and 68.95 kPa (10 psi).           10.0 mg/ml          5.0 mg/ml           2.5 mg/ml 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of Concentration on Measurement
_ __ _ 2.5 mg/ml 
y = 5E-05x + 0.0016
R2 = 0.979
- - - - 5.0 mg/ml
y = 3E-05x + 0.0008
R2 = 0.8997
___ 10.0 mg/ml
y = 1E-05x + 0.0006
R2 = 0.5586
0
0.002
0.004
0.006
0.008
0.01
0.012
0.014
0 50 100 150 200
cc/min NO
Ab
so
rb
an
ce
 111
A representative calibration curve is presented in Figure 8.12 at a total flow rate of 200 
cc/min., concentration of 5.0 mg/ml and 68.95 kPa (10 psi).  The system is sensitive to a 
minimum NO concentration of 5 ppm and can be linearized in the concentration range 
between 5 and 175 ppm.   
 
Figure 8.12.  Representative calibration curve (NO at 200 cc/min., 68.95 kPa (10 psi) with 
a 5 mg/ml cytochrome-c sensor)  
 
In summary, these results provide pertinent information regarding a number of sensor 
parameters.  It was shown that referencing at the beginning of each cycle with heme 
would yield a system with the lowest amount of drift.  The evaluation of flow time 
proved that at the given heme concentration, system pressure and gas flow rate, the 
reaction would saturate at 4 minutes and reach 95% of full-scale at 2.9 minutes.  A time 
of 1 minute was chosen for the remainder of the experiments.  A flow rate of 200 cc/min. 
was found to maximize the signal value without saturation of the heme.  The system 
pressure was determined to directly affect the measurement level.  Increasing pressure 
increased the measurement level.  A maximum point was not determined due to the 
constraints of the system.  The concentration of the heme also affected the absorbance 
level in a similar manner.  A representative calibration curve was included with sensor 
parameters and configuration set as described above. 
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8.5 Data Processing 
The effect of integration time on the number of counts reaching the detector was 
examined by increasing the integration time from 0.03 seconds until the detector reached 
a maximum level without saturating.  It was found that a maximum is reached at 
approximately 0.07 seconds.  If the integration time is increased beyond this point the 
detector will saturate and spectral information will be lost.  See Figure 8.13. 
 
Figure 8.13.  The effect of integration time on the number of counts reaching the detector.  
For a 14 bit A/D converter, the maximum count number is 16384.  In order of increasing 
A/D counts, the integration time was set at 0.03 seconds, 0.05 seconds and 0.07 seconds. 
 
Averaging was examined by varying the number of spectra that the system averages and 
determining the noise level between 500 nm and 600 nm for two methods of acquisition. 
Results are provided in Table 8-11.  The first column refers to acquiring a single 
spectrum at a time and then averaging the results.  The second column refers to filling a 
buffer with 17 spectra and averaging the results.  This average is then considered to be a 
single spectrum.  These two options are provided by CDI’s custom software.  It was 
found that for both methods the noise level decreases progressively as the number of 
spectra that are averaged increases.  Increasing the number of spectra averaged above 5 
does not significantly decrease the noise level.  In addition, by comparing the two 
methods, it is evident that there is no significant difference between the two methods. 
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Table 8-11:  Noise level comparison for averaging experiments, single spectrum 
acquisition vs. filling the buffer and averaging. 
 
Number of 
Spectra Averaged 
Noise Level (Abs Units) 
Single 
Noise Level (Abs Units) 
Fill Buffer 
1 0.00021 0.00021 
2 0.00018 0.00019 
3 0.00016 0.00015 
4 0.00013 0.00013 
5 0.00013 0.00013 
7 0.00012 0.00012 
10 0.00012 0.00011 
15 0.00011 0.00011 
20 0.00010 0.00009 
 
Point to point averaging was examined by collecting spectra for NO concentrations 
between 0 and 173 ppm.  The raw data was then point to point averaged at 563 nm.  A 
calibration curve was determined for each set of data and the minimum detectable limit 
was calculated at 5 times the noise level.  Results are presented in Table 8-12.  It can be 
seen that the slope, r2 value and noise level all decrease as the number of points that are 
averaged increases.  The minimum detectable limit also decreases as the number of points 
averaged increases, the relationship being logarithmic.  It is evident from the data that 
after 10 point averaging, the changes in the slope and r2 are small, but there is a 
significant decrease in minimum detectable limit. 
 
Table 8-12:  Calibration curve parameters and minimum detectable limit (MDL) calculated 
from point to point averaged data. 
 
Points 
Averaged 1 2 3 4 5 10 15 20 
Slope 3.74x10-5 3.39x10-5 3.33x10-5 3.37x10-5 3.31x10-5 3.30x10-5 3.12x10-5 3.11x10-5 
R2 0.9818 0.9648 0.9646 0.9558 0.9523 0.9484 0.9416 0.9336 
Intercept 3.00x10-4 1.64x10-4 2.02x10-4 1.83x10-4 1.85x10-4 7.23x10-5 5.67x10-5 4.11x10-5 
Noise 2.40x10-4 1.35x10-4 9.50x10-5 8.50x10-5 7.50x10-5 2.50x10-5 1.87x10-5 1.00x10-5 
Noise*5 1.20x10-3 6.75x10-4 4.75x10-4 4.25x10-4 3.75x10-4 1.25x10-4 9.35x10-5 5.00x10-5 
MDL 
(cc/min) 
24.08 15.10 8.19 7.17 5.74 1.60 1.18 0.29 
MDL (ppm) 20.83 13.06 7.08 6.20 4.96 1.38 1.02 0.25 
 
Difference spectral measurements were compared to absolute absorbance measurements 
by generating calibration curves for both methods.  It was found that the relationship 
between nitric oxide concentration and the absorbance values was linear for the 
difference measurements as determined in past experiments, but was not linear for the 
absolute absorbance measurements.  In addition, a polynomial, logarithmic, exponential 
or power series could not be fit to the data.  When the area under the 563 nm peak was 
calculated and plotted against the concentration of NO, a linear relationship could not be 
found.  Again, a polynomial, logarithmic, exponential or power series could not be fit to 
the data. 
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8.6 System Testing 
Sensitivity was examined by generating calibration curves two times per day for four 
days and determining the slope, intercept and minimum detectable limit based on a 
calculated noise level and five point spectral averaging.  The optimized system was 
examined twice in two days.  It was found that the slope of the calibration curve increases 
by 58% when just the data under 25 ppm is used in the calculations.  The optimized 
system (cytochrome-c concentration of 10 mg/ml, 137.90 kPa (20 psi), and a post-gas 
flow equilibrationtime of 15 seconds) yielded an increase in slope of 219% over the 
original system.  Using only the data under 25 ppm for the optimized system further 
increased the slope by 96%.  Data is shown in Tables 8-13 through 8-16.  The slope 
increases and the minimum detectable limit increases when only data under 25 ppm is 
used for the standard system.  The slope increases and the minimum detectable limit 
decreases for the optimized system when data under 25 ppm is used. 
 
Table 8-13:  Sensitivity and minimum detectable limit for entire concentration range, 
standardized system 
 
Trial # R2 Slope 
Abs/ppm 
Intercept 
Abs 
Noise Level 
Abs 
Min det limit 
(ppm) 
1 0.9892 3.26x10-5 3.38x10-4 9.54x10-5 4.28 
2 0.9887 3.33x10-5 3.20x10-4 1.01x10-4 5.62 
3 0.9898 3.49x10-5 2.95x10-4 9.67x10-5 5.41 
4 0.9896 3.37x10-5 3.20x10-4 9.20x10-5 4.15 
5 0.9905 3.42x10-5 3.14x10-4 8.90x10-5 3.81 
6 0.9890 3.23x10-5 3.34x10-4 9.39x10-5 4.18 
7 0.9865 3.22x10-5 3.58x10-4 9.47x10-5 3.57 
8 0.9899 3.46x10-5 2.98x10-4 8.90x10-5 4.24 
Average 0.9892 3.35x10-5 3.22x10-4 9.40x10-5 4.41 
Stdev 0.0012 1.04x10-6 2.10x10-5 4.14x10-6 0.73 
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Table 8-14:  Sensitivity and minimum detectable limit for standardized system, data under 
25 ppm 
 
Trial # R2 Slope Abs/ppm 
Intercept 
Abs 
Noise Level 
Abs 
Minimum det 
limit (ppm) 
1 0.9967 5.21x10-5 1.01x10-4 9.54x10-5 7.22 
2 0.9994 4.97x10-5 1.15x10-4 1.01x10-4 7.89 
3 0.9996 5.17x10-5 3.25x10-5 9.67x10-5 8.73 
4 0.9959 5.24x10-5 1.32x10-4 9.20x10-5 6.26 
5 0.9984 5.16x10-5 1.09x10-4 8.90x10-5 6.51 
6 0.9973 4.82x10-5 4.95x10-5 9.39x10-5 8.72 
7 0.9992 6.73x10-5 1.11x10-4 9.47x10-5 5.38 
8 0.9986 5.06x10-5 1.26x10-4 8.90x10-5 6.30 
Average 0.9981 5.30x10-5 9.70x10-5 9.40x10-5 7.13 
Stdev 0.0014 5.97x10-6 3.62x10-5 4.14x10-6 1.23 
 
Table 8-15:  Sensitivity and minimum detectable limit for entire concentration range, 
optimized system 
 
Trial # R2 Slope Abs/ppm 
Intercept 
Abs 
Noise Level 
Abs 
Minimum det 
limit (ppm) 
Error 
ppm 
1 0.9885 1.09x10-4 1.28x10-3 8.82x10-5 4.04 11.74 
2 0.9862 1.04x10-4 1.48x10-3 9.53x10-5 4.58 14.23 
Average 0.9874 1.07x10-4 1.38x10-3 9.76x10-5 4.31  
 
Table 8-16:  Sensitivity and minimum detectable limit for data under 25 ppm, optimized 
system 
 
Trial # R2 Slope Abs/ppm 
Intercept 
Abs 
Noise Level 
Abs 
Minimum det 
limit (ppm) 
Error 
ppm 
1 0.9993 2.07x10-4 4.94x10-4 8.82x10-5 2.13 2.39 
2 0.9983 2.13x10-4 4.39x10-4 9.53x10-5 0.17  
Average 0.9988 2.10x10-4 4.66x10-4 9.76x10-5 1.15  
 
Specificity was examined by generating calibration curves for data obtained with oxygen 
concentrations between 0 and 90%.  The average was noted in addition to the slope, 
intercept and r2 value at each oxygen concentration.  Procedures were repeated with the 
optimized configuration.  It was found that the slope steadily decreased as oxygen 
concentration increased.  For the optimized system there was no change in slope with 
changing oxygen concentrations.  Results are presented in Tables 8-17 and 8-18. 
 
 116
Table 8-17:  Specificity for NO in the presence of oxygen, n=8, where n is the number of 
runs at each concentration 
 
Average absorbance values, n=8 
% O2 [NO] ppm 0 5 25 50 70 90 
173.00 0.00608      
86.50 0.00320 0.00281 0.00278 0.00272   
43.25 0.00171 0.00209 0.00187 0.00191 0.00169  
21.63 0.00144 0.00120 0.00117 0.00110 0.00103  
12.98 0.00091 0.00082 0.00075 0.00069 0.00061 0.00058 
8.65 0.00062 0.00059 0.00049 0.00050 0.00046 0.00039 
4.33 0.00033 0.00027 0.00025 0.00022 0.00016 0.00013 
0.00 0.00002 0.00012 0.00006 0.00004 0.00004 0.00004 
Rsq 0.9936 0.9829 0.9957 0.9924 0.9717 0.9702 
Slope 6.01x10-5 5.62x10-5 5.35x10-5 5.17x10-5 4.64x10-5 4.35x10-5 
Intercept 1.10x10-4 8.39x10-5 3.99x10-5 2.85x10-5 1.69x10-5 2.76x10-6 
 
Table 8-18:  Specificity for NO in the presence of oxygen, optimized configuration, n=2 
 
Average absorbance values for optimized system, n=2 
% O2 [NO] ppm 0 5 25 50 70 90 
173.00 0.02022      
86.50 0.01064 0.01058 0.01061 0.01057   
43.25 0.00571 0.00573 0.00572 0.00570 0.00563  
21.63 0.00478 0.00484 0.00480 0.00484 0.00484  
12.98 0.00302 0.00303 0.00300 0.00302 0.00300 0.00298 
8.65 0.00207 0.00206 0.00206 0.00207 0.00209 0.00207 
4.33 0.00111 0.00110 0.00110 0.00113 0.00113 0.00110 
0.00 0.00045 0.00045 0.00044 0.00044 0.00046 0.00046 
Rsq 0.9928 0.9925 0.9936 0.9945 0.9948 0.9932 
Slope 2.01x10-4 2.01x10-4 2.00x10-4 2.00x10-4 1.98x10-4 1.97x10-4 
Intercept 3.61x10-4 3.57x10-4 3.57x10-4 3.64x10-4 3.84x10-4 3.75x10-4 
 
Response time was noted to be 45 seconds less for the optimized system than for the 
normal configuration.  Results are presented in Tables 8-19 and 8-20. 
 
Table 8-19:  Response time broken up into segments for the normal system 
 
Cycle Time 
Heme ejection/injection 5 seconds 
System stabilization 30 seconds 
Reference measurement Negligible 
Gas delivery 1 minute 
Reaction equilibrium 1 minute 
Measurement Negligible 
Total time 2 min 35 seconds 
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Table 8-20:  Response time broken up into segments for optimized system 
 
Cycle Time 
Heme ejection/injection 5 seconds 
System stabilization 30 seconds 
Reference measurement Negligible 
Gas delivery 1 minute 
Reaction equilibrium 15 seconds 
Measurement Negligible 
Total time 1 min 50 seconds 
 
Stability was examined by randomizing the order in which the measurements were taken 
and taking these measurements once per hour for eight hours.  Data points included those 
used to make calibration curves for previous experiments (173, 86.5, 43.25, 21.63, 12.98, 
8.65, 4.33, 1.73 and 0 ppm) and those generated randomly (162, 143, 113, 107, 82, 57, 
24, 23, 17, 11, 8, 3 and 1 ppm).  Results are presented in Table 8-21 and 8-22.  As seen, 
the standard deviation around the average is low for all nitric oxide concentrations 
throughout the studied time course.  Although it was found that measurements for 
specific points are stable, by virtue of the low standard deviation, the error at 
concentration less than 25 ppm is quite high.  There are two possibilities.  The first stems 
from the fact that the calibration curves were generated from trial numbers 1, 6, 8, 11, 15, 
17 and 20 for the entire NO range.  Thus, the fit for points less than 25 ppm is poor and 
the error is higher at concentrations less than 25 ppm.  The calibration curve for the entire 
range has a lower slope than the calibration curve generated with points less than 25 ppm.  
Thus, when the calibration curve generated from the entire range is used to determine 
values less than 25 ppm, the error is high.  The second possibility is that the stability 
measured is not adequate to produce a reasonable error at low concentrations of nitric 
oxide. 
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Table 8-21:  Data for absorbance measurements randomized and acquired once per hour for 
eight hours.  Error in ppm calculated from the calibration equation determined at the 
beginning of experimentation.  Calibration equation generated in two parts, with data less 
than 25 ppm and data from 25 to 173 ppm. 
 
Trial# [NO] ppm Average 
Absorbance 
Stdev of 
Absorbance 
error in ppm % error 
1 173.00 0.0061 1.77x10-4 0.4327 0.25 
2 161.83 0.0058 1.41x10-4 1.7310 1.07 
3 143.20 0.0051 1.20x10-4 0.6538 0.46 
4 112.66 0.0041 8.94x10-5 0.1348 0.12 
5 106.63 0.0039 8.50x10-5 0.1091 0.10 
6 86.50 0.0032 4.53x10-5 0.9938 1.15 
7 56.65 0.0022 4.17x10-5 1.1649 2.06 
8 43.25 0.0017 3.65x10-5 2.0754 6.42 
9 23.61 0.0016 1.26x10-4 0.5939 2.52 
10 23.42 0.0016 1.22x10-4 0.4039 1.72 
11 21.63 0.0015 6.22x10-5 0.1667 0.77 
12 16.51 0.0011 8.29x10-5 1.2580 7.62 
13 12.98 0.0009 7.26x10-5 0.8336 6.42 
14 11.11 0.0007 5.26x10-5 2.0693 18.63 
15 8.65 0.0007 2.67x10-5 0.3907 4.52 
16 7.77 0.0006 4.22x10-5 0.2821 3.63 
17 4.33 0.0004 3.20x10-5 0.0522 1.21 
18 3.30 0.0003 4.60x10-5 0.4706 14.26 
19 1.31 0.0001 4.95x10-5 1.5862 121.09 
20 0.00 0.0001 1.60x10-5 0.2762  
 
Table 8-22:  r2, slope and intercept calculated for each run using trials 1, 6, 8, 11, 15, 17 
and 20 shown in the shaded rows in table 8-21 
 
Trial # r2 Slope (Abs/ppm) Intercept 
1 0.9908 3.30x10-5 3.11x10-4 
2 0.9873 3.32x10-5 3.35x10-4 
3 0.9892 3.46x10-5 3.22x10-4 
4 0.9914 3.35x10-5 3.23x10-4 
5 0.9886 3.39x10-5 3.17x10-4 
6 0.9911 3.25x10-5 3.33x10-4 
7 0.9872 3.21x10-5 3.67x10-4 
8 0.9885 3.46x10-5 3.07x10-4 
Average 0.9893 3.34x10-5 3.27x10-4 
Standard Deviation 0.0017 9.20x10-7 1.88x10-5 
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Accuracy was examined by delivering known concentrations of NO to the system, 
obtaining the absorbance and using this value to calculate the NO concentration from 
various calibration schemes.  Calibration curves were generated with two methods.  The 
first is a simple linear calibration scheme with 2, 3, 4 and 5 points as outlined in Table 8-
23. 
 
Table 8-23:  Number of points and [NO] used to create calibration equations to assess 
calibration method for accuracy 
 
# points [NO] ppm 
2 173.00 0.00    
3 173.00 23.61 0.00   
4 173.00 56.65 12.98 0.00  
5 173.00 86.5 21.63 7.77 0.00 
 
The second method involves splitting the NO concentration range into 2 segments.  Thus, 
an independent linear calibration curve is generated for each segment.  For calibrations 
conducted with two independent ranges, between 0 ppm and 25 ppm and 25 ppm and 200 
ppm, the points are given in Table 8-24. 
 
Table 8-24:  Points used in determination of accuracy, method 2. 
 
[NO] ppm #points 
Upper range (200 ppm to 25 ppm) Lower range (25 ppm to 0 ppm) 
2 173.00 43.25    23.61 0.00    
3 173.00 112.66 43.25   23.61 11.11 0.00   
4 173.00 143.20 86.50 43.25  23.61 16.51 7.77 0.00  
5 173.00 143.20 106.63 56.65 43.25 23.61 16.51 8.65 3.30 0.00 
 
The true concentration is compared to the estimated concentration to determine accuracy.  
Results are reported as a percentage error and as an error in ppm NO.  Results are 
presented in Tables 8-25 and 8-26, where n=8 for the normal system and n=2 for the 
optimal system.  It was found that the normal system with 2 ranges gave the best results, 
with accuracy improving as the number of points used in the calibration increased.  With 
two range 2-point calibrations the accuracy was to within 2.25 ppm for the upper 
concentration range of 25 ppm to 200 ppm and to within 1.50 ppm for the lower 
concentration range of 0 ppm to 25 ppm.  For a 5-point calibration, the accuracy was to 
within 1.50 ppm for both the upper and lower concentration ranges. 
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Table 8-25:  System accuracy as ppm NO error.  Calibration curves generated each day 
with 2, 3, 4 and 5 points, for both normal and optimal system. 
 
[NO] 
ppm 
2 point 
ppm NO error 
3 point 
ppm NO error 
4 point 
ppm NO error 
5 point 
ppm NO error 
Normal Average Stdev Average stdev Average stdev Average stdev 
173.00 0.00 0.00 1.79 0.42 0.83 0.17 1.04 0.89 
161.83 2.49 1.13 0.90 0.78 1.42 0.94 1.11 0.37 
143.20 2.81 1.09 1.11 0.69 1.22 0.77 0.52 0.35 
112.66 2.77 0.90 2.28 1.18 0.58 0.44 1.06 0.45 
106.63 4.71 0.87 1.09 0.86 1.85 0.73 0.70 0.41 
86.50 4.09 2.61 3.23 1.48 1.89 1.66 1.83 1.38 
56.65 5.59 0.73 2.38 1.61 1.11 0.58 0.92 0.78 
43.25 5.02 2.18 3.63 2.70 1.54 1.17 2.52 1.92 
23.61 21.86 4.83 13.10 3.10 16.83 5.05 14.54 4.31 
23.42 21.16 4.73 12.35 2.99 16.10 4.96 13.80 4.21 
21.63 19.05 1.48 9.98 1.58 13.86 1.53 11.47 1.00 
16.51 15.29 3.58 5.76 1.67 9.80 3.85 7.28 2.91 
12.98 11.95 0.91 3.16 1.24 6.25 0.60 3.58 1.77 
11.11 8.84 2.78 1.74 0.50 3.13 2.92 1.49 1.30 
8.65 8.52 1.01 1.91 1.97 2.56 1.07 0.92 0.70 
7.77 8.86 2.40 1.95 0.91 2.99 2.64 1.17 1.18 
4.33 4.63 1.00 6.19 2.56 1.62 1.21 4.55 1.47 
3.30 3.42 2.47 7.54 2.63 3.74 1.53 5.88 2.22 
1.31 1.71 1.88 10.58 3.06 6.00 2.61 8.90 2.39 
Optimal Average Stdev Average stdev Average stdev Average stdev 
173.00 0.00 0.00 1.64 0.33 1.30 1.05 2.62 0.48 
161.83 7.75 7.96 5.97 8.00 6.42 7.10 6.17 7.14 
143.20 8.69 1.76 8.70 2.52 7.80 1.24 9.07 3.57 
112.66 10.15 8.28 10.04 2.15 8.91 4.07 10.28 1.35 
106.63 6.87 7.10 4.62 3.18 3.65 4.99 4.87 2.39 
86.50 8.56 0.82 2.97 1.97 4.64 3.59 2.50 1.69 
56.65 7.53 5.65 3.19 0.57 2.64 2.42 3.21 0.24 
43.25 12.58 5.52 5.03 4.29 7.41 2.11 4.85 4.26 
23.61 20.21 3.83 12.05 2.39 14.62 0.10 11.94 2.29 
23.42 19.40 6.28 11.20 4.96 13.80 2.62 11.10 4.84 
21.63 19.62 4.11 11.33 2.66 13.95 0.33 11.24 2.54 
16.51 13.71 4.66 4.86 3.13 7.67 0.66 4.84 2.94 
12.98 11.95 7.46 4.25 4.03 5.76 3.44 4.08 4.07 
11.11 10.70 5.05 2.45 2.01 4.38 0.89 2.26 2.07 
8.65 10.50 3.60 1.35 1.53 4.07 0.67 1.16 1.60 
7.77 8.60 3.14 0.99 1.35 2.08 1.21 0.89 1.11 
4.33 5.46 5.69 4.42 4.01 1.26 1.29 4.30 3.67 
3.30 4.97 2.39 5.00 0.53 1.83 2.16 4.88 0.20 
1.31 3.77 4.43 7.02 3.58 3.77 0.80 6.87 3.20 
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Table 8-26:  System accuracy as ppm NO error.  Separate calibration curves generated each 
day for points between 25 ppm and 200 ppm and points between 0 and 25 ppm with 2, 3, 4 
and 5 point calibrations, for both normal and optimized system. 
 
[NO] ppm 
2 ranges 
2 point 
ppm NO error 
3 point 
ppm NO error 
4 point 
ppm NO error 
5 point 
ppm NO error 
Normal Ave stdev Ave stdev Ave stdev Ave stdev 
173.00 0.00 0.00 0.21 0.18 0.84 0.56 1.11 0.43 
161.83 2.15 1.06 2.00 1.02 1.35 0.61 1.05 0.75 
143.20 1.73 0.83 1.57 0.73 0.99 0.25 0.72 0.45 
112.66 0.58 0.50 0.39 0.33 0.42 0.26 0.57 0.25 
106.63 2.22 0.66 2.07 0.45 1.61 0.57 1.21 0.24 
86.50 1.72 1.33 1.57 1.19 1.08 0.69 1.46 1.12 
56.65 1.45 1.01 1.27 0.95 1.41 0.86 0.60 0.49 
43.25 0.00 0.00 0.18 0.15 0.74 0.61 1.01 0.57 
23.61 0.00 0.00 0.29 0.10 0.13 0.19 0.09 0.08 
23.42 0.27 0.03 0.10 0.13 0.36 0.19 0.31 0.10 
21.63 1.36 0.93 1.45 0.88 1.46 1.00 1.35 0.93 
16.51 0.22 0.26 0.24 0.15 0.18 0.08 0.19 0.14 
12.98 1.16 0.84 1.39 0.74 1.27 0.94 1.20 0.86 
11.11 0.93 0.31 0.62 0.21 1.01 0.37 0.87 0.43 
8.65 0.63 0.44 0.82 0.53 0.67 0.43 0.59 0.35 
7.77 0.86 0.73 1.12 0.52 0.60 0.45 0.76 0.50 
4.33 0.55 0.46 0.65 0.66 0.55 0.44 0.47 0.47 
3.30 0.74 0.85 0.74 0.69 0.56 0.69 0.47 0.59 
1.31 0.91 0.90 0.67 0.79 0.99 0.65 0.80 0.51 
Optimal  Average Stdev Average stdev Average stdev Average stdev 
173.00 0.00 0.00 3.29 0.14 3.51 1.14 4.22 0.48 
161.83 7.58 8.65 7.47 4.01 8.14 3.92 7.80 2.72 
143.20 8.58 2.17 5.40 2.35 6.26 1.75 5.07 1.53 
112.66 9.24 0.44 6.15 0.26 7.95 0.56 6.45 1.49 
106.63 3.37 0.84 0.49 0.42 2.25 1.21 1.55 1.12 
86.50 3.52 0.10 6.52 0.01 3.93 0.65 5.49 2.01 
56.65 4.14 0.58 4.23 3.51 4.12 1.78 2.53 1.04 
43.25 0.00 0.00 2.86 0.12 1.18 0.03 1.72 1.28 
23.61 0.00 0.00 0.38 0.25 0.39 0.03 0.40 0.08 
23.42 0.97 0.58 0.59 0.83 0.60 0.57 0.60 0.68 
21.63 0.58 0.27 0.41 0.27 0.58 0.27 0.48 0.30 
16.51 0.77 0.39 0.46 0.54 0.41 0.55 0.58 0.53 
12.98 2.02 0.46 1.62 0.20 1.69 0.23 1.65 0.11 
11.11 1.20 0.80 0.80 0.53 0.86 0.52 0.80 0.14 
8.65 1.62 1.04 1.43 0.47 1.40 0.56 1.11 0.45 
7.77 1.01 0.92 0.82 0.35 0.77 0.44 0.45 0.32 
4.33 1.85 1.17 1.44 0.90 1.54 0.73 1.45 0.20 
3.30 1.12 0.90 0.92 0.32 0.79 0.43 0.40 0.28 
1.31 1.89 1.37 1.47 1.09 1.59 0.85 1.48 0.25 
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System resolution was determined by calculating the change in nitric oxide concentration 
due to the smallest detectable change in absorbance.  It was found that the resolution 
decreased (improved) by 37.0% when just the points under 25 ppm were used.  In 
addition, the optimal system resulted in a decrease in resolution (improvement) from 2.81 
ppm to 0.91 ppm or 67.6% and the points under 25 ppm yielded a further decrease of 
resolution by 49.5%.  The improvement in resolution is due to the increase in the slope of 
the calibration curve.  Results are presented in Table 8-27. 
 
Table 8-27:  System resolution 
 
 All data (ppm) < 25 ppm (ppm) 
Normal trials 2.81 1.77 
Optimal trials 0.91 0.46 
8.7 Modeling 
8.7.1 Calculations 
 
Table 8-28 should be interpreted as follows.  The first column provides the parameter 
being studied along with its units.  The second column gives the concentration of NO 
being used to determine the absorbance equation in the fourth column.  For the fourth 
column, the first row of each section gives the absorbance as a function of the studied 
parameter.  The next rows give the absorbance as a function of nitric oxide concentration 
for a set parameter value.  For example, for pressure, the first row gives the absorbance as 
a function of pressure at one nitric oxide concentration.  The next three rows gives the 
absorbance as a function of nitric oxide concentration for a fixed pressure value.  The 
fifth column gives the minimum detectable limit (MDL), determined as the pressure at 
which the absorbance is five times the expected noise value of 0.0001 absorbance units.  
The final column gives the time it took for the highest reacted nitric oxide concentration 
to reach equilibrium.  This was determined by plotting the absorbance as a function of the 
parameter of interest over time until no change in absorbance was seen. 
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Table 8-28:  Expected (theoretical) absorbance values as functions of the parameter of 
interest at a fixed NO concentration and as functions of nitric oxide concentration with a 
fixed parameter of interest.  Parameters include pressure, heme concentration, path length, 
flow time and flow rate.  
 
Expected values [NO] 
ppm 
Values used to 
determine 
absorbance 
equations 
Absorbance MDL 
ppm 
Equil 
Time
(sec) 
Pressure (psi)  173 5, 10, 20, 40 A=0.134xP-1.2163   
 range 5 A=5·10-5xcno+7x10-9 10 500 
 range 10 A=0.0004xcno+5x10-7 1.25 410 
 range 20 A=0.0033xcno+3x10-5 0.14 330 
 range 40 A=0.0262xcno+0.0019 0.05 205 
Pressure (kPa)  173 34.48, 68.95, 
137.90, 275.80 
A=0.0195xP-0.1770   
 range 34.48 A=5·10-5xcno+7x10-9 10.00 500 
 range 68.95 A=0.0004xcno+5x10-7 1.25 410 
 range 137.90 A=0.0033xcno+3x10-5 0.14 330 
 range 275.80 A=0.0262xcno+0.0019 0.05 205 
[Heme] (mg/ml) 173 2.5, 5, 10 A=0.0010xcc+0.0016   
 range 2.5 A=0.0002xcno+3x10-7 2.50 440 
 range 5 A=0.0004xcno+5x10-7 1.25 410 
 range 10 A=0.0007xcno+7x10-7 0.71 400 
Path length (cm) 173 0.01, 0.02, 0.03, 
0.04, 0.05 
A=-19xl4+2.9xl3-
0.16xl2+0.0043xl+0.712 
  
 range 0.01 A=4.12x10-5xcno+1.42x10-7 12.13 390 
 range 0.02 A=4.12x10-5xcno+7.10x10-8 12.13 400 
 range 0.03 A=4.12x10-5xcno+4.736x10-8 12.13 410 
 range 0.04 A=4.12x10-5xcno+3.55x10-8 12.13 425 
 range 0.05 A=4.12x10-5xcno+2.84x10-8 12.13 450 
Flow time (min) 173 0.5, 1.0, 2.0 5.0 A=0.0156xft-0.8814   
 range 0.5 A=0.0001xcno+5x10-8 5.00 360 
 range 1.0 A=0.0004xcno+5x10-7 1.25 410 
 range 2.0 A=0.0019xcno+1x10-5 0.26 455 
 range 5.0 A=0.0233xcno+0.0015 0.04 490 
Flow rate 
(cc/min) 
173 50, 100, 200, 400 A=0.0004xfr+6x10-6   
 range 50 A=0.0001xcno+3x10-8 5.00 300 
 range 100 A=0.0002xcno+1x10-7 2.50 330 
 range 200 A=0.0004xcno+5x10-7 1.25 410 
 range 400 A=0.0008xcno+8x10-6 0.61 525 
 
 
The information in Table 8-28 was used to compare the theoretical information to values 
obtained from actual experiments (Table 8-29).  All data for actual values was taken from 
the experiments outlined and discussed earlier.  Note that in this table, calibration curves 
were run between 0 and 173 ppm NO, and the effect of the parameter in question on the 
absorbance was reported for 173 ppm NO.  All equilibration time values were taken as 
the time it takes the reaction to come to 100% equilibrium after flow of NO has been 
turned off.   
 124
Table 8-29:  Actual absorbance values as functions of the parameter of interest at a fixed 
NO concentration and as functions of nitric oxide concentration with a fixed parameter of 
interest.  Parameters include pressure, heme concentration, path length, flow time and flow 
rate. 
 
Actual values [NO] 
ppm 
Values Absorbance MDL 
ppm 
Equil 
Time
(sec) 
Pressure (psi) 173 5, 10, 20 A=0.0007xP-0.0005   
  5   76 
  10   60 
  20   38 
Pressure (kPa) 173 34.48, 68.95, 
137.90, 275.80 
A=0.0048xP-0.0005   
  34.48   76 
  68.95   60 
  137.90   38 
[Heme] (mg/ml) 173 2.5,5.0,10.0 A=0.0011xcc+0.0011   
  2.5 A=2x10-5xcno+0.0006 25 36 
  5 A=3x10-5xcno+0.0008 17 60 
  10 A=6x10-5xcno+0.0016 8 73 
Path length (cm)      
Flow time (min) 173 0.5, 0.75, 1.0, 1.25, 
1.5, 1.75, 2.0, 2.5, 
3.0,  4.0 
A=0.0034xft2+0.0106xft-0.0002   
  0.5   57 
  1.0   60 
  2.0   62 
  4.0   66 
Flow (cc/min) 173 50, 100, 200, 400 A=0.0004xln(fr)+0.0039 
Note:  A linear relationship 
could not be determined with a 
good fit 
  
  50   53 
  100   56 
  200   60 
  400   68 
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8.7.2 Graphs 
 
Figure 8.14.  Effect of pressure on calibration curves, theoretical evaluation. 
Figure 8.15.  Effect of pressure on absorbance at 173 ppm, theoretical and actual 
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Figure 8.16.  Effect of heme concentration on calibration curves, theoretical and actual.  
Theoretical (___) and Actual (- - -).  10 mg/ml (u), 5 mg/ml (s) and 2.5 mg/ml (n). 
Expected:  10 mg/ml
y = 0.0007x + 7E-07
Expected:  5 mg/ml
y = 0.0004x + 5E-07
Expected:  2.5 mg/ml
y = 0.0002x + 3E-07
Actual:  10 mg/ml
y = 6E-05x + 0.0016
R2 = 0.979
Actual:  5 mg/ml
y = 3E-05x + 0.0008
R2 = 0.8997
Actual:  2.5 mg/ml
y = 2E-05x + 0.0006
R2 = 0.5586
0
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Figure 8.17.  Effect of path length on calibration curve, theoretical evaluation  Note:  The 
bottom trendline corresponds to 0.01 cm, the top trendline corresponds to 0.02, 0.03, 0.04, 
0.05 cm.  There is no significant difference between these lines. 
 
 
Figure 8.18.  Effect of path length on absorbance at 173 ppm, theoretical.  
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Figure 8.19.  Effect of flow time on absorbance at 173 ppm, theoretical 
Figure 8.20.  Effect of flow time on absorbance at 173 ppm, theoretical and actual, flow 
time of 0.5, 1, 2 and 5 min..  
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Figure 8.21.  Effect of flow rate on calibration curve theoretical evaluation. 
 
Figure 8.22.  Effect of flow rate on absorbance at 173 ppm, theoretical and actual, flow 
rates of 50, 100, 200 and 400 cc/min..  
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Figure 8.23.  Theoretical and actual calibration curves with 5 mg/ml Cyt-c sensor, 68.95 
kPa (10 psi) 200 cc/min, 1 min flow time, 1 min equilibration period and 0.03 cm path 
length. 
 
In summary, mathematical modeling was used to determine how sensor performance 
differs from ideal with respect to pressure, heme concentration, path length, flow time 
and flow rate.  The models were used to determine expected sensitivity, minimum 
detectable limit and response time and compare these values to ones obtained from actual 
experiments.  If the model was deemed accurate in predicting sensor performance, then 
the information was used for system optimization. 
 
Results for the theoretical evaluation are presented in Table 8-28.  Column 4 gives the 
sensitivity of the system to nitric oxide in the form of an equation.  The equation relates 
the absorbance to nitric oxide concentration at a specified parameter setting.  For 
example, pressure sensitivity equations are given at 34.48, 68.95 and 137.90 kPa (5, 10 
and 20 psi respectively).  The sensitivity of the system is the slope of this line in 
Abs/ppm.  Column 5 gives the minimum detectable limit in ppm, calculated by 
determining the absorbance at five times the noise level (0.0001 absorbance units), and 
the final column provides the time it takes for the reaction to reach equilibrium, or the 
response time of the sensor, excluding the electromechanical portion, which is a constant. 
 
Results from actual experiments for pressure, flow time and flow rate were taken from 
experimentation outlined earlier and conducted using a single point of 173 ppm NO, 
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actual calibration curves were not generated.  Actual calibration curves were generated 
for heme concentration experiments. 
 
Table 8-30:  Summary of results:  Trends.  For example ↑w/ ↑P indicates that the 
Absorbance increases with (w/) increasing Pressure (P) 
 
 
Paraeter 
of interest 
 
Absorbance 
 
Sensitivity 
(Abs/ppm)  
Minimum 
detectable limit 
(ppm)  
Response time 
(sec) excluding 
electromechanical 
portion  
 Theoret Actual Theoret Actual Theoret Actual Theoret Actual 
Pressure  ↑w/ ↑P ↑w/ ↑P ↑w/ ↑P ↑w/ ↑P ↓w/ ↑P  ↓w/ ↑P ↓w/ ↑P 
Heme 
conc 
(mg/ml) 
↑w/ 
↑[Hem] 
↑w/ 
↑[Hem] 
↑w/ 
↑[Hem] 
↑w/ 
↑[Hem] 
↓w/ 
↑[Hem] 
 ↓w/ 
↑[Hem] 
↓w/ 
↑[Hem] 
Path 
length 
(cm) 
No sig 
change 
↑w/ ↑l No sig 
change 
 No sig 
change 
 ↑w/ ↑l  
Flow time 
(min) 
↑w/ ↑ft ↑w/ ↑ft ↑w/ ↑ft  ↓w/ ↑ft  ↑w/ ↑ft ↑w/ ↑ft 
Flow rate 
(cc/min) 
↑w/ ↑fr ↑w/ ↑fr ↑w/ ↑fr  ↓w/ ↑fr  ↑w/ ↑fr ↑w/ ↑fr 
 
From studies using NO pressure at 173 ppm, it was found that the actual values 
corroborate the upward trend in absorbance as a function of pressure, and there is a strong 
correlation between actual and expected values.  The r2 value is 0.9392. Theoretical 
information shows that the sensitivity increases as the pressure rises and the minimum 
detectable limit correspondingly decreases (improves).  Theoretically, the response time 
decreases with increasing pressure and there is a large discrepancy between theoretical 
and actual values in terms of the amount of time the reaction takes to reach equilibrium.  
Actual values are an order of magnitude lower than expected theoretically. 
 
The same situation is seen in the heme concentration data. Sensitivity at 2.5 mg/ml is 
10.0% of the expected, at 5.0 mg/ml it is at 7.5% of the expected and at 10 mg/ml it is at 
8.6% of the expected.  The trends for actual and expected both show that the increase in 
heme concentration corresponds to an increase in sensitivity and the correlation, which 
improves as heme concentration increases, is strong (>0.84 for all concentrations).  Both 
theoretical and actual values show a decrease in minimum detectable limit with 
increasing sensitivity and heme concentration as expected.  Theoretically, increasing the 
heme concentration decreases the time it takes for the reaction to occur, but actual 
experimentation shows an increase in response time with increasing heme concentration. 
 
It is not possible to evaluate the influence of path length on the experimental system 
because the physical design of the system was not created to allow for varying path 
lengths.  Theoretically, increasing path length has a negligible effect on the sensitivity 
and the minimum detectable limit.  It does serve to increase the response time. 
 
Flow time experiments were conducted to note the effect of flow time on the absorbance 
during the period of flow.  Measurements were taken during the flow period.  The graphs 
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showing expected and actual absorbance vs. flow time at 173 ppm show that there is an 
upward trend in the data, and the corroboration between expected and actual is good 
(r2=0.9827).  The theoretical calibration curves show that sensitivity greatly increases 
with increasing flow time and there is a corresponding decrease in the minimum 
detectable limit. The response time increases as flow time increases for both the 
theoretical model and the actual system. 
 
Flow rate effects on absorbance were minimal with respect to actual experimentation.  
Theoretically, there is an increase in sensitivity with increasing flow rate with a 
corresponding decrease in minimum detectable limit and an increase in the response time. 
 
The results indicate that for all experiments the overall trends, or the direction of change, 
is similar to the expected (modeled) trends.  The only exception is the expected decrease 
in response time due to increasing heme concentration.  This modeled behavior was not 
evident in actual experimentation. 
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C h a p t e r  9  
9. DISCUSSION OF RESULTS 
9.1 Sensing Compounds 
A number of compounds were evaluated for their application in a sensor to be used for 
the monitoring of therapeutically administered gaseous NO.  These compounds included 
naturally occurring heme compounds in addition to Fe(II)EDTA, iron chloride, 
Mn(TPP)CN- and FeCl(TPP).  Fe(II)EDTA proved to be unsuitable for the current 
application because of oxygen sensitivity.  It irreversibly oxidized immediately upon 
exposure to room air.  Iron chloride, Mn(TPP)CN- and FeCl(TPP) could not be monitored 
spectrophotometrically in the visible region of the spectrum under the given conditions.  
FeCl(TPP) reacts with NO to produce a weak band at 380 nm and a stronger one at 250 
nm.  There was no significant change in the spectrum between 400 nm and 700 nm 
(Vaska, 1973).  The band at 380 nm could not be resolved with the current spectrometer 
or optical configuration.  A blue filter was placed in the path to filter out the wavelength 
region of interest and the band could still not be resolved.  Mn(TPP)CN- reacts with NO 
to produce an isolable red solid.  This solid was formed in extremely small quantities, but 
the dispersion of the solid throughout the liquid medium was not uniform and could not 
be captured spectrophotometrically.  This compound was not further pursued because the 
solid would have to be isolated and then analyzed (Wayland and Olson, 1976). The 
remainder of the discussion will focus on the heme compounds studied for this 
application. 
 
The naturally occurring heme compounds hemoglobin, myoglobin and cytochrome-c 
were evaluated for their application in a sensor to be used for the monitoring of 
therapeutically administered gaseous NO.  This evaluation determined their sensitivity to 
NO in pH 7.0 aqueous solution in the presence and absence of oxygen. Deoxymyoglobin, 
deoxyhemoglobin and cytochrome-c (Fe III) were found to be sensitive to nitric oxide.  
Cytochrome-c (Fe II) did not react with NO to form a measurable product.  
Metmyoglobin and methemoglobin both reacted with NO to form spectrophotometrically 
monitorable products, but the relationship between NO concentration and absorbance was 
not linear in the region of interest, in addition the complexed product was not stable.  In 
general, there are deviations from Beer’s Law at concentrations above 0.01 M due to 
decreased distance between molecules and changes in refractive index.  The solutions 
used for this study were two orders of magnitude less dilute than this practical cutoff 
point.  Thus, the concentration of the absorbing species was not determined to be a factor 
in Beer’s Law deviations. The reaction between the methemes (methemoglobin and 
metmyoglobin) and NO does not proceed in a straight forward manner.  The met forms 
do react with nitric oxide to produce a complex, but the complex immediately starts to 
auto-reduce.  This reduced complex will then spontaneously lose NO, leaving the reduced 
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form of the heme (DiFeo and Stephanos, 1990).  At higher concentrations of NO, more 
molecules of the complex will auto-reduce, and more molecules of the reduced complex 
will lose NO.  Thus, in a given time period the signal loss will be greater.   
 
The specificity of the chosen sensing element in the presence of oxygen was also 
determined. Inhaled nitric oxide is delivered in a ventilator circuit along with oxygen.  
Thus, a sensing element that is specific to NO in the presence of oxygen is preferred.  In 
addition, NO combines with oxygen (O2) to form nitrogen dioxide (NO2), where levels of 
5 ppm for short term exposure are considered toxic.  Thus, the sensing element must react 
quickly with NO so as not to allow time for the nitric oxide - oxygen reaction to occur 
and to allow for breath to breath measurements.  The Fe III forms of myoglobin and 
hemoglobin react quickly with NO and must be reduced to the Fe II forms before reaction 
with oxygen is possible (Ignarro et al., 1986).  The Fe II forms of myoglobin and 
hemoglobin readily react with oxygen to form oxymyoglobin and oxyhemoglobin, 
although it has been shown that NO reacts with the iron center of the heme faster than 
oxygen (Giardina and Amiconi, 1981).  Cytochrome-c cannot be oxygenated in either 
state. 
 
Since patients receiving inhaled NO therapy would typically be on a ventilator circuit 
receiving oxygen in conjunction with the NO, cytochrome-c (Fe III) would be the best 
material for the sensor. Cytochrome-c (Fe III) was least sensitive to nitric oxide in 
solution, but is the only compound insensitive to high concentrations of oxygen.  By 
monitoring the 563 nm band of cytochrome-c-NO with our fiber optic spectrometer it is 
possible to detect concentrations of NO.  
 
Since cytochrome-c (Fe III) was determined to be the only evaluated compound that 
reacts with nitric oxide quickly and is not sensitive to varying oxygen concentrations, 
calculations were done to ensure adequate sensitivity for the current application.  The 
noise level, as determined from the reference spectrum, was calculated to be 0.001 
absorbance units.  Given that the relationship between cytochrome-c (Fe III) and nitric 
oxide is linear, the NO concentration at five times the absorbance of the noise level was 
determined as an estimate of sensitivity.  Thus, the concentration of nitric oxide at 0.005 
absorbance units is the minimum detectable limit with the given optical and physical 
configuration.  The average minimum detectable limit over the four runs was 2.51 µM, 
corresponding to 56.2 ppm at 563 nm.  This indicates that a large increase in sensitivity is 
needed to make measurements in the range of interest (5 to 20 ppm).  Methods of 
increasing sensitivity through noise reduction, signal processing and physical sensor 
configuration have been explored. 
 
In conclusion, three naturally occurring hemes:  cytochrome-c, myoglobin and 
hemoglobin were evaluated as potential sensor materials for use in an inhaled nitric oxide 
sensor.  Since cytochrome-c(Fe III)  reacts with nitric oxide quickly and is not sensitive 
to varying oxygen concentrations, it would be the sensing compound of choice to 
measure absolute inhaled nitric oxide levels relevant to a surgical or respiratory patient.   
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The next step in sensor design was to determine the sensor configuration to minimize cost 
and maximize sensitivity and response time.  In an ideal sensor the reaction would be 
reversible and the sensing element reusable or easily replaceable.  Although reversible 
chemistry has been evaluated for the non-heme compounds, the reversibility of heme-NO 
reactions has not been examined.  It has previously been shown that the reaction between 
hemes and nitric oxide are photoreversible (Tamura et al., 1978), (Hoffman and Gibson, 
1978).  Thus, the next section focused on the photo-reversibility of heme-NO reactions.   
9.2 Reversibility of Heme-NO Reactions 
It was proposed to use the light absorbing property of a natural heme, cytochrome-c, 
myoglobin or hemoglobin as the basis of an inhaled nitric oxide sensor.  If the heme is to 
be incorporated into a sensor to measure breath to breath concentrations of inhaled NO, 
the sensor must be viable over a certain period of time.  This can be accomplished by 
regenerating and reusing the starting compound, by utilizing a flow-thru configuration, or 
by configuring the sensor such that the sensing element is usable for an extended period 
of time without replacement.  This can be accomplished by incorporating enough heme to 
react with the nitric oxide over a long period of time without saturating the optical 
detector.  Our evaluation was geared towards regenerating and reusing the starting 
compound by the photo-reversing the hemes’ reaction with nitric oxide in their Fe III, Fe 
II and oxy forms.   
 
The Fe III forms of each heme were found to reversibly react with nitric oxide.  
Cytochrome-c and myoglobin complexes completely dissociated within 120 seconds, 
hemoglobin within 180 seconds.  The Fe II forms of myoglobin and hemoglobin reacted 
with NO to form an unstable complex which gave way to their respective met forms 
before complete photolysis was possible with the current optical configuration.  Because 
cytochrome-c (Fe II) does not react with NO, photolysis is not possible.  Oxymyoglobin 
and oxyhemoglobin’s reaction with NO to form metmyoglobin and methemoglobin 
cannot be reversed photolytically since the end product is not a dissociable complex. 
 
Referring to Table 8-5, the standard deviation of the peak intensity of the reactant, 
complex, photolysis product and re-reacted product (n=3) was low showing that the 
results are reproducible.  For each of the three hemes, the lysed product had relevant peak 
absorbances within ±6% of the original heme, demonstrating  that complete dissociation 
of the complex did occur.   In addition, the fact that the intensity of the re-reacted product 
was within ±6% of the original complex shows that the regenerated material has the same 
NO-reacting properties as the original compound. 
 
Under conditions studied, the time course of the lysis reaction, 120 to 180 seconds, is too 
long for use in measuring breath-to-breath concentrations of NO.  The intention of this 
study was to examine the feasibility of photoreversing heme-NO reactions using a readily 
available, inexpensive light source.  The results show that photodissociation of ferric 
heme-NO complexes is possible, but slow under the given conditions.  There are two 
possibilities for improvement.  Literature shows that the dissociation of ligands including 
NO from heme molecules is a very rapid process and the rebinding of the displaced nitric 
oxide is slower than the rate of dissociation, although still almost instantaneous (Saffran 
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and Gibson, 1977), (Sawicki and Morris, 1981).  With the current optical configuration, it 
is impossible to catch the photodissociated product before its re-reaction with NO.  Thus, 
the displaced nitric oxide is re-reacting with the heme and the immediate dissociation 
cannot be seen.  Gradually, the nitric oxide escapes after repeated photodissociation and 
the lysed reaction product can be seen.  Finally, it is possible that there was not sufficient 
bandwidth or intensity from the light source to produce an immediate and permanent 
dissociation of the complex since the rate of ligand dissociation is proportional to the 
light intensity (Saffran and Gibson, 1977). Thus, steps were taken to help displace the 
released nitric oxide and to optimize the optical configuration in order to shorten the time 
course of the photolytic reaction. 
 
The first step involved bubbling nitrogen through the cuvette during photolysis in order 
to displace the lysed nitric oxide before it could re-react with the heme.  When this 
produced no observable difference, nitrogen was bubbled through the cuvette 
continuously in case the nitric oxide was re-reacting slower than previously assumed.  
Again, this produced no observable change in the time course of the reaction.  This 
suggests that the nitrogen is not displacing the lysed nitric oxide before it re-reacts with 
the heme, or that re-reaction was not the inherent problem. 
 
The spectral bandwidth and intensity of the radiation reaching the complex are important 
parameters.  The higher the intensity, the faster the dissociation rate, thus maximum 
intensity is preferred.  The bandwidth is controlled by filters placed in the incident light 
path as well as in the transmitted light path.  These filters are necessary for two reasons.  
Light source is filtered to reduce photolysis of the sample by the monitoring beam.  The 
transmitted light is filtered to exclude the residual flash intensity from the detector.  Due 
to these considerations, the cuvette material was examined.  A typical polystyrene cuvette 
transmits between 75% and 80% of light energy between 380 nm and 750 nm.  At 340 
nm, 70% of light energy is transmitted.   On either side of this range the attenuation of the 
light source intensity limits the usefulness of these cuvettes.  In addition, polystyrene 
cuvettes will melt when overexposed to an intense light source.  Thus, the polystyrene 
cuvettes were replaced with quartz cuvettes to increase the spectral bandwidth and 
intensity.  Quartz cuvettes are optically clear in the UV, VIS and NIR spectral ranges and 
transmit close to 100% of the incident light intensity.  There was no observable 
difference between the lysis results with polystyrene cuvettes and the results from the 
quartz cuvettes, suggesting that bandwidth and light intensity are not a significant 
problem, or that the problem lies in the optical configuration and not in the cuvette 
material. 
 
Next, the ELH bulb was swapped with a more expensive and sophisticated high intensity 
xenon flash lamp apparatus, similar to that described in pertinent literature (Tamura et al., 
1978).  In this case photolysis could not be observed suggesting that the duration or 
intensity was not sufficient, or again, the nitric oxide was re-reacting with the heme 
before a measurement could be taken.  Steps were taken to provide an optimal 
configuration with the given components in order to get the most intensity and duration 
without harming the protein, but dissociation could not be observed.  Continuous 
exposure of the heme complex to the light source, with continuous spectral data 
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collection resulted in denaturation of the protein.  This again leads to the conclusion that 
photodissociation of nitric oxide-heme complexes is slow, but possible with the given 
optical configuration, or that the released NO is re-reacting with the heme before a 
measurement can be made. 
 
In conclusion, the photoreversibility of heme – nitric oxide reactions was studied in order 
to regenerate the starting compound and elongate sensor lifetime. It was found that 
photodissociation of all studied Fe(III) – NO complexes was slow, but possible with the 
current optical configuration.  The Fe(II) forms of hemoglobin and myoglobin reacted 
with NO to form an unstable product that reverted to their respective met forms before 
dissociation was possible.  The oxy forms of hemoglobin and myoglobin reacted with NO 
to form an undissociable new species.  As discussed in the previous section, of the three 
dissociable heme complexes, cytochrome-c (Fe III) offers the greatest sensitivity and 
specificity in the presence of oxygen.  Thus, it would be the sensing compound of choice 
based on sensitivity, specificity and photoreversibility.  The next phase of research 
focused on the immobilization of these hemes into a polymer matrix to yield a solid 
phase, photoreversible sensor. 
9.3 Heme Immobilization Techniques 
This section discusses the results of heme immobilization techniques with PVA and 
Agarose.  It was found that cytochrome-c could easily be cast into either films or gels 
with either material (which remained reactive as evidenced by the color change when 
immersed in a sodium dithionite solution).  In general, it was found that although films 
and gels retained their reactivity, reaction with gaseous nitric oxide was slow and the 
absorbance level was low even at high nitric oxide concentrations.  Attempts to increase 
sensitivity through increasing the surface area available for reaction were not successful 
as it reduced light transmission through the sensing element.  PVA immobilized supports 
had better consistency and better reactivity and they were more uniform than the Agar 
counterparts.  Siloxanes, hydrophobic immobilizing compounds, which are extremely gas 
permeable, could not be cast into an appropriate configuration and attempts to dissolve 
the heme into the siloxane failed. 
 
The first set of experiments on PVA films yielded pertinent information on how a film 
should be cast and how drying protocols affect the final product.  Early in the 
experimentation it was found that pipetting the solution too quickly or straight down 
produced bubbles in the final product.  It was also found that solvent choices and volume 
of immobilizing agent played an important role in the integrity of the sensing element.  
Water was the solvent of choice since water and ethanol mixes produced uneven drying 
due to differing volatilities.  Lower PVA concentrations were chosen since higher 
concentrations produced uneven films. 
 
The next set of experiments focussed on drying methods.  Since air drying took too long, 
ovens and water baths were examined.  Water baths produced condensation on the 
sensing element, thus ovens were the method of choice.  Care was taken to place the 
sensing element in an appropriate position in the oven since air flow through the oven is 
not uniform.  The drying temperature was also critical in that lower temperatures 
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extended drying time and higher temperatures increased the non-uniformity of the 
sensing element. 
 
In order to create a more uniform atmosphere within the drying container, thus producing 
more uniform films, attempts were made to isolate the drying container from the whole 
oven.  It was found that covering the solution with foil poked with holes isolated the film, 
but still provided a passage for the evaporation of the liquid.  Film #16 (see Table 8-6) 
was created with these parameters and results were shown in Figure 8.5.  It was found 
that the time course for reaction with NO (300 seconds) was too long and the sensitivity 
of the film to NO was too low for this application.  In addition, the results were not 
reproducible.     
 
The next step in experimentation focussed on reducing the reaction time and increasing 
the sensitivity by increasing the surface area available for reaction and decreasing the 
thickness of the sensing element since it was assumed that it was only a surface reaction 
and there was minimal penetration into the sensing element.  Immobilization onto the 
side of a cuvette failed because of the logistics of slow drying a PVA based heme 
solution onto opposite sides.  Attempts at increasing the surface area by stacking hemes 
immobilized onto cover slips, stacking independent films and films immobilized into a 
hole in a spacer all failed due to loss of signal from reflection at all surfaces along the 
light path. 
 
At this point, it was known that the films were reactive, but the time course of the 
reaction was too long and the sensitivity was too low.  It was thought that increasing the 
water content of the films might increase the absolute absorbance level, thus the amount 
of PVA used was increased and the drying time decreased.  This produced a uniform and 
reactive gel with the consistency of Jell-O.  When the gel was exposed to nitric oxide, no 
reaction was evident.  Efforts to increase the surface area available for reaction were not 
successful, reaction with nitric oxide could still not be seen. 
 
In addition to testing PVA films and gels, Agarose was also examined.  It was determined 
that PVA immobilized supports had a better consistency, better reactivity and the samples 
were more uniform when dried.  Reaction with nitric oxide could not be seen with any of 
the configuration examined. 
 
It was determined that although PVA could be used to immobilize the heme while 
maintaining its reactivity, the time course of the reaction was too slow and the sensitivity 
was too low.  Effort to increase the sensitivity did not produce favorable results; thus 
decreasing the response time was not examined.  Due to the limitations of an 
immobilized heme system and a reversible sensor, the final configuration to be tested 
involved a thin-layer liquid flow-thru cell.  Please refer to Figure 9.2 for a schematic of 
the course of experimentation to obtain an overview. 
9.4 Flow-thru Sensor Design 
This section discusses the results of optimizing sensor performance through physical 
design and sensor parameters.  Implementing the physical design of the system involved 
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the evaluation of a number of parameters including tubing height, flowmeter and solenoid 
placement, heme injection/ejection methods, the thickness of the sensing element and the 
distance between the input and output lenses.  Sensor parameters tested include the 
referencing method, the time it takes for the system to come to equilibrium after heme 
injection, the total time of NO flow, the time it takes for the reaction to equilibrate, flow 
rate, system pressure and heme concentration.   
 
In general, it was found that tubing height needed to be kept level with the sensing 
element to ensure that fluid did not move during the reaction or measurement phases.  
Both the solenoid and flowmeter need to be placed before the sensing element to 
eliminate any pressure due to the placement of these components.  A one pump system 
for fluid injection/ejection was implemented to ensure that the incoming and outgoing 
fluid volumes were exact.  The optimal thickness of the sensing element was determined 
to be 12.5 mm (0.5”) with a 22.5 gauge needle for heme input and output.  A larger space 
and/or a smaller needle increased response time.  Finally, the distance between the input 
and output lenses was set at 50 mm (2”).  Referencing once at the beginning of each cycle 
gave the lowest system drift.  The system took 25 seconds to come to equilibrium after 
heme injection and the reaction took 60 seconds to equilibrate after introduction of the 
gas sample.  For each of the remaining sensor parameters that were studied, the trend was 
the same.  Increasing the parameter resulted in an increase in the signal level until a 
certain point was reached at which saturation was evident.  Each criterion will be 
discussed separately below. 
 
Tubing delivering heme to and from the sensor was kept at a height level with the sensing 
element to ensure proper fluid dynamics because all configurations except a level setup 
resulted in undesirable fluid movement through the system. 
 
Placement of the flowmeter and solenoid also affected the sensitivity of the system. 
Placement of the gas flowmeter or the solenoid after the sensing element produced a 
pressure buildup in the system because the orifice to the flowmeter was much smaller 
than the tubing used in the rest of the system.  This excess pressure pushed down on the 
membrane and reduced the pathlength of the system by pushing heme out of the sensing 
element.  If pathlength is reduced, the absorbance (the signal level) is reduced too, as 
given by Beer’s Law.  Thus, the slope of the calibration curve, used to evaluate 
sensitivity, is reduced by an equal factor.  Solenoid placement before the sensing element 
resulted in constant flow when the solenoid was on and slow, but constant drainage 
through the system of any residual gasses when the solenoid was off and vented to air.  
Placing the vent tubing in water resulted in a small amount of drainage in a short period 
of time until inside and outside pressures were equalized.  This was chosen as the final 
configuration. 
 
Fluid injection and ejection methods were also compared.  A two pump air system caused 
profound problems.  Setting the exact volume of air necessary to eject the heme is a 
matter of trial and error, thus fluid replacement is not exact.  This results in fluids mixing 
due to an inadequate volume of air or undesirable pressures due to an excessive volume.  
Air bubbles in the system were troublesome regardless of air volume.  A two pump fluid 
 140
system was also difficult to implement.  Lower volumes resulted in mixing of fluids due 
to inadequate system purging.  All volumes resulted in some fluid mixing due to the 
configuration of the system:  Heme is used to replace buffer and buffer is used to replace 
heme.  All volumes resulted in air bubbles entering the system.  The single pump system 
produced the best results due to the exact exchange of fluids. 
 
The thickness of the sensing element was determined by needle size, spacer size and 
reaction time.  Spacers smaller than 12.5 mm (0.5”) could not accommodate the 22.5 
gauge needle and larger spacers resulted in too large a space to fill with heme solution.  
The larger the space, the longer it took to fill and purge the space and the longer the 
reaction took to equilibrate.  Smaller needles proved to be extremely flimsy and difficult 
to work with.  As the orifice of the needle decreased in size, the time it took to fill the 
chamber increased and required force to push the heme through by the motor increased. 
 
According to the manufacturer, the distance between input and output lens should 
optimally be less than 250 mm (10”) and optimally be 43.75 mm.  The physical 
configuration of the sensor dictated that the lenses be 50 mm (2”) apart due to the size of 
the lenses and physical constraints of the liquid and gas chambers and ports necessary for 
injection and ejection of fluids and gasses. 
 
A good referencing procedure is instrumental in the design of an optical probe since the 
light source and detector are never 100% stable over the course of time.  Two questions 
were addressed: what to reference with and how often referencing was necessary.  
Referencing once with cytochrome-c at the beginning of an eight hour time period 
resulted in an average standard deviation of 0.0022 absorbance units.  The value is 
relatively high because of a variety of factors.  Hemes, although kept cold and free from 
light and air, are not completely stable.  Temperature changes and light reaching the 
heme in transport to the sensing element affect them.  Thus, if heme is to be used as the 
reference, the system must be referenced each time.  Referencing once with buffer 
reduced the average standard deviation to 0.0009 absorbance units due to the stability of 
the buffer, but not to a minimum level.  In addition, referencing with buffer does not 
allow for a difference spectrum to be taken, it requires the measurement of absolute 
absorbance.  Referencing each time with cytochrome-c gave the best results, with an 
average standard deviation of 0.0007 absorbance units.  If cytochrome-c is used once as 
the reference, system drift increases dramatically.  For the purpose of this study, 
referencing each time with heme was chosen. 
 
The amount of time it took for the system to come to equilibrium after heme injection 
was found to be 25 seconds.  For the remainder of experiments, the time allowed for 
equilibrium was set at 30 seconds to allow for small physical design changes.  This value 
can be shortened by revamping the physical design.  The predominant reason that this 
value is high is because the tubing used to transport the heme is narrow and the orifice 
through which the heme enters the sensing element is small.  If the tubing diameter and 
the orifice are enlarged, then the transport time will decrease.  In addition, the system 
used to pump the heme into and out of the system plays a role.  If the rate of rotation of 
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the motor is increased, then the heme will be deployed at a faster rate and withdrawn at a 
faster rate. 
 
Flow time, which is the amount of time NO is flowing through the system, was also 
found to affect the sensitivity of the system.  As expected, longer flow times resulted in 
higher absorbances at set parameters, reaching equilibrium at approximately 240 seconds.  
This suggests that the reaction does not saturate at the highest NO concentration until 240 
seconds.  Since this flow time is too long to accommodate a reasonable response time, a 
lower flow time of 60 seconds was chosen for the other experiments.  When flow time is 
increased, it allows more NO molecules to come in contact with the surface of the 
sensing compound, allowing more molecules to react and thereby increasing the 
absorbance level.  Increasing the flow time should also serve to increase the time it takes 
for the reaction to equilibrate given that more molecules of NO have to react with the 
same number of heme molecules. 
 
The amount of time given for the reaction to come to equilibrium was set at 60 seconds, 
which is the time at which the reaction reached full-scale value.  This is directly related to 
the heme concentration, the pressure of the system, the flow time and the flow rate.  
These parameters will be discussed elsewhere in this chapter. 
 
It was found that an increasing flow rate increases the absorbance level, under the given 
conditions, until 250 cc/min., at which point the reaction saturates.  This indicates that a 
flow rate below this level, but as high as possible will maximize the sensitivity of the 
system.  A flow rate of 200 cc/min. was chosen for the remainder of the experiments.  
Although the flow rate is independent of NO concentration, at higher flow rates there are 
more molecules of NO touching the surface of the membrane than at lower flow rates 
during a specified period of time, allowing more molecules of NO to react with the 
cytochrome-c and thereby increasing the absorbance.  Increasing flow rate will also 
increase the time it takes the reaction to equilibrate since more reactions need to occur.  
 
Increasing the pressure within the system also increased the absorbance level under the 
conditions studied.  This increase was linear between 5 and 20 psi (34.48 and 137.90 kPa) 
and did not reach saturation.  Higher pressures were not studied because of the physical 
constraints of the system.  The gas flowmeter could only handle input pressures below 25 
psi (172.38 kPa).  For this reason, a pressure of 10 psi (68.95 kPa) was chosen for the 
remainder of the experiments.  When pressure within the sensing element is increased, it 
acts to drive more molecules through the membrane and into the cytochrome-c.  This 
allows more NO molecules to come into contact with the cytochrome-c molecules, 
increasing absorbance linearly with pressure.  There will be a point at which increasing 
the pressure further will result in no further increase in absorbance because a saturation 
point will be reached.  In addition, at a certain point increasing the pressure will also act 
to depress the membrane and force cytochrome-c out of the chamber.  More molecules of 
NO will react with the cytochrome-c as a percentage of the total, but depression of the 
membrane will result in a shorter pathlength and smaller absorbance values.  Examining 
the results shows that doubling the pressure of the system more than doubled the 
absorbance at a high concentration of nitric oxide, a significant increase in absorbance.  
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Increasing the pressure in the system will also reduce the amount of time the reaction will 
take to equilibrate since the increased pressure will drive more molecules of NO through 
the membrane in a shorter period of time. 
 
When cytochrome-c concentration was increased, there was also an increase in the 
absorbance level.  This suggests that at higher concentrations of cytochrome-c, there are 
more molecules of cytochrome-c available for reaction with NO.  Thus, in the time given 
more molecules of NO will hit cytochrome-c molecules and react with them.  If the 
amount of time allowed for the reaction is increased, the absorbance at the lower 
concentration should increase to a comparable level.  A cytochrome-c concentration of 5 
mg/ml was chosen for the remainder of the experiments to minimize the cost in running 
the system, but not overly sacrifice sensitivity.  The calibration curve at 2.5 mg/ml shows 
that the r2 value is quite low.  Further inspection shows that the reaction actually plateaus 
at approximately 85 ppm.  This shows that a concentration of 2.5 mg/ml is too low to 
accommodate higher nitric oxide concentrations.  At 5 mg/ml, there is no saturation of 
cytochrome-c at higher concentrations.  Examination of the results shows that increasing 
the concentration of cytochrome-c significantly increased the sensitivity of the system, 
although not in a linear fashion.  A representative calibration curve is included under the 
following conditions:  0.05 second integration time, averaging of 5 times per cycle, 
cytochrome-c concentration of 5 mg/ml, flow time of NO 60 seconds, 10 psi (68.95 kPa) 
and 200 cc/min total gas flow.  A representative calibration curve shows that the system 
is linear between 5 and 175 ppm NO, with a minimum detectable concentration of 5 ppm 
when 5 point spectral averaging is utilized.  Five-point spectral averaging resulted in a 
noise level of 0.0001 absorbance units.  Thus, an absorbance of at least 0.0005 is 
necessary to keep the S/N level above five.  At this absorbance value, the nitric oxide 
concentration is found to be five ppm. 
 
From the given results, it is evident that all evaluated configuration issues play a crucial 
role in the physical design of the sensor to ensure proper and stable operation.  Sensor 
parameters such as referencing procedures, flow time, flow rate, system pressure and 
heme concentration also play a critical role in sensor design and can be adjusted to 
optimize sensitivity without overly sacrificing response time.  
 
From examining the results it can be seen that the flow time increases absorbance 
steadily, reaching an equilibrium state at about 240 seconds and reaching 90% value at 
174 seconds.  In this case, it is clear that sensitivity has to be sacrificed for response time.  
Other methods of decreasing response time will be discussed in a later section.  A flow 
time of 60 seconds was chosen to ensure a reasonable sensitivity without overly 
sacrificing response time for the remainder of the experiments.  The amount of time 
required for the system to come to equilibrium after heme injection was found to be 25 
seconds.  This value can be reduced by physical design of the system including tubing 
and orifice size and using a faster motor to drive the pump system.  The time it takes the 
reaction to equilibrate is dependent on the flow time, flow rate, pressure and heme 
concentration as discussed above.  Flow rate plays a minor role in increasing the 
absorbance at a high concentration of nitric oxide.  The change in absorbance for flow 
rates ranging from 25 to 400 cc/min., is on the order of 0.001 absorbance units, which is 
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negligible.  For the current application, lower flow rates would be more acceptable since 
the gas is being sampled from the ventilation circuit.  This would reduce the amount of 
gas taken from the patient for the measurement.  In contrast, doubling the pressure of the 
system more than doubled the absorbance at a high concentration of nitric oxide, 
suggesting that the sensitivity would also increase proportionally.  The pressure of the 
system should be increased to a maximum safe operating level at which pathlength is not 
lost.  Increasing the heme concentration significantly increased the sensitivity of the 
system, although not in a linear fashion.  The drawback in increasing cytochrome-c 
concentration lies in the expense of running the system and in allowing enough light to 
the detector.  Reducing the amount of light reaching the detector reduces the signal to 
noise ratio, raising the minimum detectable concentration of nitric oxide.  Doubling the 
concentration doubles the expense of the sensing compound and reduces the amount of 
light reaching the detector by a factor of two.  The best solution is to use a low flow rate, 
a safe, but high operating pressure and a concentration of cytochrome-c, which allows for 
a minimum detection of 1 ppm and does not increase the cost of the system to an 
unmanageable level. 
9.5 Data Processing 
The purpose of these experiments was to, through the use of various data collection and 
processing techniques, maximize sensitivity without sacrificing response time.  
Techniques that were explored included variation of integration time, averaging, 
comparing acquisition of single spectra to filling a buffer and averaging the results, point 
to point averaging over a wavelength region, comparing absolute absorbance 
measurements to difference spectra and comparing integration over a peak to single 
wavelength measurements. 
 
Integration time is used to maximize the number of counts reaching the detector with the 
sensing element in the path.  For an identical system a lower integration time will mean 
that the system will receive fewer counts and will not be able to detect as high an 
absorbance as the same system with a higher integration time.  For this system a 0.07 
second integration time gave the maximum number of counts without saturating the 
detector.  This system saturates at 16,000 counts.  A 0.05 second integration time is used 
because it allows for changes in heme concentration, but still provides an adequate signal 
for the detector. 
 
Averaging of singly acquired spectra is used to reduce noise by dampening fluctuations 
in the signal.  Averaging also increases response time because it requires more 
measurements.  The data shows that increasing the averaging above five does not provide 
any significant decrease in noise, but does increase the response time.  The second 
method tested involved acquiring and storing 17 consecutive spectra in an on-board FIFO 
memory, which are then averaged and displayed.  This should serve to decrease noise and 
increase response time as explained above.  This method did increase response time, but 
the decrease in noise was not any larger than the decrease obtained by obtaining only a 
single spectrum and not filling the buffer. 
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Point to point averaging, which involves averaging a number of points around the 
wavelength of interest, is used to decrease system noise.  It also decreases the signal level 
because the peak value is dampened by smaller absorbance values surrounding it.  This 
method worked very well.  It was found that with five-point averaging the minimum 
detectable limit fell to just below five ppm.   Increasing the number of points that were 
averaged brought the minimum detectable limit to just over 1 ppm.  Although the goal is 
to reduce the minimum detectable limit, other factors need to be considered.  As the 
number of averaged points increases the sensitivity decreases, the r2 value decreases and 
the noise decreases.  If the r2 value is overly decreased then accuracy and precision get 
sacrificed.  It is possible to reduce the slope if the decrease in noise compensates for the 
decrease in slope, meaning that the minimum detectable limit is still decreasing.  If the 
averaging is increased beyond five then the r2 value falls below 0.95.  At this point in 
system design the r2 value will be kept above 0.95 and other options will be explored to 
increase sensitivity. 
 
Difference spectral measurements were compared to absolute absorbance measurements 
to determine which method would yield a higher sensitivity.  It was found that the 
relationship between nitric oxide concentration and the absorbance values was not linear 
for the absolute absorbance measurements and no mathematical relationship could be 
found to relate the nitric oxide concentration to the calculated values.  This could be due 
to the referencing procedure.  With this method, a reference with buffer was taken instead 
of referencing to cytochrome-c at the beginning of each cycle.  This would not 
accommodate any changes in the measurement due to changes in the heme solution.  
Heme solutions are inherently sensitive to light, air and temperature.  Relating integrating 
over the 563 nm peak to the concentration of nitric oxide did not provide any linear or 
other mathematical relationship.  The method used to calculate the area under the peak 
was subject to human error since the peak start and end points were determined by eye.  
Since this method is not always exact due to human error and the peak is already small, 
minute differences in peak width would translate into large errors.  Since both absolute 
measurements and integration over a peak did not give favorable results, rote absorbances 
from difference spectra were used to generate calibration curves during system operation. 
 
From this set of experiments it was found that system sensitivity and the minimum 
detectable limit could be optimized through data collection and processing techniques.  It 
was found that the integration time should be 0.05 seconds.  Averaging was set at a point 
(5) where any increase in averaging did not produce a significant decrease in noise, but 
did increase system response time.  Filling the internal buffer with each acquisition did 
not provide any returns in terms of increasing S/N.  Point to point averaging did provide 
very promising results.  Increasing the number of points averaged not only decreased the 
minimum detectable limit, it decreased the sensitivity of the system and the r2 value.  It 
was necessary to choose a value which brought down the minimum detectable limit 
without overly sacrificing the sensitivity or the accuracy and precision.  A value of 5 kept 
the r2 value above 0.95 and the minimum detectable limit below five ppm.  Other 
methods have been explored for increasing the sensitivity and decreasing the minimum 
detectable limit and will be discussed in a later chapter.  Two other methods were 
examined for effects on the sensitivity of the system.  Absolute absorbance measurements 
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were compared to difference spectra and integration over a peak was compared to single 
wavelength measurements.  It was found that neither method provided a linear 
relationship with NO concentration or any other mathematical relationship.  Since all 
hardware and software components have been determined and data collection and 
processing techniques have been evaluated, the next section will deal with system testing. 
9.6 System Testing 
This chapter dealt with the determination of system specifications including sensitivity, 
minimum detectable limit, resolution, accuracy, specificity, stability and response time.  
It was found that with the optimized system (cytochrome-c concentration of 10 mg/ml, 
137.90 kPa (20 psi), and a post-gas flow equilibration time of 15 seconds), NO 
concentrations less than 25 ppm yielded a sensitivity of 0.0002 Abs/ppm, a minimum 
detectable limit less than 1.5 ppm and a resolution less than 0.5 ppm.  The sensitivity was 
determined from the slope of the line as presented in Table 8-15.  In addition, the system 
was specific to nitric oxide in the presence of oxygen.  The normal system yielded a 
sensitivity of 5x10-5 Abs/ppm with a minimum detectable limit of 7 ppm and a resolution 
of 1.8 ppm.  In addition, the system was not specific in the presence of oxygen.  Stability 
experiments showed that the normal configuration, for data under 25 ppm, was stable 
over the course of eight hours.  This system was accurate to within 2.25 ppm with a 2-
point, 2 range calibration for data above 25 ppm.  For data under 25 ppm, the system was 
accurate to within 1.50 ppm.  The optimized system gave an accuracy of 2.00 ppm for 
data less than 25 ppm and 10.00 ppm for data in the upper concentrations with a 2-point, 
2 range calibration.  In general, accuracy improved as the number of points used in the 
calibration increased.  Finally, the response time was shown to be 155 seconds for the 
normal system versus 110 seconds for the optimized system. 
 
Sensitivity experiments provided interesting results.  With the normal trials it was 
determined that the sensitivity was 3.35x10-5 Abs/ppm, with a minimum detectable limit 
of 4 ppm.  When data less than 25 ppm is used to calculate sensitivity, the sensitivity 
increases to 5.30x10-5 Abs/ppm, but the minimum detectable limit increases to 7 ppm.  
This can be explained by examining the graph in Figure 9.1. 
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Figure 9.1.  Comparison of sensitivity using calibration lines generated with data from 0 to 
173 ppm NO and data from 0 to 25 ppm (steeper line). 
 
As seen, the offset (intersection of the calibration line with the y axis) is lower for the 
data under 25 ppm.  Five times the noise level falls at a lower NO concentration for the 
calibration curve generated with all data than for the calibration curve generated with 
data less than 25 ppm, thus the minimum detectable limit of the data under 25 ppm is 
higher.  Five times the noise level is the same for both data sets.  The concentration of 
NO that corresponds to this number (5 x the noise level) is lower for the entire 
concentration range than for the <25 ppm concentration range.  This concentration of NO 
is defined as the minimum detectable limit (MDL), thus the MDL is lower for the 
calibration curve generated with all the data than for the calibration curve generated for 
just less than 25 ppm  With the optimized system, results are much more favorable.  It 
was found that the sensitivity increased to 1.04x10-4 Abs/ppm.  When data under 25 ppm 
is used, the sensitivity further increases to 2.10x10-4.  Deviations from Beer’s Law are a 
result of both chemical and instrumental parameters.  In general, curvature of a 
calibration plot will generally arise due to chemical interference.  Non-zero intercepts are 
usually due to improper blank measurements or standards.  What is seen with this system 
is a non-zero intercept.  Although the r2 values are extremely good for all sets of data, it is 
evident that there is a very different trend for data above and below 25 ppm.  When data 
below 25 ppm is used to generate a curve the sensitivity almost doubles.  It also increases 
the minimum detectable limit, due to the decrease in the offset for the normal system.  
Other mathematical relationships, including logarithmic, did not produce a good fit.   
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Nonlinear sensitivity can be attributed to a variety of factors including a shift in 
equilibrium or a change in the refractive index of the solution with concentration.  It is 
possible that after a certain number of molecules have reacted with the heme, the rate of 
reaction significantly changes and the reaction reaches equilibrium at a different point 
(Gillespie et al., 1986), changing the overall absorbance level.  There is still a linear, but 
different relationship.  It is also possible that at higher nitric oxide concentrations the 
refractive index of the solution changes (Harris, 1987), changing how the light interacts 
with the solution and consequently changing the measured absorbance.  The change in 
concentration could also affect how light passes through the membrane.  Although the 
gas permeable membrane is optically clear in the visible region of the spectrum, it does 
have a visible sheen to it.  According to the manufacturer of the membrane changes in 
concentration will change the dynamics of light scattering, and subsequently affect the 
overall absorbance measurement.  In terms of the non-zero intercept there are also two 
possibilities.  The system is designed to obtain a reference to cytochrome-c prior to every 
measurement.  At the time of heme injection there might be residual NO in the system 
from the previous cycle even though the reaction had reached an equilibrium state.  At 
any given equilibrium point there will be a certain number of unreacted NO molecules.  If 
these molecules begin to react with the heme during the referencing procedure then the 
absorbance will be lower than expected.  If it continues to react even after the reference is 
taken, the absorbance will go positive.  This can be overcome by purging the system with 
nitrogen before each injection of heme.  It is also possible that having the system closed 
during referencing introduces a pressure in the system that reduces the path length.  
When the system is opened to gas flow the system pressure changes negatively and the 
result is an artificially high absorbance. 
 
Specificity in the presence of oxygen gave interesting results.  With the normal system 
there were definite decreases in sensitivity as the oxygen concentration increased.  It is 
possible that the oxygen is reacting with NO before NO is reacting with the heme, thus, 
less NO is reacting with heme.  Since the rate of NO’s reaction with heme is 106 times 
faster than oxygen’s reaction with heme, there should be a point at which oxygen 
concentration is a negligible problem.  With the optimal system, the heme concentration 
and the pressure were doubled.  This allowed for a decrease in the time it took for the 
reaction to equilibrate post gas flow to 15 seconds.  This change in sensitivity due to 
oxygen concentrations was evident, but not significant.  If this time is further decreased, 
then the response time will decrease and specificity will be absolute.  If less time is given 
than it takes for the reaction to come to complete equilibrium, then precautions need to be 
taken to purge the system of unreacted NO before the next cycle is begun.  This is 
possible by purging the system with nitrogen after the measurement is taken and before 
heme is re-injected.  Thus, there is a trade-off between specificity and sensitivity.  If the 
amount of time given for the reaction to equilibrate is decreased, then the absorbance 
level will decrease, but the system will be completely specific.  Taking a measurement 
before complete equilibration could also affect the linearity of the system.  The rate of 
reaction will change as a function of nitric oxide concentration and temperature, thus the 
reaction will be at a different point in the equilibration process.  This might affect the 
linearity of the system.  Further testing should be done to examine the affects of taking a 
measurement prior to complete equilibration.  With the optimal system, the change in 
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sensitivity due to changing oxygen concentrations was not significant and was sufficient 
for this application. 
 
The response time is not satisfactory for the current application.  A response time of less 
than 3 seconds is desirable to measure breath to breath concentrations of nitric oxide as 
delivered in a ventilator circuit.  The optimized system gave a response time of 110 
seconds, 45 seconds less than the original system.  The limiting factor in the response 
time of this sensor is the diffusion of nitric oxide through the gas-permeable membrane, 
not the reaction between the heme and nitric oxide as this is relatively instantaneous.  
Regardless, there are a number of places that improvements could be made to reduce the 
response time without regard to the diffusion of nitric oxide through the membrane.  The 
heme injection/ejection time and the time it takes the system to stabilize post injection is 
due to movement of fluid through the system and temperature changes.  The movement 
of fluid is tied to the speed of the motor and the size of the tubing and orifice of the 
sensing element.  If the diameter of the tubing and orifice are increased and the speed of 
the motor is increased, or if the syringe pump apparatus was replaced with a more 
powerful piston, then the heme injection/ejection period could theoretically be 
instantaneous.  The heme is kept cold to ensure stability of the sensing compound.  Once 
the heme leaves the reservoir, it takes time for the heme’s temperature to equilibrate with 
the new surroundings.  If the entire apparatus is housed as one unit and kept cold, there 
will be no time necessary for temperature equilibration, but the rate of reaction might 
decrease.  The gas delivery time is set to 60 seconds to obtain a decent signal level with 
the current configuration.  If the pressure and heme concentration is maximized, it is 
possible to reduce the time of sample flow and still maintain the measurement level 
provided with the current configuration.  Currently, heme concentration is kept low to 
minimize the cost of operating the system and pressure is kept low because of physical 
constraints, including maximum allowable pressure into the digital flowmeter.  The time 
it takes for the reaction to come to equilibrium should also decrease as the system 
pressure and heme concentration are maximized.  Thus, following the steps outlined 
above can dramatically reduce response time. 
 
Stability is an indication of how repeatable the measurement is over the course of time.  
Stability experiments were run to concurrently evaluate the stability of a single NO 
concentration over time and to determine the stability of the calibration curve over time.  
This was done by taking measurements in a random order at set NO concentrations once 
per hour for eight hours.  Since measurements were taken at a range of concentrations 
every hour, stability was not monitored in a traditional sense.  Normally, a single nitric 
oxide concentration would be evaluated continuously over the course of time to evaluate 
system stability.  The chosen method introduces some error into the evaluation by 
changing the concentration of NO over time and then repeating the cycle to evaluate the 
same concentrations.  It was found that measurements at specific NO concentrations and 
calibration constants (slope and offset) are extremely repeatable as evidenced by the low 
standard deviation, although the error for NO concentrations less than 25 ppm was quite 
high as a percentage.  As an error in ppm, the error was 2 ppm or less for all 
concentrations.  It is possible that the measured stability is not adequate to determine NO 
concentrations less than 25 ppm.  In order to produce an error less than 1 ppm for data 
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less than 5 ppm, the standard deviation of the measurement must be less than 1.18x10-5 
absorbance units from the calibration curve measurement.  In testing the stability, the 
average absorbance measured for concentrations less than five ppm did not fall on the 
calibration curve and the standard deviation around the measured absorbance was high in 
comparison to the magnitude of the average absorbance for reasons outlined above. 
 
Accuracy is defined as the deviation from the true value, as expressed as a percentage of 
the true value, or as a ppm deviation from the true NO concentration.  When a single 
linear calibration curve was used, it was found that the system was less accurate for 
concentrations below 25 ppm.  The accuracy for data above 25 ppm was within 5 ppm for 
the normal system and 10 ppm for the optimized system using a single 2 point linear 
calibration.  For concentrations under 25 ppm, the accuracy was, at worst, 20 ppm for 
both systems.  This is due to the different relationships present between the upper and 
lower concentration ranges.  In general, the accuracy improved as the number of points 
used to generate the calibration curve increased. 
 
The data shows that there is a different relationship between the measurement and nitric 
oxide concentration for 0 to 25 ppm and for values above this to 200 ppm.  Thus, an 
independent calibration curve was generated for each concentration range.  It was found 
that the normal system was accurate to within 2.25 ppm with a 2-point, 2 range 
calibration for data above 25 ppm.  For data under 25 ppm, the system was accurate to 
within 1.50 ppm.  The optimized system gave an accuracy of 2.00 ppm for data less than 
25 ppm and 10.00 ppm for data in the upper concentrations with a 2-point, 2 range 
calibration.  Again the accuracy improved as the number of points used in the calibration 
increased.  5-point averaging resulted in accuracy to within 1.50 ppm for both 
concentration ranges for the normal system. 
 
For clinical applications, calibration curves generated with the lower concentration range 
will suffice since concentrations above 20 ppm are not currently delivered to patients.  
For research applications it is necessary to incorporate the entire concentration range 
from 0 ppm to 200 ppm.  In this case it is imperative that two linear, but independent, 
calibration curves be constructed for the two concentration ranges of interest.  The first 
course of action is to determine the relationship between 25 ppm and 40 ppm such that 
the cutoff for each concentration range is determined.  It is also possible that there is a 
third linear relationship between these points.  In either case, a calibration at a high and 
low for each concentration range should suffice, producing an error of less than 1.5 ppm 
for the entire concentration range if the normal system is employed.  The optimized 
system did not give an acceptable accuracy in any case or any calibration scheme. 
 
Although the error values can be optimized, the error is still higher than what would be 
feasible for a commercial device.  There are many reasons as to why a system is not 
accurate.  It is possible that the physical system itself will introduce error.  Heme 
traveling through the length of tubing could degrade due to light or temperature changes; 
dead space in the system could cause mixing of residual solution or gasses, or the plastic 
in the syringe or tubing might bind a minute amount of heme.  All of the mentioned 
effects could compound to produce a sizeable error.  These issues can be minimized by 
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reducing the length of the tubing, keeping the entire system cold and free from light, 
using non-binding materials for all components and optimizing physical sensor design to 
reduce all unnecessary dead space.   
 
The optimized system gave less accurate results than the normal system.  This is probably 
due to the fact that the system is being pushed to its limits in terms of pressure and heme 
concentration.  Increasing pressure to a certain point might decrease linearity because of 
pressure effects on the heme and movement of fluid through the system.  Increasing heme 
concentration reduces the number of counts reaching the detector for a given NO 
concentration, thus reducing the signal to noise ratio (S/N).  Thus, there is a trade-off 
between sensitivity and accuracy.  The system should be optimized to give a reasonable 
accuracy while still maintaining the sensitivity to detect NO in the lower concentration 
range of interest. 
 
System resolution is defined as the smallest NO change that can be accurately detected.  
It was found that for data less than 25 ppm from the optimized system, the resolution was 
under 0.5 ppm, which is sufficient for the application at hand. 
 
In summary, it was found that the optimized system gave good results for data less than 
25 ppm in terms of sensitivity, minimum detectable limit, resolution, specificity, and 
stability, but not accuracy.  The response time was high, although methods of reduction 
were discussed.  For concentrations above 25 ppm, the system had a different trend than 
for concentrations below 25 ppm.  Thus, the accuracy was low when the data was tested 
using a single linear calibration curve.  This was overcome by generating two 
independent calibration curves for the two concentration ranges of interest.  These results 
show that the current configuration is promising for clinical and research applications if 
the response time can be decreased and the accuracy can be improved.  Performance 
values of the optimized system using data less than 25 ppm are given in Table 9-1. 
 
Table 9-1:  Optimized system performance, data less than 25 ppm. 
 
Sensitivity 2.10x10-4 Abs/ppm 
Specificity Slightly sensitive to high oxygen concentration 
Minimum detectable limit 1.15 ppm NO 
Stability 8 hours 
Resolution 0.50 ppm NO 
Range 1-25 ppm NO 
Response time 1 min 50 sec 
Accuracy < 2 ppm error 
 
Calibration procedures were developed based on the results of system testing.  They are 
used to determine a relationship between the concentration of nitric oxide and the 
measured absorbance after signal processing.  Many calibration schemes exist to ensure 
stable and repeatable operation of the final product.  The calibration scheme for this 
sensor is built on data from testing the final configuration.  It was found that the 
relationship between the concentration of NO and the absorbance at 563 nm was linear 
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and had a good fit between 0 to 200 ppm NO, but the correlation at lower concentrations 
of NO was poor.  Thus, the data under 25 ppm was examined independently.  It was 
determined that the concentrations under 25 ppm had a much higher slope and a good 
linear fit.  Thus, two methods are available for calibration and sensor application.  If the 
sensor is used solely between 0 and 25 ppm, or between 25 and 200 ppm, then a simple 
two-point calibration will suffice for the concentration range of interest.  If the sensor is 
to be used across all concentration ranges, then two independent calibration curves for the 
two concentration ranges will be necessary.  The efficacy of the calibration procedures 
was demonstrated by the results of system accuracy testing.  This showed that a simple 2-
point calibration is sufficient for clinical applications where nitric oxide concentrations of 
less than 25 ppm are to be administered and only 0 ppm to 25 ppm nitric oxide 
concentrations are of interest.  In a research application, 2 separate calibration curves 
would be necessary for the two concentration ranges of interest. 
 
The system specifications for the optimized system are given in Table 9-1.  There are 
instruments currently available for the measurement of inhaled NO concentrations with 
specifications similar to or better than that observed with the tested system.  According to 
the manufacturers’ specifications, the PrinterNOx is an electrochemical sensor available 
from Micro Medical Devices, Inc.  This provides simultaneous measurement of NO and 
NO2 concentrations.  For NO the response range is 0 to 100 ppm, with a 0.05 ppm 
resolution and response time of less than 10 seconds.  The MicroGas, also made by Micro 
Medical Devices is a small digital meter designed to monitor concentrations of one gas.  
It can detect up to 100 ppm NO with a sensitivity of 0.1 ppm and a response time of less 
than 30 seconds.  The Sensor Stik by EIT has a response time of less than 10 seconds and 
a 0.5 ppm detection limit.  This electrochemical cell has problems with step response 
changes in nitric oxide concentrations.  A step change from 50 to 0 ppm takes 2 hours to 
stabilize.  The Drager PAC II gives an 11 second response time for the same step in the 
positive direction and a 60 second response time in the negative direction (Strauss et al., 
1996). 
 
One particular study compared electrochemical monitors to chemiluminescence monitors.  
It was found that electrochemical monitors may be used to guard against toxic NO 
concentrations ( > 20 ppm), but not to regulate NO at low critical levels between 1 and 5 
ppm because of low system accuracy and precision (Frawley and Tibballs, 1997). 
Another study indicated that chemiluminescent monitors were also sensitive to high 
oxygen concentrations.  They consistently under-read NO concentrations in the presence 
of high NOx levels (Etches et al., 1995). 
 
The most recent development has been in the immobilization of hemes in sol-gels to yield 
a reversible sensor for the measurement of gaseous nitric oxide.  This sensor has a 
response time of 200 seconds and a reverse phase of 300 seconds.  It is linearly sensitive 
to NO between 0 and 25 ppm, but it is not specific to NO in the presence of high oxygen 
concentrations due to NOx sensitivity.  This research is still in the initial phases and they 
are attempting to increase specificity by using cytochrome-c’ which is specific to NO in 
the presence of NOx and decrease the response time by changing the configuration of the 
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sensing element(Aylott et al., 1999).  All mentioned monitors provide a sensor life of up 
to one year. 
 
As shown, monitors are available for the measurement of inhaled NO concentrations.  
The Micro Medical Devices instruments provide 1 order of magnitude better resolution 
and a larger operating range between 0 and 100 ppm than the instrument designed for this 
project.  They also provide significantly faster response times.  The Sensor Stik and 
Drager models, also electrochemical cells, provide a good detection limit, but the 
response was variable in relation to the size and direction of the step, which is not 
acceptable.  Independent research has shown that although electrochemical monitors are 
available for this application, a representative sample did not provide the necessary 
accuracy or precision.  The new sol-gel encapsulated heme based sensors seem promising 
for this application, but they are still in the initial feasibility stages.   
 
The sensor produced for this project will provide an acceptable sensitivity and resolution, 
although on par with currently available instruments.  The specificity needs to be enhanced, 
possibly with the use of cytochrome-c’  as the sensing compound since it is specific to NO 
in the presence of oxygen and other oxides of nitrogen due to steric hindrance.  In both 
cytochrome-c and cytochrome-c’, the heme is bound to two cystines.  The difference 
between the two molecules lies in the coordination and spin of the iron atom.  Cytochrome-
c contains a low-spin, hexa-coordinated iron atom while cytochrome-c’ contains a high-
spin, penta-coordinated iron atom.  The sixth ligand site of cytochrome-c’ is free for 
binding, but it is buried within the protein, making it only possible for small diatomic 
ligands (such as NO and CO) to bind (Barker 1998), (Aylott, 1999), (Yoshimura, 1987).  
Auto-oxidation of the Fe II form yields the Fe III form, which binds to NO, but not CO.  
This allows both direct spectrophotometric determination in the visible region, either by 
monitoring the shift in the soret region, or monitoring another specific wavelength, and 
fluorescence measurements.  Nitric oxide binding produces conformational alterations 
which can be monitored by fluorescence between 630 and 640 nm (Barker, 1998). 
The response time is also poor for this sensor, but methods of decreasing response time 
by exploring other sensor configurations are available as an option.  Sensor life is short 
due to the constraints of using a heme solution which is sensitive to light, air and 
temperature.  It must be mixed immediately before use and be kept free from light and 
air.  The advantage of using this method over electrochemical cells stems from the fact 
that the output due to step responses in either direction does not change with respect to 
the size or direction of the step. 
 
In order to make this sensor into a commercially viable product methods to decrease 
response time, increase sensitivity, increase resolution, improve accuracy and increase 
sensor life by immobilization of the heme into a well-configured sol-gel matrix should be 
explored.  Details of the future of this work will be described in Chapter 11 along with an 
in-depth discussion of the course of experimentation in the design of this sensor. 
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9.7 Mathematical Modeling 
Mathematical modeling was used to determine the effect of sensor parameters, including 
pressure, heme concentration, path length, flow time and flow rate on the function of the 
instrument.  Thus, the models were used to provide guidance in improving sensor 
performance.  The model-generated data was compared to actual data to evaluate the 
performance of model.  If the model was deemed accurate in the sense that it adequately 
described system response, then they were used to estimate the expected sensitivity, 
minimum detectable limit and response time given certain system parameters.  The 
experiments for pressure, flow time and flow rate were conducted using a single 
concentration of 173 ppm NO. 
 
It was determined from earlier experiments that although the r2 value is good (>0.95) for 
a calibration curve generated with NO concentrations between 0 and 200 ppm NO, the 
sensitivity is in fact much higher for concentrations of NO below 25 ppm.  The 
mathematical modeling analysis was done on calibration curves generated with the entire 
concentration range.  It must be understood that if the same system was tested only with 
nitric oxide concentrations under 25 ppm, the sensitivities would be much higher.   
 
From modeling pressure variations at 173 ppm NO, it was found that values from actual 
experimentation corroborate the upward trend in absorbance as a function of pressure.  
When the expected absorbance is plotted as a function of actual absorbance, there is a 
strong linear correlation between the two, producing an r2 value of 0.9392, but there is a 
large difference in signal magnitude.  The discrepancy in the magnitude of the signal is 
probably due to inaccurate values for the permeability coefficient of the membrane to 
NO, the diffusion coefficient of NO in the heme and the solubility coefficient for NO in 
the heme.  In addition, it was assumed that it was largely a surface reaction, meaning that 
only the molecules of NO that touch the membrane will travel through the membrane and 
react with the heme.  Theoretical modeling was used to predict the direction of the 
change in signal due to a parameter change.  Theoretical information shows that the 
sensitivity increases as the pressure rises and the minimum detectable limit 
correspondingly decreases.  This is due to the increasing pressure acting to drive more 
molecules of NO into the sensing element, thereby increasing the absorbance and 
decreasing the minimum detectable limit.  Theoretically, the response time will decrease 
due to the molecules reaching their destination in less time.  There is a large discrepancy 
between the actual and expected in terms of the amount of time the reaction takes to 
reach equilibrium.  This is probably due to the fact that the diffusion coefficient for NO 
through the heme was taken from a value for myoglobin and not cytochrome-c and that 
the solubility was assumed to be one.  The shorter actual response time indicates that the 
solubility is probably not equal to one.  There will also be a point at which a higher 
pressure will produce other undesirable effects in the system such as pushing the liquid 
heme out of the sensing element.  This pressure was not found due to constraints in the 
physical design of the system.  The digital flow meter could not tolerate pressures above 
20 psi (137.90 kPa).  In a final design, the pressure should be set to a value that 
maximizes sensitivity without affecting the placement of the heme within the sensing 
element.  All conclusions are derived keeping in mind the assumptions outlined above, 
including the fact that the permeability coefficient is only an estimate. 
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The same situation is seen in the heme concentration data.  Sensitivity of 2.5 mg/ml is 
10.0% of the expected, at 5.0 mg/ml it is at 7.5% of the expected and at 10 mg/ml it is at 
8.6% of the expected.  The trends for actual and expected both show that the increase in 
heme concentration corresponds to an increase in sensitivity.  The correlation between 
expected and actual also increases as heme concentration increases.  When the expected 
absorbance is plotted as a function of actual absorbance, the r2 value increases as heme 
concentration increases.  For 2.5 mg/ml, the correlation is poor, r2 of 0.5488.  But for 5 
and 10 mg/ml, the correlation is quite good, r2 of 0.9750 and 0.9878 respectively.  In 
terms of the minimum detectable limit both actual and theoretical values show a decrease 
with increasing sensitivity and heme concentration as expected.  When heme 
concentration is increased, the reaction equilibrium is pushed to the right, increasing the 
number of NO molecules that will bind.  This increases the absorbance and decreases the 
minimum detectable limit, since the signal value is higher for the same NO concentration.  
Increasing the heme concentration should increase the time it takes for the reaction to 
occur because more molecules will bind and it will take longer for NO to diffuse to the 
heme molecules due to increased heme solution density, but there is also a compensatory 
increase in the rate of reaction since the reaction rate is dependent on the concentrations 
of the reacting species.  Thus, the increase in response time is not as large.  Finally, the 
increase in heme concentration reduces the amount of light reaching the detector for any 
given nitric oxide concentration.  This effectively decreases the S/N and adversely affects 
the resolution.  There will be a point at which the heme concentration is so high that the 
detector does not have enough light to produce an acceptable signal, thus decreasing 
resolution.  This was not a problem with the studied heme concentrations.  In conclusion, 
a heme concentration that maximizes signal and still allows enough light penetration to 
maintain a decent resolution is required. 
 
It is not possible to evaluate the influence of path length on the system in practice 
because the physical design of the system does not allow for varying path lengths.  
Theoretically, increasing path length marginally increases sensitivity (no significant 
change) and does not significantly decrease the minimum detectable limit as evidenced 
by Beer’s Law.  It will also serve to slightly increase the response time as it will take 
longer for the NO molecules to diffuse to the heme molecules.  Thus, there is a small 
tradeoff between sensitivity (and minimum detectable limit) and response time with 
respect to path length.  Increasing the path length also decreases the amount of light 
reaching the detector for any given NO concentration since absorbance increases.  Thus, 
the S/N ratio will decrease, decreasing system resolution. 
 
Flow time experiments were conducted to note the effect of flow time on the absorbance 
during the period of flow.  Measurements were taken during the flow period.  The graphs 
showing expected and actual absorbance vs. flow time at 173 ppm show that there is a 
general upward trend in the data, but the magnitude of the actual data is much lower than 
theoretically expected.  This could again be due to the assumed values for the 
permeability coefficient of the membrane to NO, and for the diffusion coefficient and the 
solubility coeffient of NO in the heme.  The correlation between expected and actual at 
173 ppm NO is good.  Graphing expected vs. actual produces a linear relationship with 
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an r2 of 0.9827.  The theoretical calibration curves show that sensitivity greatly increases 
with increasing flow time and there is a corresponding decrease in the minimum 
detectable limit.  The response time will obviously increase due to an increased flow time 
and slightly due to the increase in the number of NO molecules reacting. 
 
Flow rate effects on absorbance were minimal with respect to actual experimentation.  
The absorbance barely changed as a function of flow rate.  This might be due to the fact 
that permeation of NO through the membrane is the limiting factor and not flow rate.  
Since absorbance is barely changing as a function of flow rate it can be assumed that 
regardless of flow rate the same number of NO molecules will diffuse through the 
membrane since it is time dependent and probably slow.  In addition, although more 
molecules are passing over the heme, the faster rate leaves less time for the reaction to 
occur.  Thus, the effect of the increase in number of moles should be negated by a portion 
of the effect of having less time to react.  Theoretically, there is an increase in sensitivity 
with increasing flow rate with a corresponding decrease in minimum detectable limit and 
an increase in the response time due to more molecules being available to react, although 
the reaction rate will increase due to increasing concentration.  A graph of expected 
absorbance vs. actual absorbance again produces a nonlinear relationship, although there 
is an upward trend in both sets of data.  The nonlinearity might be due to the nonlinear 
nature of flow.  Increasing flow rate might change the dynamics of flow and the number 
of molecules reaching the heme as a percentage of flow. 
 
The discrepancy between actual and expected sensitivity can be attributed to a number of 
parameters.  As mentioned earlier, it is likely that the assumed values for the permeation 
coefficient of the membrane to nitric oxide, the diffusion coefficient for NO in the heme 
and the solubility of NO in the heme are possible culprits.  In practice, it has been noted 
that the reaction takes on the order of minutes to equilibrate and the depth of penetration 
into the heme solution is unknown.  Thus, the rate and level of reaction is limited by the 
diffusion of NO through the gas permeable membrane and into the sensing element.  The 
above discussion shows that a deviation (decrease) in the expected sensitivity is expected 
and is seen in the experimental data. 
 
In general, when pressure increases, more molecules of NO are driven through the 
membrane, the absorbance increases and the minimum detectable limit (mdl) decreases.  
The rate of reaction should also increase due to the increased pressure.  When the path 
length of the heme solution increases, the absorbance increases as evidenced by Beer’s 
Law.  Theoretically, the increase was very minimal.  In addition, the amount of light 
getting to the detector decreases and the S/N ratio decreases.  The response time will also 
increase because the depth of penetration has increased.  Flow time basically serves to 
present more molecules of NO to the heme solution over a longer period of time, 
although most molecules will flow through the chamber without ever being in contact 
with the membrane.  Thus, the benefit is minimal.  Flow rate increases essentially serves 
the same purpose.  It delivers more molecules of NO in the same amount of time, 
although even more molecules will flow through the chamber without being in contact 
with the membrane due to the increased flow rate.  Increases in heme concentration will 
increase the absorbance due to a shift in equilibrium.  Although, there is a corresponding 
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decrease in the S/N ratio due to less light reaching the detector.  The rate of reaction 
should increase due to the increased heme concentration, but more molecules of NO will 
react so there is a trade-off. 
 
The data shows that for all experiments the overall trends, or the direction of change, is 
similar to the expected trends.  Since the diffusion of nitric oxide into the heme solution 
after passage through the gas permeable membrane and outward flow of NO from the 
chamber are both limiting factors and were not modeled, deviations from the expected 
values are attributed to them.  
9.8 Summary 
Please refer to Figure 9.2 for a schematic representation of the course of experimentation.  
The goal of this project was to design and develop a novel sensor for the measurement of 
inhaled, or gaseous, nitric oxide in concentrations relevant to a clinical setting – see 
Figure 9.2.  Materials with the highest sensitivity to nitric oxide were identified and 
incorporated into a sensing element.  A system was built to sample the gas, react it with 
the sensing element and subsequently acquire, process, store and display the processed 
signal.  Equations were developed to relate sensor design features to sensor performance 
and evaluate the credibility of the sensor.  Finally, sensor testing was performed to 
evaluate sensitivity, specificity, response time, stability and accuracy and precision, 
completing the final phase of the research. 
 
Evaluation of sensing compounds showed that NO has varying affinity for hemoglobin 
and myoglobin in their Fe3+, Fe2+ and oxy forms and for cytochrome-c in its Fe3+ and 
Fe2+ forms.  Myoglobin and hemoglobin(Fe 2+) were extremely sensitive to oxygen and 
their oxy forms were not stable in room air, immediately converting to their respective 
met forms upon exposure.  The met forms of all hemes produced complexes with nitric 
oxide, cytochrome-c having the best sensitivity in the group.  Cytochrome-c(Fe2+) did 
not react with NO to produce a spectrophotometrically monitorable product in the region 
of interest.  Since cytochrome-c (Fe III) was determined to be the only compound that 
reacted with nitric oxide quickly and is not sensitive to varying oxygen concentrations, 
calculations were done to ensure adequate sensitivity for the current application.  It was 
found that the average minimum detectable limit was 2.51 µM (56.2 ppm) at 563 nm.  
This indicated that a large increase in sensitivity is needed to make measurements in the 
range of interest (5 to 20 ppm).  Thus, methods of increasing sensitivity through noise 
reduction, signal processing and physical sensor configuration were explored subsequent 
to examination of sensor configuration issues. 
 
Reversibility issues were then examined through photolysis techniques.  The Fe III forms 
of each heme were found to reversibly react with nitric oxide.  Cytochrome-c and 
myoglobin complexes completely dissociated within 120 seconds, hemoglobin took 180 
seconds.  The Fe II forms of myoglobin and hemoglobin reacted with NO to form an 
unstable complex which gave way to their respective met forms before complete 
photolysis was possible with the current optical configuration.  Because cytochrome-c 
(Fe II) does not react with NO, photolysis is not possible.  Oxymyoglobin and 
oxyhemoglobin’s reaction with NO to form metmyoglobin and methemoglobin cannot be 
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reversed photolytically since the end product is not a dissociable complex.  For the 
Fe(III) complexes, it was found that the lysed heme has the same NO-reacting properties 
as the original compound, but under conditions studied, the time course of the lysis 
reaction, 120 to 180 seconds, is too long for use in measuring breath-to-breath 
concentrations of NO.  This shows that photodissociation of ferric heme-NO complexes 
is possible, but slow under the given conditions.  There were two explored possibilities.  
First, it was assumed that the complex was being dissociated, but NO was re-reacting 
with the heme before a measurement could be taken.  Next, the possibility that the 
bandwidth and duration of the source light was not sufficient to promote rapid and 
complete dissociation of the complex was explored.  Thus, steps were taken to help 
displace the released nitric oxide and to optimize the optical configuration in order to 
reduce the time course of the photolytic reaction.  Experiments to improve the time-
course of the photodissociation were unsuccessful and alternate configurations including 
disposable solid-phase sensors and liquid flow-thru systems were explored. 
 
Experiments on casting the heme into a polymer to immobilize the sensing compound 
were both successful and unsuccessful.  It was found that although cytochrome-c could 
easily be cast into either films or gels, which retained their reactivity, reaction with 
gaseous nitric oxide was slow and the absorbance level was low even at high nitric oxide 
concentrations.  This was due to the fact that transport of NO through the polymer was a 
limiting factor and the reaction was largely a surface reaction.  Attempts to increase 
sensitivity through increasing the surface area available for reaction were not successful 
as it reduced light transmission through the sensing element and increased scattering.  
Siloxanes, hydrophobic immobilizing compounds, which are extremely gas permeable, 
could not be cast into an appropriate configuration and attempts to dissolve the heme into 
the siloxane failed.  It was determined that although PVA could be used to immobilize 
the heme while maintaining its reactivity, the time course of the reaction was too slow 
and the sensitivity was too low.  Efforts to increase the sensitivity did not produce 
favorable results; thus decreasing the response time was not examined.  Due to the 
limitations of an immobilized heme system and a reversible sensor, the final 
configuration was based on a thin-layer liquid flow-thru cell. 
 
The next phase of research involved optimizing sensor performance through physical 
design and sensor parameters.  Once the optimal physical design parameters were 
identified and implemented, other sensor parameters were evaluated to optimize sensor 
performance.  Findings are summarized in Table 9-2.  It was found that flow time could 
be increased until saturation, yielding an increased signal to noise ratio and a 
corresponding increase in response time.  Pressure could also be increased to increase 
S/N until a point is reached where the excess pressure pushed down on the membrane, 
displacing sensing fluid and decreasing path length.  Heme concentration could also be 
increased to increase the sensitivity of the system, but increasing heme concentration 
increases the cost of the system and decreases the total number of counts reaching the 
detector, thus decreasing the S/N.  Flow rates did not have a profound effect on the 
operation of the system.  In addition, the flow rate is limited to a percentage of total flow 
because the sample is taken from a ventilator circuit. 
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Table 9-2:  Summary of flow-thru sensor parameters 
 
Parameter Setting Notes 
Tubing height Level with sensing element To ensure fluid stagnancy during 
measurement 
Solenoid/Flowmeter 
placement 
Placed before sensing 
element 
Pressure elimination 
Injection/ejection system One-pump system In and out fluids remain equal 
Sensing element thickness 12.5 mm, 22.5 gauge needle Optimize S/N and response time 
Distance between I/O lenses 50 mm Physical design constraints 
Referencing procedure Once at beginning of each 
cycle 
Lowest system drift 
Post-injection equilibrium 
time 
25 sec Dependent on ID of tubing, orifice 
size, sensing element thickness and 
heme concentration 
Flow time 1 min Increases absorbance until saturation 
at 240 seconds 
Flow rate 200 cc/min Minor role in increasing absorbance 
or S/N 
Post-sample equilibrium 
time 
1 min Dependent on flow time, flow rate, 
pressure, heme concentration and 
tubing length 
Pressure 10 psi (68.95 kPa) Increasing pressure increased S/N 
until a level at which path length is 
lost 
Heme concentration 5 mg/ml Increased sensitivity, but not linearly.  
Will increase cost and reduce S/N 
 
Data collection and processing techniques were examined to maximize sensitivity 
without sacrificing response time.  It was found that the integration time should be 
increased to a point at which the detector receives the maximum number of counts, but 
does not saturate, while still leaving room for system changes such as heme concentration 
and light source fluctuations.  Averaging of singly acquired spectra was set at a point (5) 
where any increase in averaging did not produce a significant decrease in noise, but did 
increase system response time.  Filling the internal buffer with each acquisition did not 
provide any returns in terms of increasing S/N.  In terms of averaging around the 
wavelength of interest, increasing the number of points averaged not only decreased the 
minimum detectable limit, it decreased the sensitivity of the system and the r2 value.  It 
was necessary to choose a value which brought down the minimum detectable limit 
without overly sacrificing the sensitivity or the accuracy and precision.  A value of 5 kept 
the r2 value above 0.95 and the minimum detectable limit below 5 ppm.  Finally, absolute 
absorbance values were compared to difference spectra and peak integration was 
examined over single or double wavelength measurements.  It was found that neither 
method provided a linear relationship with NO concentration or any mathematical 
relationship.   
 
Mathematical modeling was used as a tool to optimize the system.  If the model is 
deemed to adequately describe sensor performance, then it can be used as a guide in 
improving sensor performance.  It was found that the actual overall trend in sensor output 
due to changes in parameters was corroborated by the theoretical model, but the 
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magnitude of the signal was markedly lower for the experimental results.  Thus, the data 
shows that for all experiments the overall trends, or the direction of change, are similar to 
the expected trends.  Discepancies in absorbance magnitude were found due to the 
inavailibility of a permeation coeffient for NO through the chosen membrane, of a 
diffusion coefficient for NO in cytochrome-c(Fe III) and of a solubility coefficient for 
NO in the heme.  Deviations from the expected values are attributed to these drawbacks. 
 
From system testing, it was found that the optimized system gave good results for data 
less than 25 ppm in terms of sensitivity, specificity, minimum detectable limit, resolution, 
specificity, stability and accuracy.  The response time was high, although methods of 
reduction were discussed.  For data above 25 ppm, the system had a different trend than 
the data below 25 ppm.  These results show that the current configuration is promising 
for clinical applications if a two-point piecewise calibration is conduction prior to 
operation of the device to accommodate the different trends for concentrations above and 
below 25 ppm.  Figure 9.2 provides an overview of the research elements showing the 
successes and failures of experimentation. 
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Sensitivity to NO  Specificity  Reversibility  Immobilization 
 
Cyt-c(Fe III)  → Cyt-c(Fe III)  → Cyt-c(Fe III)a  → Cyt-c(Fe III)b 
 
Cyt-c(Fe II) 
 
Mb(Fe III) 
 
Mb(Fe II)  → Mb(Fe II) 
 
MbO2 
 
Hb(Fe III) 
 
Hb(Fe II)  → Hb(Fe II) 
 
HbO2 
 
 
 
        Flow-through sensor designed 
 
        Data Processing 
 
        Testing 
 
        Modeling 
 
 
 
Figure 9.2.  Overall review of the research elements.  Arrows indicate that the element 
passed the test.  Abbreviations are as follows, Mb (myoglobin), Hb (hemoglobin), O2 refers 
to their respective oxy forms. 
 
a Time course for reverse reaction too long for this application 
b Time for reaction between solid phase element and NO too long for this 
application 
 Sensitivity of solid phase heme to NO not sufficient for this application 
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C H A P T E R  1 0  
10.  CONCLUSIONS 
The goal of this project was to design and develop a sensor to directly and continuously 
monitor concentrations of inhaled nitric oxide.  The sensor developed during the course of 
this project might be used to produce a commercially viable product, however, major 
modifications would be needed to improve upon specificity in the presence of NOx, 
sensitivity to encompass the entire concentration range of interest (0-80 ppm) and response 
time to allow for breath-to-breath measurements. 
10.1 Conclusions on Project Aims 
 
Aim I:  Selection of Nitric Oxide Sensitive Compounds 
Aim I was achieved.  This involved the identification of compounds whose optical 
properties change as a function of nitric oxide concentration.  Several chosen compounds 
were evaluated for sensitivity to NO and specificity for NO in the presence of oxygen.  
Experiments showed that cytochrome-c would deliver the specificity necessary for this 
application (in the presence of oxygen), but the sensitivity was not at an applicable level 
with the given configuration.  Thus, steps were taken to increase the sensitivity through 
physical sensor design and data processing techniques.  In terms of specificity, the major 
concern lies in that oxygen has an adverse effect on the operation of this sensor because it 
can react with NO to form NO2.  Initial specificity testing on the sensor showed that the 
reaction of cytochrome-c with NO was impervious to oxygen at higher cytochrome-c 
concentrations.  At lower concentrations of cytochrome-c, there was a marked decrease in 
sensitivity.  This is due to either O2 reacting with NO to form NO2 or to the shift in 
equilibrium due to lower cytochrome-c concentrations.  NO2 can decrease the signal level 
by decreasing the amount of NO available to the heme or by reacting with the heme itself.  
Currently, it is possible for NO to react with O2 as well as the heme, even though the heme-
NO reaction is orders of magnitude faster because the reaction is limited by the diffusion of 
NO into the liquid phase sensing element through a gas permeable membrane.  Increasing 
the heme concentration increases the rate of reaction between the heme and NO and 
decreases the likelihood that NO will react with O2 significantly prior to reacting with the 
heme.  It is also possible that cytochrome-c will react with NO2 and other oxides of 
nitrogen because of its configuration.  Thus, it might not be specific for NO in the presence 
of NOx. 
Since these experiments were conducted, the specificity of cytochrome-c’ for NO in the 
presence of oxygen and other oxides of nitrogen has been determined.  Thus, cytochrome-c' 
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will provide for selective detection of NO and not NOx.  Cytochrome-c’ is selective to NO 
over NO2 due to steric hindrance preventing NO2 from gaining access to the heme binding 
site.  Theoretically, if cytochrome-c’ is selective to NO in the presence of NOx and O2, then 
an accurate assessment of NO is possible.  In addition, the sensor should sample NO just as 
it is delivered to the body and the reaction should occur instantaneously such that NO does 
not react with O2, skewing the results due to a decreased amount of NO available. 
Subsequently the reversibility of the sensing compounds reaction with nitric oxide was 
determined to identify potential sensor configurations.  The optical configuration used to 
attempt photolysis was not efficient for the current application.  The heme was re-reacting 
with NO due to inadequate displacement of the lysed NO or incomplete lysis of the 
complex, although eventual dissociation was seen.  This eventual dissociation was due to 
the auto-dissociation of the complex, a slow process.  As mentioned earlier, the complex of 
the metheme will auto-reduce to a reduced complex (Fe2+-NO).  This will auto-dissociate 
to Fe2+ and NO.  The heme will then auto-oxidize to the met form if left out in ambient air.  
This process can be sped up by flow of a displacing gas (such as nitrogen) through the 
system.  Literature has also shown that the reaction is completely and immediately 
reversible if a displacement gas such as nitrogen is flowed through the system during 
photolysis.  Further research into the design and development of this sensor should include 
a thorough examination of methods to reverse the reaction and reuse the sensing element.  
If the final design encompasses the reversible and reusable technique, consideration should 
be made to bacterial accumulation within the sensing element.  Even though the unit 
samples gas from the ventilator circuit and is not an in-line device, there is a risk of 
infection due to bacterial accumulation.  A reusable sensing element would still have to be 
replaced in intervals of less than 24 hours to avoid risk of infection. 
Aim II:  Design and Develop a Nitric Oxide Sensor 
Aim II was achieved, though a suboptimal design was attained.  The design of the physical 
sensor involved many components.  First it was determined if the sensing compound could 
be immobilized in a polymer matrix to produce a solid phase sensor.  The examined 
immobilizing agents did not produce favorable results for a number of reasons.  The 
immobilization of the sensing compound rendered it inaccessible to NO, yielding a very 
slow surface reaction.  Attempts were made to modify the configuration to decrease 
response time and increase sensitivity.  Thin films were examined to decrease response 
time, but the sensitivity was low.  Stacking of thin films was explored, but signal was lost 
due to reflection of light at each surface.  Methods to increase surface area with patterning 
resulted in attenuation of signal due to scattering.  Since the completion of the phase of this 
research that deals with immobilization, a new method for the immobilization of biological 
compounds has surfaced: sol-gels (Aylott, 1997), (Lan, 1998), (Dave, 1997). 
Methods for encapsulating hemes with sol-gels have been developed such that the heme 
retains its integrity and reactivity throughout the curing process.  Just recently, sol-gel 
encapsulated hemes were started being examined as potential biosensors for monitoring in-
vivo gas concentrations and ex-vivo concentrations in the gas phase.  Sol-gels provide a 
unique environment for the immobilization of hemes in that they retain reactivity, are 
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optically clear in the wavelength region of interest, and can easily be molded into a variety 
of configurations.  A potential configuration would involve making a waveguide from the 
sol-gel encapsulated heme.  Thus, the gas sample would have a large surface area for 
reaction and the optical signal would be high due to a large path length.  It has also been 
shown that the reaction is reversible upon exposure to nitrogen flow, the rate of which 
could potentially be increased with a photolysis apparatus.  In addition, sol-gel 
encapsulated hemes retain reactivity on the shelf for up to one year, stored at room 
temperature under normal conditions.  During the development phase of this product, the 
capabilities of sol-gels and methodology for easy curing had not been elucidated.  Thus, a 
thin-film flow-thru liquid system, similar to that used for heme-gas reaction studies, was 
designed to achieve an acceptable response time and sensitivity. 
In the absence of an appropriate immobilizing agent, it was determined that a flow-through 
liquid phase system could be developed.  Liquid sensing environments present a number of 
problems in a practical or clinical setting.  The heme solution would have to be prepared 
just prior to use since dissolved hemes are susceptible to light, temperature and air.  In 
addition, the liquid phase causes problems on the manufacturing and user end.  All tubing 
must be kept level with the sensor, clean and free from contamination.  The device cannot 
be factory calibrated because the sensor is not supplied with the heme until the user is 
ready.  There is also a potential for more calibrations being necessary than for a solid phase 
system.  Methods for checking the integrity of the sensing element would have to be built 
in and the sensor will be susceptible to movement.  The required hardware has to be more 
sophisticated due to the necessity of constantly moving a liquid system.  Disposing of the 
sensing compound is also more difficult with a liquid than for a solid sensing element, as 
hemes are a bio-hazardous material.  Despite these limitations, liquid cell sensors are being 
used such as in hemoglobin gas reaction studies (Dolman, 1978).  They are not 
commercially available, but are feasible in the absence of other technologies. 
The sensor for this project was optimized under the constraints of the selected 
configuration, available budget, and areas of technical expertise.  If further research is done 
to enhance the capabilities of this system there are numerous options, which need to be 
explored.  It was found that the response time of the sensor was limited by diffusion of the 
gas into the heme solution and the thickness of the solution was limited by the 
physical/mechanical design of the system.  Manufacturing methods are available for 
making the heme layer thinner to allow faster diffusion of NO into the heme.  The decrease 
in path length can be compensated for by an increase in heme concentration and this should 
not overly affect cost since there is also a proportional decrease in volume with decreasing 
path length. 
The remainder of sensor design issues involved building the hardware/software elements 
around the sensing element.  These included: 1) designing the hardware necessary to 
implement the chosen physical sensor scheme;  2) designing the software drivers for all 
hardware components, ensure timely sensor operation, collect and process signals, as well 
as store, display and process data;  3) designing – developing the required signal processing 
routines, including sample averaging and integration, to maximize sensitivity without 
sacrificing response time; and,  4) optimizing SNR through signal filtering and time-based 
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averaging methods.  Efforts should be made to hardwire the tubing and minimize tubing 
length to increase stability.  In addition, an active injection pump system should be 
implemented in place of the rotary motor to decrease the amount of time it takes to deliver 
the heme to the solution and equilibrate the system post injection. 
Methods for increasing sensitivity include increasing system pressure and heme 
concentration and looking at different wavelength regions or different methods to relate 
NO concentration to the optical signal.  Pressure increases were limited to that allowed by 
the flow meter on one end and high pressure displacement of the sensing fluid on the other.  
Pressures as high as 275.80 kPa (40 psi) were tested without the inline flowmeter and there 
was no noticeable decrease in signal or pathlength due to constriction of the fluid level.  In 
a practical system, the flowmeter should not be necessary and pressure constraints due to 
the flowmeter would not exist.  The system could be pressurized to drive the NO into the 
heme solution, decreasing response time and increasing sensitivity.  Heme concentration 
increases also increase sensitivity, but this approach was not utilized due to cost constraints. 
The design of this system was also limited by the available optical configuration.  It is 
known that the absorbance of hemes is an order of magnitude higher in the soret region 
than in the α and β regions of the visible spectrum.  The optical spectrograph card used for 
this application did not allow for proper resolution of the bands in the soret region.  Better 
sensitivity might be afforded if peak shift or difference spectral measurements were 
recorded in the soret region.  A recently published paper on the reaction of sol-gel 
encapsulation hemes with gaseous NO (Aylott, 1997) describes monitoring in this region 
and the absorbance change was approximately one order of magnitude higher than that 
achieved by our configuration.  In addition, the current optical configuration, without 
regard to the chosen wavelengths, could be improved upon.  Currently the light source is 
delivering light to the sensing compound that is placed just anterior to the detector.  The 
optical system should have the sensing element in the center of the chamber to optimize the 
amount of light reaching the sample and the detector.  Implementing this design would 
have been much harder and much more expensive and it was out of the scope of this 
project. 
Remaining optimization possibilities fall on software and data processing techniques.  The 
software package (LabVIEW) used for this system is state of the art and improvements, if 
necessary, would be minimal.  A final system would incorporate a single LED and a 
detector and not an entire spectrometer system which would most likely provide a stronger 
optical signal at the wavelength of interest.  The output of the photodetector would be 
converted to a voltage and processed to give optical information, which would then be used 
to determine a NO concentration from previously stored calibration data.  The final value 
would be stored and displayed for the end user. 
Aim III:  Development of Mathematical Model and Calibration Procedures 
Aim III was achieved but it did not accurately describe the system.  In this phase of 
research the mathematical/physical/computer models that relate NO sensitivity to factors 
that are controlled by instrument design were developed.  In addition, calibration methods 
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to relate the measured optical properties of the sensing compound to the acquired signal 
were developed.  Mathematical modeling was used as a tool to improve sensor 
performance.  It was deemed that the model accurately described the direction of change 
that sensor output would take based on a change in sensor parameters, but did not 
accurately describe the magnitude of the output.  Thus, the model can be used to determine 
which direction the parameters need to be changed to improve sensor performance, but not 
to determine the magnitude of the parameter in question for optimization.  The models 
were used to determine expected sensitivity, minimum detectable limit and response time 
and compare these values to one obtained from actual experiments.  In general, when 
pressure increases, more molecules of NO are driven through the membrane, the 
absorbance increases and the minimum detectable limit (mdl) decreases.  The rate of 
reaction should also increase due to the increased pressure.  When the path length of the 
heme solution increases, the absorbance increases as evidenced by Beer’s Law.  However, 
the amount of light getting to the detector decreases and the S/N ratio decreases.  In 
addition, the response time will increase because the depth of penetration has increased.  
Flow time basically serves to present more molecules of NO to the heme solution over a 
longer period of time, although most molecules will flow through the chamber without ever 
being in contact with the membrane.  Thus, the benefit is minimal.  Flow rate increases 
essentially serves the same purpose.  It delivers more molecules of NO in the same amount 
of time, although even more molecules will flow through the chamber without being in 
contact with the membrane due to the increased flow rate.  Increases in heme concentration 
will increase the absorbance due to a shift in equilibrium.  Although, there is a 
corresponding decrease in the S/N ratio due to less light reaching the detector.  The rate of 
reaction should increase due to the increased heme concentration, but more molecules of 
NO will react so there is a trade-off. 
The data shows that for all experiments the overall trends, or the direction of change, is 
similar to the expected trends.  The r2 value, relating the expected values to the actual 
values, was good for all parameters, indicating that there is a good correlation between 
expected and actual values.  The magnitude of the actual data did deviate from expected 
values, in general being lower than expected.  This was attributed to the assumed values for 
the permeability coefficient of the membrane to NO, for the diffusion coefficient of NO in 
the heme and for the solubility of NO in the heme.  It is also possible that the assumption 
that only the NO molecules which are in direct contact with the membrane during the 
period of flow will react with the heme by passing through the membrane is not correct.  It 
may be more than just a surface reaction.  Although the actual values were not indicative of 
theory for the reasons outlined above, the modeling did provide information on which 
direction a parameter change would affect system response.   
In the course of examining sensor design issues in relation to creating a product that meets 
the required specifications, a number of other issues need to be examined.  A major 
concern in the design of any product is reproducibility.  It must be possible to manufacture 
the sensing element to within a certain specification to discount any error in measurement 
due to manufacturing procedures.  The variability in heme concentration and the uniformity 
of the sensing element will change the signal level and the response time.  Thus, the device 
must be delivered with specifications to account for manufacturing variability and 
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calibration procedures must be devised to account for variability in the sensing element due 
to manufacturing processes and changes in the sensor integrity over time. 
The ideal device would be designed such that calibration procedures are not necessary 
because the measurement is independent of manufacturing differences and degradation of 
the sensing element over time.  In real life, calibration procedures are always necessary.  
The question always lies in the method and how often.  The ideal system would allow for a 
one-time factory calibration of the sensing element.  Because heme solutions are 
susceptible to temperature, light, humidity and air, an on-site calibration is necessary 
subsequent to preparation of the heme solution.  The calibration procedure must be 
automatic and user friendly.  Currently, the device must be two-point calibrated prior to 
each 8 hour period to account for variations in the prepared liquid sensing element. 
Aim IV:  System Testing 
Aim IV was achieved.  The final requirements for this project fell to system testing 
sensitivity to nitric oxide, specificity for NO in the presence of oxygen, response time, 
stability of the sensor over an 8 hour period and accuracy and precision.  System testing 
provided extremely interesting results and yielded pertinent information for the 
determination of the future of this project.  Tested system specifications included 
sensitivity, minimum detectable limit, resolution, accuracy, specificity, stability and 
response time for both the normal and the optimized system.  The optimized system was 
created to test a best-case scenario for the sensor configuration being tested under the 
constraints of available hardware/software.  Thus, this system was also a compromise from 
an ideal system.  It was not used for extensive testing because of safety and budget 
concerns.  In addition, the results should be interpreted with caution since the data set was 
smaller (n=2) than for the normal system (n=8) and not adequate.  It was found that with 
the optimized system (cytochrome-c concentration of 10 mg/ml, 137.90 kPa (20 psi), and a 
post-gas flow equilibration time of 15 seconds), data less than 25 ppm yielded a sensitivity 
of 2 x 10-4  Abs/ppm with a minimum detectable limit less than 1.5 ppm and a resolution of 
0.5 ppm.  In addition, the system was fairly specific to nitric oxide in the presence of 
oxygen.  The normal system yielded a sensitivity of 5 x 10-5 Abs/ppm with a minimum 
detectable limit of 7 ppm and a resolution of 1.8 ppm.  In addition, the system was 
insufficiently specific in the presence of oxygen.  Stability experiments showed that the 
current configuration was stable over the course of eight hours and was accurate to within 1 
ppm for data under 25 ppm with the optimized system.  Finally, the response time was 
shown to be 2 minutes 35 seconds for the normal system versus 1 minute 50 seconds for 
the optimized system. 
10.2 Conclusions on main hypotheses 
In accordance with the development of the specific aims, several hypotheses were 
established.  Each will be discussed in terms of the completed research project. 
1. A nitric oxide sensitive compound, which for the clinically relevant concentration 
range provides a spectrophotometrically monitorable reaction in the visible 
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region of the spectrum, exists and can be identified. 
A nitric oxide sensitive compound which provides a spectrophotometrically monitorable 
reaction in the visible region of the spectrum was identified as cytochrome-c.  This 
compound did not have sufficient specificity or sensitivity.  The specificity issue lies in the 
possibility of a reaction between cytochrome-c and other oxides of nitrogen since it is 
possible that oxygen will react with NO before NO reacts with cytochrome-c.  As 
mentioned, a cytochrome-c analog, cytochrome-c’ is specific to NO in the presence of 
other oxides of nitrogen and is readily available.  In terms of sensitivity, increasing it to a 
point where the entire concentration range of interest could be monitored might be possible 
with some alterations in the given configuration through pressure and path length/heme 
concentration changes.  Therefore, hypothesis#1 was proven to be true, although its results 
were not used in the developed NO sensor prototype. 
2. The chosen compound can be incorporated into a sensing element and still retain 
its reactivity. 
A configuration which allowed cytochrome-c to be incorporated into a physical sensor 
design and still retain its reactivity was determined to be a flow-thru liquid cell sensor.  The 
chosen configuration allowed a spectrophotometrically monitorable reaction between 
cytochrome-c and NO in the visible region of the spectrum.  Therefore, hypothesis#2 was 
proven, although it provided a suboptimal sensor. 
3. The chosen sensing compound can be incorporated into a sensing element in a 
configuration that delivers the clinically required and acceptable sensor 
specifications.  
As previously noted, the given configuration needs to be optimized to improve upon 
specificity, sensitivity and response time.  The specificity issue might be solvable by 
replacement of cytochrome-c with a related derivative, cytochrome-c’ which is specific to 
NO in the presence of NOx.  The sensitivity issue needs to be tackled via path length/heme 
concentration changes and pressure increases.  Finally, the response time needs to be 
brought down through optimization of hardware/software components and reduction of 
path length to reduce response time.  Therefore, hypothesis#3 was not proven, but our work 
pointed towards methods that would help proving it. 
4. A unique and constant, sensitive and specific mathematical relationship can be 
found between nitric oxide concentration and the spectrophotometrically 
measured signal of the sensing element. 
 
A strong mathematical relationship was found between cytochrome-c and NO.  With the 
given sensor configuration a linear relationship between cytochrome-c and NO was 
determined.  A two-point calibration would be necessary in a clinical setting prior to each 
operation of the device over an 8 hour period of time.  Therefore, hypothesis#4 was proven. 
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10.3 Summary 
The ideal sensor for this project would have a sensitivity of 0.01 Abs/ppm, a minimum 
detectable limit 0.1 ppm, complete specificity in the presence of oxygen, anesthetic gasses 
and other oxides of nitrogen, a response time of less than three seconds, stability over 8 
hours, accuracy within 5% and a resolution of 0.025 ppm.  With the steps outlined above, it 
seems that achieving the goals of this project seem fairly realistic, with the exception of 
response time.  With a liquid environment, the specifications of the sensor are limited by 
the diffusion of the gas sample through the gas-permeable membrane and into the depth of 
the heme solution.  In addition, because of the problems of using a liquid sensor outlined 
above, the future of this plan should focus on an immobilized reversible scheme, as 
discussed above. 
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C h a p t e r  1 1  
11. FUTURE DIRECTIONS 
 
One possible path for continuation of this project would be to concentrate on quantitative 
improvements of the developed system regarding optimization and manufacturability 
issues.  A well-rounded research plan would include studying the efficacy of using 
cytochrome-c’ as the sensing compound and evaluating the outlined sensor parameters.  
A new device should encompass all changes mentioned in the chapter on the discussion 
of results.  A decreased path length would result in a faster sensor with lower sensitivity, 
but the heme concentration can be increased to compensate for this.  The pressure should 
be increased to increase the rate of reaction and the sensitivity by shifting the equilibrium 
to the right.  A pump injection system should also be implemented to decrease the heme 
delivery time and the post heme injection equilibration period.  All tubing should be 
shortened and hardwired to minimize variation of parameters (noise) and system drift. 
 
Another path for continuation of this project would be to investigate the possibilities for 
qualitative improvements.  This would include creating a reversible sensor with 
immobilized heme sol-gel technology.  The current sol-gel configuration involves the 
encapsulation of the heme into a thin-film sensor (Aylott, 1999).  This limits the surface 
area available for reaction.  An improvement would be achieved if the proposed sensor 
would incorporate a sol-gel encapsulated heme into a wave-guide configuration.  This 
configuration would dramatically increase the surface area available for reaction while 
increasing the path length for the optical measurement.  In addition, sol-gel encapsulated 
hemes are stable and reactive for up to one year post manufacturing.  Cytochrome-c’ 
would be the sensing compound of choice since it is specific to NO in the presence of 
oxygen and other oxides of nitrogen.  In addition, its reaction is photo-reversible.  There 
are a number of issues that need to be explored in a preliminary feasibility study to 
determine potential sensor characteristics as compared to ideal sensor specifications 
outlined in Table 11-1. 
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Table 11-1:  Ideal sensor specifications 
 
Parameter Specification 
Sensitivity 0.01 ppm 
Specificity In the presence of oxygen, oxides of nitrogen and 
anesthetic gasses 
Response time Less than 3 seconds 
Resolution 0.025 ppm 
Reversibility Photo-reversed and reusable 
Response range Clinical and research applications 0-100 ppm 
Linearity Between 0 and 100 ppm 
Life One year 
Stability Worst case:  calibration necessary every 8 hours 
Accuracy ±5% 
Calibration 2 point linear 
11.1  Proposal of a Research Plan for a Future Study 
The advantages of using an optical system, based on a colorimetric film, to measure 
inhaled NO concentrations include low cost, compact size and fast response time relative 
to existing technologies.  The sensing mechanism should be based on a selective 
complexation of a chromophoric compound with NO, which results in a color change in 
the visible region of the spectrum.  The sensing element should be developed as a 
disposable item that would be easily replaceable for each treatment session.  The 
hardware and monitoring system should be simple (if possible without moving 
mechanical parts) and inexpensive to operate.  The final hardware should consist of two 
silicon photodiode detectors, and two LEDs or laser diodes that emit at peak and 
minimum response wavelength bands of the chromophoric compound-NO complex.  A 
simple microprocessor could convert the detector signal into the NO concentration in 
ppm, and output to a digital display.  Patient data could be stored if needed.   The entire 
unit should be portable and battery powered to avoid power source issues for patient 
monitoring. 
 
The first step would be to characterize cytochrome-c’ for sensitivity to NO; specificity in 
the presence of oxygen, other oxides of nitrogen and anesthetic agents; and reversibility.  
In addition, appropriate wavelengths for measurement should be explored, including the 
band in the soret region and both the blue and green bands in the visible region.  The next 
step would be to incorporate NO sensing compounds into a sol-gel matrix.  The 
encapsulated heme should again be evaluated for sensitivity and reversibility.  A major 
component of incorporation into a solid phase is the determination of a configuration, 
which allows a fast reaction while still providing sensitivity.  Solid thin films should be 
examined in addition to a waveguide apparatus.  This configuration should allow 
maximum surface area, the reaction to occur quickly, while providing a large pathlength 
for the optical measurement.  The sensing compound, film matrix, and sensing probe 
geometry should be optimized and a dedicated electro-optic detection system should be 
constructed to measure optical transmission through the sensing film element.  The 
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electro-optic detection system should consist of two LED or laser diode light sources 
with fiber-optic beam delivery, and two Si photodiode detectors, with associated 
miniaturized signal processing electronics.  One detector should measure light 
transmitted through the polymer film sensing element and the second detector should 
serve as a reference to measure and normalize for the light source intensity variations.  
The sensing element and electro-optic board detection system should also be integrated to 
create a reliable, stable, compact, and low maintenance sensor system.  Finally, the 
response of the sensor should be evaluated by determining its sensitivity, specificity, 
response time and stability, and optimized to meet the required performance parameters.  
Sensor response to NO should be evaluated by monitoring the change in absorbance in 
the sensor film at a wavelength band sensitive to NO complexation, relative to a second 
wavelength band which is unaffected by NO.  The sensor should be characterized over a 
concentration range of 1-100 ppm NO.  Interference from oxygen and anesthetic gases 
such as isofluorane and nitrous oxide should also be evaluated.  The response time of the 
sensor to step changes in NO concentration within the 1 - 100 ppm range, should be 
determined.  And finally, the sensor should be aged to determine its lifetime. 
 
In summary, the goal of this project was to design and develop a sensor for the direct and 
continuous measurement of inhaled nitric oxide.  Limitations in the implemented design 
were discovered, but methods were discussed to both improve upon the existing design or 
to take a new approach to the same problem with sol-gel immobilization techniques.  To 
this date, there are no commercially available devices to accurately and continuously 
make the measurement of interest in a cost-effective manner.  Thus, the driving force 
behind this project still exists if the resources to continue the project can be found. 
 
 172
 173
REFERENCE LIST 
1. Addison AW, Stephanos JJ. Nitrosyliron(III) Hemoglobin:  autoreduction and 
spectroscopy.  Biochemistry 1986; 25:4104-4113. 
2. Al-sharma, Sunny. Nitric Oxide Scavengers.  Calbiochem Technical Service, 
1996. 
3. Anggard E. Nitric Oxide:  Mediator, murderer, and medicine.  Lancet 1994; 
343:1199-1206. 
4. Archer S. Measurement of nitric oxide in biological models.  FASEB 1993; 
7:349-360. 
5. Ascenzi, Paolo, Colleta, Massimo, Desideri, Alessandro, Petruzzelli, Raffaele, 
Polizio, Francesca, Bolognesi, Martino, Condo, Saverio G., and Giardina, Bruno. 
Spectroscopic properties of the nitric oxide derivative of ferrous man, horse and 
ruminant hemoglobins:  A comparitive study. Journal of Inorganic Biochemistry 
1992; 45, 31-37. 
6. Ascenzi, Paolo, Colleta, Massimo, Santucci, Roberto, Polizio, Francesca, and 
Desideri, Alessandro. Nitric oxide binding to ferrous native horse heart 
cytochrome-c and to its carboxymethylated derivative:  A spectroscopic and 
thermodynamic study. Journal of Inorganic Biochemistry 1994; 53:273-280. 
7. Aylott, B, Richardson, D, and Russell. Optical biosensing of gaseous nitric oxide 
using spin-coated sol-gel thin films. Chemistry of Materials 1999; 9:2261-2263. 
8. Barker S, Kopelman R.  Fiber-optic nitric oxide-selective biosensors and 
nanosensors.  Analytical Chemistry 1998; 70(5):971-976.  
9. Bazylinski DA, Hollocher TC. Metmyoglobin and Methemoglobin as Efficient 
Traps for Nitrosyl Hydride (Nitroxyl) in Neutral Aqueous Solution.  Journal of 
the American Chemical Society, 1985; 107:7982-7986. 
10. Blaise G. Editorial:  Endothelium derived relaxing factor/nitric oxide.  Canadian 
Journal of Anaesthesia 1992; 39:765-769. 
11. Bonaventura C, Bonaventura J, Antonini E, Brunori M, Wyman J. Carbon 
Monoxide Binding by Simple Heme Proteins under Photodissociating Conditions.  
Biochemistry 1973; 12:3424-3428. 
12. Bull, C., Fisher, R. G., and Hoffman, B. M. Manganese Hemoglobin:  Allosteric 
effects in redox and ligation equilibria. Biochemical and Biophysical Research 
Communications 1974; 59(1), 140-145. 
 174
13. Chien, James C. W. Reactions of Nitric Oxide with Methemoglobin. Journal of 
the American Chemical Society 91(8), 2166-2168. 
14. Chung KE, Lan EH, Davidson MS, Dunn BS, Valentine JS, Zink JI. 
Measurement of Dissolved Oxygen in Water Using Glass-Encapsulated 
Myoglobin.  Analytical Chemistry 1995; 67:1505-1509. 
15. Cornelius PA, Hochstrasser RM, Steele AW. Ultrafast relaxation in picosecond 
photolysis of nitrosylhemoglobin.  Journal of Molecular Biology 1983; 163:119-
128. 
16. Dave Bc, Dunn BS, Valentine JS, Zink JI. Sol-Gel Encapsulation Methods for 
Biosensors.  Analytical Chemistry 1994; 66:1120a-1127a. 
17. Davies, M. L., Hamilton, C. J., Murphy, S. M., and Tighe, B. J. Review:  Polymer 
membranes in clinical sensor applications. Biomaterials 13(14), 971-999. 1992. 
18. DeMaster, Eugene G., Quast, Barry L., Redfern, Beth, and Nagasawa, Herbert T. 
Reaction of nitric oxide with the free sulfhydryl group of human serum albumin 
yieldsd a sulfenic acid and nitrous oxide. Biochemistry 34, 11494-11499. 1995.  
19. DiFeo, Thomas J., Addison, Anthony W., and Stephanos, Joseph J. Kinetic and 
Spectroscopic Studies of Haemoglobin and Myoglobin from Urechis Caupo. The 
Biochemical Journal 269, 737-747. 1990. 
20. Dolman D, Gill SJ. Membrane covered thin layer optical cell for gas reaction 
studies of hemoglobin.  Analytical Biochemistry 1978; 87:127-135. 
21. Doyle, Michael P. and Hoekstra, James W. Oxidation of Nitrogen Oxides by 
Bound Dioxygen in Hemoproteins. Journal of Inorganic Biochemistry 14, 351-
358. 1981.  
22. Dunn, Bruce S., Valentine, Joan S., Oaks, Sherman, Ellerby, Lisa, Nishida, 
Fumito, Nishida, Clinton, and Yamanaks, Stacey A.  Sol-Gel Encapsulation 
Enzyme. Patent # 5,200,334, 1993. CA, USA. 
23. Epstein, Randi Hutter. The new miracle drug may be - smog? Business Week , 
108-109. 1994.  
24. Etches PC, Harris M, McKinley R, Finer NN. Clinical Monitoring of Inhaled 
Nitric Oxide:  comparison of chemiluminescent and electrochemical sensors.  
Biomedical Instrumentation and Technology 1995; 29:134-140. 
25. Etches PC, Harris ML, McKinley R, Finer NN. Clinical monitoring of inhaled 
nitric oxide:  comparison of chemiluminescent and electrochemical sensors.  
Biomedical Instrumentation and Technology 1995; 29:134-140. 
 175
26. Feldman PL, Griffith OW, Stuehr DJ. The Surprising Life of Nitric Oxide.  
C&EN 1993; 26-37. 
27. Foubert L, Fleming B, Latimer R, et al. Safety guidelines for use of nitric oxide.  
The Lancet 1992; 339:1615-1616. 
28. Frawley G, Tibballs J. Monitoring Nitric Oxide: a comparison of three monitors 
in a paediatric ventilator circuit.  Anaesthia Intensive Care 1997; 25:138-141. 
29. Giardina B, Amiconi G. Measurement of binding of gaseous and nongaseous 
ligands to hemoglobins by conventional spectrophotometric procedures.  Methods 
in Enzymology 1981; 76:417-439. 
30. Gibaldi M. What is Nitric Oxide and why are so many people studying it?  
Journal of Clinical Pharmacology 1993; 33:488-496. 
31. Gillespie, Humphreys, Bair, Robinson. Chemistry. Boston: Allyn and Bacon, 
Inc., 1986; 501-518. 
32. Gorren, A. C. F., de Boer, E., and Wever, R. The reaction of nitric oxide with 
copper proteins and the photodissociation of copper-NO complexes. Biochimica 
et Biophysica Acta 916, 38-47. 1987.  
33. Gorren, A. C. F., Van Gelder, B. F., and Wever, R. Photodissociation of 
Cytochrome-c Oxidase-NO Complexes. Annals of the New York Academy of 
Sciences 550, 139-149. 1988.  
34. Grubb WR, Putensen C, Thrush DN, Rasanen J. Can Nitric Oxide Be 
Administered Accurately With A Semiclosed Anesthesia Circuit.  ASA Abstracts 
1994; 81:A573-A573. 
35. Haire RN, Tisel WA, White JG, Rosenberg A. On the precepitation of proteins by 
polymers:  the hemoglobin-polyethylene glycol system.  Biopolymers 1984; 
23:2761-2779. 
36. Harris DC. Quantitative Chemical Analysis. New York: W. H. Freeman and 
Company, 1987; 501-502. 
37. Harvery, Steven B. and Nelsestuen, Gary L. Reaction of nitric oxide and its 
derivatives with sulfites:  a possible role in sulfite toxicity. Biochimica et 
Biophysica Acta 1267, 41-44. 1995.  
38. Higenbottam, Tim. Editorial:  Inhaled nitric oxide:  a magic bullet? Quarterly 
Journal of Medicine 86, 555-558. 1993.  
39. Hishinuma Y, Kaji R, Akimoto H, et al. Reversible Binding of NO to Fe(II)edta.  
Bulletin of the Chemical Society of Japan 1979; 52:2863-2865. 
 176
40. Ichijo H, Ichimura K, Uedaira H, et al. Immobilization of Bioactive Substances 
with PVA Supports.  Polymer Gels 1991; 135-146. 
41. Ignarro LJ. Endothelium-derived nitric oxide:  actions and properties.  FASEB 
1989; 3:31-36. 
42. Ignarro LJ. Nitric oxide-mediated vasorelaxation.  Thrombosis and Haemostasis 
1993; 70:148-151. 
43. Kavanagh BP, Pearl RG. International Anesthesiology Clinics:  New Drugs in 
Anesthesia. Boston: Little, Brown and Company, 1995; 181-211. 
44. Koshland DE. Molecule of the Year:  NO News is Good News.  Science 1992; 
258:1861-1865. 
45. Kucera I. Analytical aspects of complex formation between cytochrome-c and 
nitric oxide.  Biologia 1990; 45:333-339. 
46. Lan, Esther H., Davidson, Michael S., Ellerby, Lisa, Dunn, Bruce S., Valentine, 
Joan S., and Zink, Jeffrey I. Heme Proteins encapsulated in sol-gel derived silica 
glasses and their reaction with ligands.  Biomolecular Materials by Design 1990; 
330:289-294. 
47. Lancaster J. A tutorial on the diffusibility and reactivity of free nitric oxide.  
Nitric Oxide 1997; 1:18-30. 
48. Lapennas GN, Colacino JM, Bonaventura J. Thin-layer methods for 
determination of  oxygen binding curvs of hemoglobin solutions and blood.  
Methods in Enzymology 1981; 76:449-471. 
49. Lebovits A. Permeability of polymers to gasses, vapors, and liquids.  Plastics 
1966; 139-213. 
50. Malinski T., Taha Z.  Nitric oxide release from a single cell measured in situ by a 
porphyrinic-based microsensor.  Nature 1992; 358:676-678. 
51. Markings, Lewis R. and Tsien, Roger Y. Communication:  Caged Nitric Oxide:  
Stable Organic Molecules from which Nitric Oxide can be Photoreleased. The 
Journal of Biological Chemistry 269(9), 6282-6285. 1994.  
52. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Inhaled NO.  Archives of  
Disease in Childhood 1994; F47-F49 
53. Modlin DN, Milanivich FP. Fiber Optic Chemical Sensors and Biosensors. CRC 
Press, 1996; 237-302. 
54. Murphy, Michael E. and Noack, Eike. Nitric Oxide Assay Using Hemoglobin 
Method. Methods in Enzymology 233, 240-250. 1994.  
 177
55. Nicholls D. Nitric Oxide Complexes of Iron,  Boston: Little, Brown and 
Company, 1997; 41-45. 
56. Noack, Eike, Kubitzek, D., and Kojda, G. Spectrophotometric Determination of 
Nitric Oxide Using Hemoglobin. Neuroprotocols: A Companion to Methods in 
Neurosciences 1(2), 133-139. 1992.  
57. Parikh, Bhairavi R., Soller, Babs R., and Rencus, Tal. Reversibility of Heme - 
Nitric Oxide Reactions for use in an Inhaled Nitric Oxide Sensor.  Proc SPIE, 
2976:360-367, 1997. 
58. Parikh, Bhairavi R. and Soller, Babs R. The design and development of a sensor 
for the direct and continuous measurement of inhaled nitric oxide:  Factors 
affecting sensitivity.  Proc SPIE, 3253:47-55, 1998.  
59. Pearl, Ronald G. Inhaled Nitric Oxide:  The Past, the Present and the Future. 
Anesthesiology 78(3), 413-416. 1993.  
60. Petric, J. W., Lambary, J. C., Kuczera, K., Karplus, M., Poyart, C., and Martin, J. 
L. Ligand Binding and Protein Relaxation in Heme Proteins:  A Room 
Temperature Analysis of NO Geminate Recombination. Biochemistry 30, 3975-
3987. 1991. 
61. Petros AJ, Cox P, Bohn D. Simple method for monitoring concentration of 
inhaled ntiric oxide.  The Lancet 1992; 340:1167-1167. 
62. Petros AJ, Cox P, Bohn D. A simple method for monitoring the concentration of 
inhaled nitric oxide.  Anesthesia 1994; 49:317-319. 
63. Reif, David W. and Simmons, Roy D. Communication:  Nitric Oxide Mediates 
Iron Release from Ferritin. Archives of Biochemistry and Biophysics 283(2), 537-
541. 1990.  
64. Rimar S, Gillis CN. Selective Pulmonary Vasodilation by Inhaled Nitric Oxide is 
Due to Hemoglobin Inactivation.  Circulation 1993; 88:2884-2887. 
65. Saffran WA, Gibson QH. Photodissociation of ligands from heme and heme 
proteins.  The Journal of Biological Chemistry 1977; 252:7955-7958. 
66. Sawicki CA, Morris RJ. Flash Photolysis of Hemoglobin.  Methods in 
Enzymology 1981; 76:667-681. 
67. Sellers, Vera M., Johnson, Michael K., and Dailey, Harry A. Function of the 
[2Fe-2S] Cluster in Mammalian Ferrochelatase:  A Possible Role as a Nitric 
Oxide Sensor. Biochemistry 35, 2699-2704. 1996. 
 178
68. Sharma, Vijay and Ranney, Helen M. The dissociation of NO from 
nitrosylhemoglobin. The Journal of Biological Chemistry 253(18), 6467-6472. 
1978. 
69. Sharma, Vijay, Traylor, T. G., and Gardiner, Robert. Reaction of Nitric Oxide 
with Heme Proteins and Model Compunds of Hemoglobin. Biochemistry 26, 
3837-3843. 1987.  
70. Sharpe M, Cooper C. Reactions of nitric oxide with mitrochondrial cytochrome c:  
a novel mechanism for the formation of nitroxyl anion and peroxynitrite.  Journal 
of Biological Chemistry 1998; 332:9-19. 
71. Shibuki K. An electrochemical microprobe for detecting nitric oxide release in 
brain tissue.  Neuroscience Research 1990; 9:69-76. 
72. Singh, Ravinder Jit, Hogg, Neil, and Kalyanaraman, B. Interaction of nitric oxide 
with photoexcited rose bengal:  evidence for one electron reduction of nitric oxide 
to nitroxyl anion. Archives of Biochemistry and Biophysics 324(2), 367-373. 
1995.  
73. Soller, Babs R., Parikh, Bhairavi R., and Stahl, Russell F. Sensor Materials for an 
intravascular fiber-optic nitric oxide sensor. Lieberman, Robert A., Podbielska, 
Halina, and Vo-Dinh, Tuan. 2676, 198-204. 1996. San Jose, CA, SPIE. 
Biomedical Sensing, Imaging, and Tracking Technologies I.  
74. Sono, Masanori. Spectroscopic and Equilibrium Properties of the Indoleamine 
2,3-Dioxygenase-Tryptophan-O2 Ternary Complex and of Analogous Enzyme 
Derivatives.  Tryptophan Binding to Ferrous Enzyme Adducts with Dioxygen, 
Nitric Oxide, and Carbon Monoxide. Biochemistry 25, 6089-6097. 1986.  
75. Stone, James R. and Marletta, Michael A. Spectral and kinetic studies on the 
activation of soluble guanylate cyclase by nitric oxide. Biochemistry 35(4), 1093-
1099. 1996.  
76. Strauss JM, Krohn S, Sumpelmann R, Schroder D, Barnert R. Evaluation of two 
electrochemical monitors for the measurement of inhaled nitric oxide.  
Anaesthesia 1996; 51:151-154. 
77. Tamura, Mamoru, Kobayashi, Kazuo, and Hayashi, Koichiro. Flash photolysis 
studies on nitric-oxde-ferrihemoprotein complexes. FEBS Letters 88(1), 124-126. 
1978.  
78. Tibballs J, Hochmann M, Carter B, Osborne A. Equipment and Techniques:  An 
Appraisal of Techniques for Administration of Gaseous Nitric Oxide.  Anaesthia 
in Intensive Care 1993; 844-847. 
79. Tissue, Brian M. Charge-coupled devices (CCD):  Encyclopedia of Analytical 
Instrumentation, 1998.  
 179
80. Toothill, C. The Chemistry of the In-Vivo Reaction Between Haemoglobin and 
VArious Oxides of Nitrogen. British Journal of Anaesthesia 39, 405-412. 1967. 
81. Tsai, Ah-lim. How does NO activate hemeproteins? FEBS Letters 341, 141-145. 
1994.  
82. Vanderkooi, James M., Wright, Wayne W., and Erecinska, Maria. Nitric oxide 
diffusion coefficients in solution, proteins and membranes determined by 
phosphorescence. Biochimica et Biophysica Acta 1207, 249-254. 1994.  
 
83. Vaska L, Nakai H. Reversible Addition of Nitric Oxide to a Solid Ferric 
Porphinato Complex.  Thermodynamics of Formation and Characteriation of a 
Peculiar NO Adduct.  Journal of the American Chemical Society. 1973; 95:5431-
5432. 
84. Walda, Kevin N., Liu, X. Y., Sharma, Vijay, and Magde, Douglas. Geminate 
Recombination of Diatomic Ligands Co, O2 and NO with Myoglobin. 
Biochemistry 33, 2198-2209. 1994.  
85. Waterman MR. Spectral Characterization of Hemoglobin and its Derivatives.  
Methods in Enzymology 1978; 52:456-463. 
86. Watson, JT.  Introduction to Mass Spectrometry, 3rd edition.  New York.  
Lippincott Williams & Wilkins Publishers, 1997. 
87. Wayland BB, Olson LW. Low Spin Nitric Oxide Complexes of Manganese 
Tetraphenylporphyrin.  Inorganica Chimica Acta 1974; 11:L23-L24 
88. Wayland BB, Olson LW, Siddiqui ZU. Nitric Oxide Compelxes of Manganese 
and Chromium Tetraphenylporphyrin.  J.Am.Chem.Soc. 1976; 98:94-98. 
89. Wessel DL, Adatia I, Thompason JE, Hickey PR. Delivery and monitoring of 
Inhaled Nitric Oxide in Patients with Pulmonary Hypertension.  Critical Care 
Medicine 1994; 22:938 
90. Xu W, Yao SJ, Wolfson SK. A Nitric Oxide Sensor Using Reduction Current.  
ASAIO Journal 1995; 41:M413-M418 
91. Yoshimura T, Suzuki S, Iwasaki H, Takakuwa S. Spectral Properties of Nitric 
Oxide Complex of Cytochrome c from Rhodopseudomonas Capsulata B100.  
Biochemical and Biophysical Research Communications 1987; 145:868-875. 
92. Yoshitisugu, Shiro, Fujii, Motoyasu, Iizuka, Tetsutaro, Adachi, Shin-ichi, 
Tsukamoto, Koki, Nakahara, Kazuhiko, and Shoun, Hirofumi. Spectroscopic and 
kinetic studies on reaction of cytochrome p450nor with nitric oxide. The Journal 
of Biological Chemistry 270(4), 1617-1623. 1995. 
 180
93. Young JD, Dyar OJ. Delivery and monitoring of inhaled nitric oxide.  Intensive 
Care in Medicine 1996; 22:77-86. 
94. Zapol WM, Hurford WE. Inhaled Nitric Oxide in the Adult Respiratory Distress 
Syndrome and Other Lung Diseases.  New Horizons 1993; 1:638-650. 
95. Zhou, Xiangji and Arnold, Mark A. Response Characteristics and Mathematical 
Modeling for a Nitric Oxide Fiber Optic Chemical Sensor. Analytical Chemistry. 
1996 
96. Zhu, Leyun, Sage, Timothy, and Champion, Paul M. Observation of Coherent 
Reaction Dynamics in Heme Proteins. Science 266, 629-632. 1994. 
97. Zhujun Z, Seitz RW. Optical Sensor for Oxygen Based on Immobilized 
Hemoglobin.  Analytical Chemistry 1986; 58:220-222. 
 
